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ABSTRACT 
THE EFFECT OF AN EDUCATIONAL INTERVENTION IN WOMEN WITH  
GESTATIONAL DIABETES: A PILOT STUDY 
by 
JANEEN S.  AMASON 
 
Women with gestational diabetes (GD) are at higher risk of developing type 2 
diabetes (DM) after delivery compared to those without GD.  Numerous studies in the 
general population have identified that adoption of healthy lifestyles can prevent DM; 
however limited research has focused on women with GD.  The purpose of this 
randomized pilot study was to determine the effectiveness of an educational intervention 
of SUGAR (Start Understanding Gestational Diabetes and Risk of Type 2 Diabetes), on 
women‘s perceived risk of developing DM, knowledge of DM, self-efficacy to adopt 
healthy lifestyle behaviors and adoption of healthy lifestyle behaviors after childbirth 
among women with GD.  
   A total of 23 women (mean age of 29.7 +3.9), 18 in SUGAR group and 5 in 
control group (CG) completed self-reported standardized questionnaires (Risk Perception 
Survey for Developing Diabetes adapted for women with GD; Self-Rated Abilities for 
Health Practices; Health Promotion Lifestyle Profile II; General Sleep Disturbance Scale; 
and Demographic Questionnaire) at baseline (third trimester) and post-test (postpartum 6-
8 weeks).  Intervention was given post the baseline data collection with a booster session 
at 2-4 weeks postpartum.  The women in CG received attention control treatment.   
Study participants were obese (BMI M=33.1, SD=7.7) and a majority had a 
family history of DM.  Findings showed that self-efficacy was the single significant 
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predictor and accounted for 22% of the variance of healthy lifestyle behaviors.  
Participants had a clinical significant sleep disturbance during both pregnancy and 
postpartum.  At baseline, poor sleepers reported a lower self-efficacy.  The intervention 
significantly increased DM knowledge for women in the SUGAR group; however, not 
for perceived risk, self-efficacy nor healthy lifestyle behaviors.  There was no difference 
between groups for postpartum glucose screening rates with only 39% receiving 
recommended testing.  
Future research needs to focus on prevention programs and center on self-
efficacy, postpartum glucose screening, improve sleep, and adoption of healthy lifestyle 
behaviors. To ensure a better preventive care for GD women, education provided for both 
patients and health care provider is needed.
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CHAPTER I 
INTRODUCTION 
  Gestational Diabetes (GD) has been recognized as a complication of pregnancy 
that will resolve after childbirth, but recent research has identified that this diagnosis may 
signify a lifetime of health issues (Baptiste-Roberts et al., 2009; Bellamy, Casas, 
Hingorani, & Williams, 2009; Feig, Zinman, Wang, & Hux, 2008; Lee, Hiscock, Wein, 
Walker, & Permezel, 2007; Lee, Jang, Park, Metzger, & Cho, 2008; Reece, Leguizamon, 
& Wiznitzer, 2009).  Women with GD are at risk of developing type 2 diabetes (DM) 
after delivery, but many women have the misconception that the health threat ends with 
delivery of the neonate.  Numerous research studies in the general population have 
identified that adoption of healthy lifestyles (e.g. healthy diet, exercise, weight loss) can 
prevent DM; however there is limited research which focuses on healthy lifestyle 
behaviors in women with GD.  Comprehensive educational interventions would have 
significant clinical relevance in assisting women with GD to improve their healthy 
lifestyle behaviors during the postpartum period, thus impacting their own long term 
health and the health of their future children.  The purpose of this pilot study was to 
evaluate the effectiveness of an educational intervention in women with GD to increase 
their perceived risk of DM, knowledge of DM, self-efficacy to adopt healthy lifestyle 
behaviors, and adoption of healthy lifestyle behaviors after childbirth.  This chapter will 
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describe the background and significance of this study, an overview of the Health Belief 
Model (Rosenstock, 1974; Rosenstock, Stretcher, & Becker, 1988), the purpose of the 
study, and research questions for the study. 
Background and Significance 
  GD is the most common medical disorder of pregnancy and affects approximately 
4%-10% of pregnant women in the United States each year (ADA, 2010; AHRQ, 2009; 
Pridjian & Benjamin, 2010).  Women with a history of GD have a 35-60% chance of 
developing type 2 diabetes (DM) (CDC, 2011) and are 3.5 times more likely to develop 
DM than individuals in the general population (Lee et al., 2008) with most of these 
women developing the disease within ten years of the diagnosis of GD (Feig et al., 2008; 
Lee et al., 2008; Kapustin, 2008).  According to the CDC (2011), five to ten percent of 
women with GD are diagnosed with DM immediately after pregnancy during the 
postpartum period.  However, less than 25% of women with GD are screened for DM 
postpartum (Almario et al., 2008; Kim et al., 2006), thus missing an opportunity to 
prevent or delay the development of DM.  Baker, Brody, Salisbury, Schectman, & 
Hartmann (2009) found that a failure to screen patients was primarily associated with 
inconsistent screening guidelines and failure of patient‘s adherence to follow-up visits to 
obtain blood glucose screening.  Women with GD need to be informed of risk and 
preventative strategies, so they can be actively engaged in their own health decisions to 
prevent DM. 
GD is defined as a form of diabetes which begins or is first recognized during 
pregnancy, occurring due to pancreatic beta cells inability to produce sufficient insulin 
for increased demands during the third trimester of pregnancy (ADA, 2008; AHRQ, 
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2009; Pridjian & Benjamin, 2010).  In the second and third trimesters, an increase in 
pregnancy hormones including progesterone, estrogen, cortisol, and human placental 
lactogen cause a resistance to insulin allowing more free glucose to be available for the 
growth and development of the fetus (Schneiderman, 2010).  In a healthy pregnant 
woman, the insulin resistance is increased by 40%-70% and the excess glucose is usually 
tolerated, but if a woman has an underlying impaired pancreatic beta-cell function, an 
insufficient secretion of insulin will lead to hyperglycemia (Ben-Haroush, Yogev, & Hod, 
2003; Ciani, Ghio, Resi & Volpe, 2010; Pridjian & Benjamin, 2010).  The prevalence of 
GD has more than doubled since 1990 (Gethun, Nath, Ananth, Chavez, & Smulian, 2008) 
and may be associated with high maternal age at pregnancy, obesity, sedentary lifestyle, 
multiple pregnancies, and polycystic ovarian syndrome (Kim et al., 2010; Soheilykkah et 
al., 2010).  Recent research has also identified that insufficient sleep is associated with 
glucose intolerance, thus increasing risk for GD (Qiu, Enquobahrie, Frederick, Abetew, 
& Williams, 2010). 
In the United States, approximately 10.8% (12.6 million) of women who are aged 
20 years or older have been diagnosed with DM, with higher rates identified in minority 
groups including Hispanics, non-Hispanic Blacks, and Asian Americans (CDC, 2011).  
Similarly, GD is more frequent in women who are African American, Asian, Hispanic, or 
Native American (Ferrara, 2007; Reece et al., 2009; Schneiderman, 2010).  The World 
Health Organization (WHO, 2010) predicts that if no action is taken, the deaths 
associated with DM will double by the year 2030, shortening an individual‘s life 
expectancy by one-third (CDC, 2008).  The most common complications of DM include 
cardiovascular disease, kidney failure, neuropathy, and retinopathy (CDC, 2008; NIH, 
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2008; WHO, 2010) and is the seventh leading cause of death in the United States (CDC, 
2011).  Obesity, sedentary lifestyles, sleep disturbance, and stress have been associated 
with the development of DM (Chaput, Despres, Bouchard, & Tremblay, 2007; 
Gunderson et al., 2008; Knutson & Cauter, 2008).  Early prevention strategies, such as 
weight loss, increase of physical activity, and healthy diet, will decrease the incidence of 
DM and the associated complications in populations at risk for developing DM (CDC, 
2011; Knowler et al., 2002; NIH, 2008), therefore specific populations, such as women 
with a history of GD, should institute health behavior strategies to prevent or delay DM. 
Standard Care for GD 
Universal screening using a two-step screening and diagnosis approach of GD is 
the common practice among obstetricians (Pridjian & Benjamin, 2010).  Early screening 
performed at the first prenatal visit is recommended if women are at high risk for GD 
(e.g. history of GD, advanced maternal age, obese, history of polycystic ovarian 
syndrome (PCOS), at-risk ethnic group, and insulin therapy in previous pregnancy).  If 
not diagnosed at this screening, she will be rescreened during traditional testing at 24-28 
weeks gestation (Bottalico, 2007; Serlin & Lash, 2009).  All pregnant women (unless 
previously diagnosed with type 1 or type 2 diabetes) are screened for GD between 24-28 
weeks gestation using a one hour 50g glucose challenge test (GCT) for initial screening.  
If results are abnormal (>140mg/dl), then step two of the process is performed using a 
three-hour 100g glucose tolerance test (OGTT).  A diagnosis of GD is made if two or 
more values meet or exceed the standard criteria (fasting=105mg/dl, one hour 190mg/dl, 
two hours 165mg/dl, three hour 145mg/dl) (Pridjian & Benjamin, 2010; Reece et al., 
2009; Serlin & Lash, 2009; Theodoraki & Baldeweg, 2008).   
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Once GD is diagnosed, management of the disorder is focused on glycemic 
control (glucose levels between 60-90mg/dl) with initiation of medical nutritional 
therapy, exercise, and glucose monitoring (Pridjian & Benjamin, 2010).  Diet 
management is individualized according to weight, height and caloric needs for 
pregnancy and counseled by a registered dietician when possible.  A common diet 
therapy of 1900-2400kcal/day with prescribed restrictions of carbohydrates (35-40% of 
calories) is recommended.  In addition, if there are no contraindications for exercise, 
women with GD should engage in moderate exercise at least three times a week (e.g. 
walk 1-2 miles per day) to achieve glycemic control (Metzger et al., 2007; Pridjian & 
Benjamin, 2010; Theodoraki & Baldeweg, 2008).  
If pharmacological management is warranted, the use of oral hypoglycemic 
agents (such as Metformin or Glyburide) or insulin therapy will be instituted if initial diet 
and exercise fail to achieve glycemic control (Deshpande, 2010; Pridjian & Benjamin, 
2010; Theodoraki & Baldeweg, 2008).  To determine fetal well-being, weekly non-stress 
testing (NST) will begin at 32 weeks gestation for women using insulin therapy and at 36 
weeks for other therapies such as medical nutritional management (Schneiderman, 2010).  
If no complications occur, delivery by 40 weeks is recommended due to greater incidence 
of shoulder dystocia associated with macrosomia in delivery after 40 weeks gestation 
(Pridjian & Benjamin, 2010).  During the immediate postpartum period, GD women 
should have fasting or random glucose testing to identify persistent impaired glucose 
tolerance (Pridjian & Benjamin, 2010). 
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Preventative Care of DM in Women with GD 
In the identification of women with GD as an at risk group for developing DM, 
the American Diabetes Association (ADA) and the American College of Obstetricians 
and Gynecologists (ACOG) have instituted guidelines for women with previous GD for 
postpartum blood glucose screening and counseling for adoption of healthy lifestyle 
behaviors (ACOG, 2009; ADA, 2010).  Blood glucose screening is recommended 6-12 
weeks postpartum with a fasting blood glucose or two hour oral glucose tolerance test 
(OGTT).  If the results are normal, the professional societies recommend that screening is 
performed every three years, but if results are abnormal, the blood glucose screening 
should be performed annually.  The position statement on postpartum glucose screening 
from the ADA and ACOG also suggests the women maintain a healthy diet of reduced fat 
and adequate fiber as well as a modest weight loss if BMI is > 25.  Recommendations of 
moderate physical activity (150 minutes per week) and resistance training are also 
important in prevention of DM (ACOG, 2009; ADA, 2010; Jones, Roche, & Appel, 
2009).  The recommendation of implementation of healthy lifestyle behaviors is 
supported through research identifying engagement of the behaviors significantly reduces 
the risk of developing DM (Knowler et al., 2002; Tuomilehto et al., 2001).  The National 
Diabetes Education Program (2010) has also developed a Gestational Diabetes 
Prevention Initiative which focuses on information for the patient and health care 
provider.  The recommendations include educating that GD is a lifelong risk of DM, 
prevention strategies of DM including weight loss, nutrition, and physical activity, and 
glucose screening 6-12 weeks postpartum and every 1-2 years, therefore the health care 
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provider (including registered nurses) has an important role of preventative care for DM 
in women with GD.  
Impact of GD to Maternal and Infant Health 
Many women have the misconception that GD only affects them during 
pregnancy, and that once the baby is delivered the complication is no longer a health 
threat (Kapustin, 2008; Kim, McEwen, Kerr et al., 2007); in fact long term consequences 
of obesity and risk of DM are significant (Reece, 2010).  There are strong evidences 
demonstrating that health promotion behavior such as weight loss, exercise, and healthy 
diet will decrease the risk of developing DM (England et al., 2009; Knowler et al., 2002; 
Tuomilehto et al., 2001).  In addition, lifestyle modification (e.g. weight loss, healthy 
diet, and exercise), follow up physician appointments, and postpartum glucose screening 
are essential for early diagnosis and prevention of DM in women with GD (ACOG, 2009; 
Baker et al., 2009).   
Women with GD and their offspring are at risk for short term and long term 
consequences of the disease (Reece, 2010).  Complications associated with GD for the 
mother include an increased risk of prolonged labor, postpartum hemorrhage, 
polyhydraminos, and infection (Schneiderman, 2010).  Cesarean section rates are high in 
women with GD due to cephlopelvic disproportion and macrosomia (Desphande, 2010; 
Holmes, Lo, McIntire, & Casey, 2010; Schneiderman, 2010), leading to potential 
postpartum complications associated with a surgical procedure.  The fetus is exposed to 
high levels of glucose; forcing the production of large amounts of insulin leading to a 
macrosomic newborn with a birth weight greater then 4000gm (Deshpande, 2010; 
Metzger et al., 2008; Reece et al., 2009).  The newborn has an increased risk of shoulder 
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dystocia, birth injury, or death during a vaginal delivery (Metzger et al., 2008; Reece, 
2010).  Other associated complications to the newborn include hypoglycemia, respiratory 
distress syndrome, hyperbilirubinemia, and an increased need for advanced medical care 
in the neonatal intensive care unit (Metzger et al., 2008; Reece et al., 2009; 
Schneiderman, 2010).  The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) 
study identified that four primary outcomes of intrauterine hyperglycemia (macrosomia, 
cesarean delivery, neonatal hypoglycemia, and neonatal hyperinsulinemia) were 
significantly higher in women with higher maternal glucose levels (e.g. fasting > 
100mg/dl) (Metzger et al., 2008).  This epidemiology study in nine countries gives strong 
support to debate the importance of glucose control during pregnancy and possible 
redefining thresholds for diagnosis of GD (Yogev, Metzger, & Hod, 2009).  The HAPO 
study has led to recent diagnostic criteria change for diagnosis of GD (ADA, 2011; CDC, 
2011). 
Long-term health consequences of intrauterine hyperglycemia have been well 
established identifying that children of women with GD have a predisposition of obesity, 
metabolic syndrome and DM (Clausen et al., 2008; Damm, 2009; Deshpande, 2010; 
Reece et al., 2009; Reece, 2010).  In a follow-up study (Clausen et al., 2008) to determine 
glucose tolerance in 597 adults (primarily Caucasian) aged 18-27 years who were 
offspring of women with GD or type 1 diabetes, determined that approximately 20%  of 
the children with a mother who had GD had DM/pre-diabetes.  In comparison to the 
general population, the GD offspring had an eight fold increase risk of diabetes and/or 
pre-diabetes (Clausen et al., 2008); therefore identifying that glucose control during 
pregnancy is essential for the health of children born by a mother with GD. 
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Significance of the Research 
Although healthy lifestyle behaviors (e.g. healthy diet, exercise, and weight loss) 
are strongly associated with prevention of DM, the incidence rate of DM continues to 
increase due to unhealthy eating habits, obesity, and sedentary lifestyles.  Over three 
million people diagnosed in 2010 (CDC, 2011), resulting in a major health concern in the 
United States.  Similarly, the rate of GD continues to escalate and is comparable to the 
current national trends of obesity and DM, thus leading to poor maternal and fetal 
outcomes of pregnancy and lifelong health complications associated with impairment of 
glucose tolerance.  Research of prevention strategies focusing on weight loss, adoption of 
healthy diet, and exercise has been well established in the general population to prevent 
DM (Knowler et al., 2002; Tuomilehto et al., 2001).  However, limited studies have 
focused on women with GD and whether interventions to promote healthy lifestyle 
behaviors are appropriate for women of childbearing age.  Therefore, women with GD 
are identified as an at-risk group of developing DM and would benefit from established 
DM prevention strategies to avoid long-term health complications. 
Current treatment practices have focused on management of glucose intolerance 
throughout the pregnancy for positive maternal and fetal outcomes, but management has 
been lacking after childbirth to prevent or delay the development of DM in childbearing 
women.  Many women with a diagnosis of GD are unaware of future risk of DM, while 
others simply do not engage in healthy lifestyle behaviors after delivery.  If women with 
GD convert to DM, they may have lifelong health consequences including cardiovascular 
disease, kidney failure, neuropathy, and retinopathy (CDC, 2008; NIH, 2008; WHO, 
2010).  A recurrence rate of GD of up to 70% (Bottalico, 2007) identifies that women 
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with a history of GD are at risk in subsequent pregnancies for insulin intolerance, 
therefore,  prevention of DM is not only important for their own health, but also for the 
health of children in future pregnancies.  High rates of congenital anomalies are 
associated with uncontrolled hyperglycemia during pregnancy (Kitzmiller, Dang-Kilduff, 
& Taslimi, 2007; Ross, 2006; Zeck & McIntyre, 2008), thus control of glucose levels 
prior to conception is essential to prevent the anomalies.  Offspring are also at higher risk 
of developing obesity and DM in their lifetime after intrauterine exposure to high levels 
of glucose (Clausen et al., 2008; Damm, 2009; Deshpande, 2010; Reece et al., 2009; 
Reece, 2010).  
Healthy People 2020 (U.S. Department of Health and Human Services, 2010) 
have included objectives for Americans centering on promotion of health and avoidance 
of preventable chronic diseases such as DM.  The agenda encourages prevention 
activities, the guidance of individuals to make informed health decisions, and 
collaborative efforts for health.  In conjunction with these objectives, focusing on an at 
risk population for DM and implementing innovative strategies to prevent this chronic 
disease incorporates the goals of Healthy People 2020 for health and healthy behaviors in 
women with GD.  
The diagnosis of GD is an opportunity to engage women in performing healthy 
lifestyle behaviors after childbirth to prevent DM, but little is known of appropriate 
strategies to encourage healthy lifestyle behaviors for women with multiple 
roles/responsibilities.  After childbirth, women have additional responsibilities with 
caring for a newborn which often leads to fatigue and time constraints interfering with 
health promoting activities.  Therefore, research is needed to determine appropriate 
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strategies to meet the unique needs of a woman with GD to influence her decisions to 
adopt healthy lifestyle behaviors to prevent DM after childbirth.  The research testing an 
intervention that educates and motivates women will validate an effective strategy to 
assist women with GD adopt healthy lifestyle behaviors after childbirth by addressing 
specific influences of her decision making process to engage in health promotion.  In 
clinical practice these strategies, adapted specifically for the needs of women with GD, 
can assist health care providers incorporate DM preventative care into standard care 
practices for this at risk population postpartum.  This adaptation to standard care practices 
would follow recommended DM guidelines from the ADA and ACOG which encourages 
counseling of healthy lifestyle behaviors and glucose screening for women diagnosed 
with GD (ACOG, 2009; ADA, 2010).  
Theoretical Framework of the Health Belief Model 
The Health Belief Model (HBM) is one of the most widely used theories in the 
field to examine the barriers and foundation of a person‘s participation in programs 
which focus on prevention of disease and promotion of healthy lifestyle (NCI, 2005).  In 
studies of women‘s health issues, this framework has been used primarily to address 
breast cancer screening (Janz & Becker, 1984; Lee-Lin et al., 2007; Wu, West, Chen, & 
Hergert, 2006).  The HBM has been used to explain and predict participation in long term 
and short term health behaviors including smoking cessation (Schofield, Kerr, & Tolson, 
2007), condom use (Macintyre, Rutenberg, Brown, & Karim, 2004; Sayles et al., 2006; 
Zak-Place & Stern, 2004), exercise (Fallon, Wilcox, & Ainsworth, 2005; Schwarzer et 
al., 2007) and breast cancer screening (Janz & Becker, 1984; Lee-Lin et al., 2007; Wu et 
al.,  2006), but has limited use in women with GD (Jones et al., 2009).  The application of 
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the HBM is a useful tool to examine commonalities that influence people to adhere to 
health promotion activities.   
The HBM (see Figure 1) is organized into three categories which include 
individual perceptions, modifying behaviors, and likelihood of action to show 
relationships of the concepts to an individual‘s motivation to participate in a health action 
or behavior.  All of the concepts of the model influence a person‘s decision making about 
whether or not she will engage in prevention, screening, and measures to control for an 
illness (Family Health International, 2002; NCI, 2005; Rosenstock, Strecher, & Becker, 
1988).  To meet the investigator‘s goals, original concepts of the HBM of perceived 
seriousness and perceived benefits are omitted from this study due to limited literature 
support of these variables as strong predictors of health behavior.
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Figure 1.  Adapted Health Belief Model for Study in Self-Care of Women with   
                 Gestational Diabetes to Prevent Type 2 Diabetes (Rosenstock, 1974) 
 
Individual Perceptions    Modifying Factors   Likelihood of Action 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Theoretical Assumptions 
The premise of the model is that an individual‘s health behavior is based on their 
beliefs or perceptions about a disease and prevention of the illness by available strategies.  
The core assumptions of the HBM is based on the thought that a person will adopt a 
health behavior to avoid disease if the individual believes that he/she is susceptible to a 
disease, believes the consequence of the disease would be serious, believes that the 
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or > 9 hours) 
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to Adopt Healthy 
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Action (Adoption of 
Healthy Lifestyle 
Behaviors) 
Cues to Action 
SUGAR Intervention 
Self-Efficacy to Adopt Healthy 
Lifestyle Behaviors 
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disease occurrence can be avoided, believes the benefit of taking action to reduce a health 
threat exceeds any associated cost, and believes that he/she can effectively implement the 
recommended health behavior (Janz & Becker, 1984; Rosenstock, 1974; Rosenstock et 
al., 1988).  The behavior depends also on the value of the goal and the probability that an 
action will be successful in achieving the goal (Janz & Becker, 1984).  
Conceptual Definition of Terms 
  Perceived Susceptibility (Risk) is a person‘s belief (perception) of her chance of 
developing DM which influences the adoption of health behaviors to prevent DM.  The 
assumption is the greater the sense of susceptibility, the greater the possibility that a 
person will engage in behaviors which will decrease their risk for a disease (Rosenstock, 
1974).    
Perceived Barriers are the person‘s perception of the ―cost‖ of implementing the 
healthy lifestyle behaviors.  The woman will determine the possible negative 
consequences of adopting healthy lifestyle changes and any obstacles (physical, 
psychological, and financial demands) that may interfere with instituting the lifestyle 
behavior change (Maiman & Becker, 1974; NCI, 2005; Rosenstock, 1974).  The 
assumption for this study is that a woman with GD with less perceived barriers will more 
likely engage in healthy lifestyle behaviors to prevent DM.   
  Cues to Action addresses the influences of an individuals‘ environment on the 
adoption of healthy lifestyle behaviors to prevent the development of DM.  Rosenstock 
(1974) believed that some type of ―trigger‖ was essential in the decision-making process.  
The cues make the individual aware of his/her own feelings about a problem, thus 
assisting in the readiness to make a change or adopt a health action (Janz & Becker, 
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1984; Rosenstock, 1974).  Education from health care providers influence the adoption of 
healthy lifestyle behaviors, therefore the individual is more likely to engage in the 
behavior if she receives counseling of behavior. 
Self-Efficacy is a person‘s belief or confidence in their own ability to adopt 
healthy lifestyle behaviors to prevent the development of DM (Rosenstock et al., 1988).  
The woman with GD will initiate and maintain behavioral change if she feels competent 
and confident that she can institute those changes.  
Modifying factors which include demographic variables (use of insulin during  
pregnancy, BMI>25 before pregnancy, sleep duration) and structural variables 
(knowledge of diabetes, family history of type 2 diabetes) affect a person‘s perceptions 
about the health threat and perceived barriers of health actions that prevent disease 
(Roden, 2004; Rosenstock, 1974).  A GD woman‘s individual characteristics have an 
influence on her perceptions, thus influence her adoption of healthy lifestyle behaviors to 
prevent the development of DM after childbirth.  For example, a woman with a greater 
knowledge of DM will have a higher perceived risk of developing DM, thus impacting 
behavioral change. 
Use of Health Belief Model to Guide Study 
Although, the HBM framework has been used in numerous studies associated 
with adoption of healthy behaviors, limited studies have focused on the adoption of 
health behaviors in women with GD (Jones et al., 2009).  To meet the investigator‘s 
goals, the Health Belief Model was selected as an appropriate model and adapted by this 
author to guide the study in self-care for women with GD to prevent DM after childbirth. 
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The Health Belief Model was selected to guide the design of this pilot study 
because of its focus on the health beliefs and attitudes of individuals and the effect on 
health behaviors.  This model has been viewed as one of the most influential in relation to 
health promotion, has strong empirical support, and has been evaluated thoroughly for 
use in a variety of health behavior studies (Roden, 2004).  In relation to this model, 
women with a history of GD who perceive themselves at risk for developing DM will 
more likely advocate to be screened for the disease and implement healthy behaviors to 
decrease their risk for developing DM.  Studies have demonstrated that women with a 
history of GD often do not perceive themselves at risk for developing DM (Jones et al., 
2009; Kim, McEwen, Piette et al., 2007; Malcolm, Lawson, Gaboury, & Keely, 2009).  
This framework was useful to guide the development of interventions designed to 
increase knowledge about GD and long term risks of DM, recommended follow up 
glucose screening postpartum, and healthy lifestyle strategies to prevent or delay the 
development of DM.  According to the Health Belief Model, the women with a higher 
perceived threat and higher self-efficacy to adopt healthy behaviors are more likely to 
engage in positive health behavior.  Interventions can also be implemented to increase 
women‘s perceived susceptibility of DM and self-efficacy to adopt healthy lifestyle 
behaviors.  Specific barriers can be identified which hinder adoption of behaviors and 
lead to development of essential resources which assist the woman with GD to adopt 
healthy lifestyle behaviors.  Also, demographic and structural variables have an influence 
on perceived risk of the woman.  Research has indicated that women with a family 
history of diabetes, who are obese, have impaired sleep, and who use insulin during 
pregnancy are more likely to develop DM after GD.  According to the HBM, these types 
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of variables will influence the perception of risk of developing DM in a woman with a 
history of GD.  The goal is for women with GD to adopt healthy lifestyle behaviors (e.g. 
weight loss, healthy diet, and exercise) to prevent the development of DM and obtain 
blood glucose screening as indicated, therefore identification of these influences is 
important to develop effective intervention strategies.  The development of an 
educational intervention based on known influences of behavior will be beneficial in 
helping women with GD adopt healthy behaviors to prevent DM. 
Statement of Purpose 
Current treatment practices have focused on management of glucose intolerance 
throughout the pregnancy for positive maternal and fetal outcomes, but little attention has 
been given to management after childbirth to prevent or delay the development of DM in 
childbearing women.  Although general population studies have demonstrated the 
benefits of healthy lifestyle behaviors (weight loss, healthy diet, exercise) for prevention 
of DM, there is insufficient evidence that interventions have been used to assist women 
with GD adopt healthy lifestyle behaviors after childbirth.  The development of a 
comprehensive educational intervention would have significant clinical relevance in 
assisting women with GD improve their healthy lifestyle behaviors postpartum, thus 
impacting their long term health and the health of future children.  Therefore, the purpose 
of this pre-test, post-test, two group study was to determine the effectiveness of SUGAR 
(Start Understanding Gestational Diabetes and Risk of Type 2 Diabetes), an educational 
intervention designed to enhance women‘s perceived susceptibility (risk) of developing 
DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors (e.g. weight 
loss, healthy diet, and exercise) and adoption of healthy lifestyle behaviors after 
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childbirth among women with GD.  The HBM was selected as a guide for the pilot study 
because this framework assist health care providers to understand perception of 
susceptibility of a health problem (e.g. GD and DM), how knowledge of a disease 
influences that perceived risk, and how barriers and self-efficacy to adopt healthy 
lifestyle behaviors influence the likelihood that an individual will take action to promote 
their own health.  
Research Questions 
Based on the purpose of this study, literature support, and the theoretical framework 
of the Health Belief Model, the following research questions were used.  In a sample of 
women with a history of GD:  
1. To what degree is the likelihood of adopting healthy lifestyle behaviors explained 
by pregnant woman‘s selected demographics (age, education, ethnicity, use of 
insulin during pregnancy, BMI>25 before pregnancy, sleep duration), structural 
variable (knowledge of diabetes, family history of type 2 diabetes), perceived risk, 
and self-efficacy? 
2. What effect sizes are expected for perceived susceptibility (risk) of developing 
DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors, and 
adoption of healthy lifestyle behaviors after childbirth when comparing the two 
experimental groups (control group: standard care with attention control and 
treatment group: educational intervention) at 6-8 weeks postpartum? 
3. What are the barriers to obtaining postpartum glucose screening and adopting 
healthy lifestyle behaviors after childbirth among women with a diagnosis of GD? 
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4. What type of cues of action encourages postpartum glucose screening and 
adoption of healthy lifestyle behaviors among women with a diagnosis of GD?
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CHAPTER II 
REVIEW OF THE LITERATURE 
This chapter provides a review of significant literature related to the incidence of 
DM in women with GD and risk factors (e.g. obesity, sedentary lifestyles, use of insulin 
during pregnancy, early diagnosis of GD, sleep impairment) associated with DM.  The 
Health Belief Model has been selected to guide this study therefore concepts identified 
with this model are explored in the literature in relation to women with GD and DM 
prevention.  These concepts include perceived susceptibility (risk) for developing DM, 
self-efficacy to adopt healthy lifestyle behaviors, healthy lifestyle behaviors to prevent  
DM, screening for DM postpartum, barriers to adopting healthy lifestyle behaviors and 
glucose screening, and strategies (cues to action) to increase adoption of healthy lifestyle 
behaviors for prevention of DM.  Directions for the future study are also addressed. 
Incidence of DM in Women with GD 
Gestational Diabetes (GD) is the most common medical disorder of pregnancy 
and is defined as a form of diabetes which begins or is first recognized during pregnancy, 
occurring due to pancreatic beta cells inability to produce sufficient insulin for increased 
demands during the third trimester of pregnancy (ADA, 2008; AHRQ, 2009; Pridjian & 
Benjamin, 2010).  Each year, this disorder affects approximately 4%-10% of pregnant 
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women in the United States (ADA, 2010; AHRQ, 2009; Pridjian & Benjamin, 2010).  
Research has identified that women diagnosed with GD are at risk of developing DM 
after childbirth (Feig et al., 2008; Knowler et al., 2002; Lee, Hiscock, Wein, Walker, & 
Permezel, 2007; Lee et al., 2008; Ratner et al., 2008).  A Canadian population-based 
study found that within nine years of the index pregnancy, the probability of the 
development of DM in women with a history of GD was 18.9% (Feig et al., 2008).  
Major findings from this study included that DM incidence increased with age of the 
woman at the time of delivery (highest rate in women who aged 46-50 years) and in 
women who lived in rural areas.  Women who lived in higher income neighborhoods 
were less likely to develop DM after delivery.  Personal characteristics that increase the 
risk of DM, such as lifestyle behaviors and body mass index (BMI), were not included in 
this study therefore it is ambiguous if GD is the sole factor for DM.  However, other 
studies also identified the risk to develop DM in women with a history of GD.  For 
example, a retrospective study that used survival analysis found that one fourth of the 
5470 women (90% Caucasian) with a history of GD developed DM within 15 years of 
the index pregnancy (Lee et al., 2007), while a case-control study identified Korean 
women with a GD history had a 3.5 times greater incidence of DM than women in the 
general population (Lee et al., 2008).  In a recent study (Kerimoglu, Yalvac, Karcaalt, & 
Kandemir, 2010), investigators performed glucose screening using a 75 gram OGTT at 
six and twelve months after delivery to evaluate glucose tolerance in women diagnosed 
with GD.  Of the 78 patients, over 70% of the women either had impaired glucose 
tolerance (IGT) or were diagnosed with DM (Kerimoglu et al., 2010). 
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A landmark epidemiological study, the Diabetes Prevention Program (Knowler et 
al., 2002), which evaluated men and women‘s risk of developing DM, found that the 
women with a history of GD had a 71% higher incidence rate of developing DM than 
those without a history of GD (Ratner et al., 2008).  Maternal BMI was positively 
correlated with the risk of DM.  Women with GD who engaged in healthy lifestyle 
behaviors decreased the risk of DM by 50%; however, compared to women with no 
diagnosis of GD, women with GD were less able to sustain the weight loss and physical 
activity as compared to women with no diagnosis of GD, thus increasing risk of DM. 
Risk Factors Contributing to Development of DM 
There are additional risk factors that contribute to the development of DM such as 
overweight/obesity (BMI>25), sedentary lifestyles, use of insulin during pregnancy, an 
early diagnosis of GD (<24 weeks gestation), and sleep duration (Baptiste-Roberts et al., 
2009; Chaput, Despres, Bouchard, Astrup, & Tremblay, 2009; Jarvela et al., 2006; 
Krishnaveni et al., 2007; Ogonowski & Miazgowski, 2009).  In a five year follow up of 
526 women (Krishnaveni et al., 2007); over one-third of the women who were diagnosed 
with GD developed DM (37%), while only 2% of the non-GD women developed DM in 
the same time frame.  These women with GD who developed DM had higher BMI‘s 
(M=26.7) and large hip ratios (0.93) five years after the index pregnancy compared to 
women who did not develop DM (Krishnaveni et al., 2007).  In addition, a relative (first 
degree) with DM was significantly associated with a higher incidence of diabetes 
(p<0.001).  The incidence rates of DM are higher in women with GD who had increased 
severity of gestational diabetes (defined by insulin use, neonatal hypoglycemia, and 
recurrent GD), requirement of insulin therapy during pregnancy, and early diagnosis (<24 
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weeks gestation) of GD during the pregnancy (Jarvela et al., 2006; Ogonowski & 
Miazgowski, 2009; Russell, Dodds, Armson, Kephart & Joseph, 2008).  A case control 
study matched 435 pairs of women (case group with women diagnosed with GD and 
control subjects without GD) based on age, parity, and date of delivery.  Over one third 
of the GD women were treated with insulin during the pregnancy and of those who were 
treated with insulin, 78% developed DM (Jarvela et al., 2006).  The retrospective cohort 
study (Lee et al., 2007) which followed a large number of women (n=5470[GD] and 
n=783[non-GD]) found the largest predictive factors for the development of DM in 
women with GD was use of insulin during pregnancy, larger BMI, and those women who 
were of Asian origin indicating that identified associated risk factors for DM (insulin use, 
obesity, and ethnicity) were evident in women who developed DM after childbirth.  
Lobner et al. (2006) reported similar findings for GD women at risk of developing DM.  
The German study identified a DM risk within eight years of the index pregnancy of 
52.7% and significant predictors of risk included women who required insulin, had a 
BMI>30, and had more than two pregnancies.  A recent study (Schaefer-Graf et al., 2009) 
found that 86% of postpartum DM was found in women with two or more of risk factors 
such as use of insulin therapy in pregnancy, early diagnosis of GD, and severity of 
hyperglycemia.  These findings are supported in a systematic review (Baptiste-Roberts et 
al., 2009) examining risk factors of developing DM in women with GD in which 
researchers concluded that DM was higher in women who had increased anthropometric 
characteristics and women who used insulin during pregnancy.  
Another modifiable risk factor identified for DM is the relationship between sleep 
duration (<6 hours per night or >9 hours per night) and impaired glucose tolerance 
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(Chaput et al., 2009; Knutson & Cauter, 2008; Knutson, Spiegel, Penev, & Cauter, 2007; 
Tasali, Leproult, & Spiegel, 2009).  Insulin sensitivity and pancreatic beta cell function is 
influenced by sleep with glucose levels remaining stable through the sleep cycle and 
glucose metabolism and insulin production is increased during the waking hours.  The 
quantity and quality of sleep affects glucose tolerance by affecting the normal 
homeostasis of the mechanisms that maintain and stabilize glucose levels (Ip & 
Mokhlesi, 2007), leading to impaired glucose tolerance if sleep patterns are altered.  
Shorter sleep (< 6 hours) and longer sleep duration (> 9 hours) decreases insulin 
sensitivity and glucose tolerance, thus increasing risk of DM.  Numerous studies have 
identified the association of sleep duration and risk for DM.  A longitudinal study 
(N=256) evaluating the relationship of sleep duration (short and long sleep period) with 
DM or impaired glucose tolerance (Chaput et al., 2009) identified sleep duration as a risk 
factor for developing DM with a significant relationship of DM and impaired glucose 
tolerance in participants with short and long duration of sleep.  Gangwisch et al. (2007) 
identified similar results in their longitudinal study (N=8992) over a period of ten years.  
Participants with fewer than five hours sleep or longer than nine hours were significantly 
more likely to have DM than participants with normal sleep duration.  Similar results 
were found in a prospective study of women (N=70,026) who were followed for a ten 
year period to determine if consistent sleep restriction resulted in a diagnosis of diabetes; 
a positive association between sleep duration (< 5 hours and > 9 hours) and diabetes was 
identified (Ayas et al., 2003).  
Limited research has focused on the impact of sleep duration as a risk factor for 
GD.  A pilot study (Qiu et al., 2010) of pregnant women (N=1290), identified that 
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women with short duration of sleep (< 4 hours) during the first trimester of pregnancy 
had an increased risk of GD than women who slept for nine hours per night.  Women 
who snored and were overweight had an increased risk of GD by 6.9 fold.  A major 
concern for this group of women is the continuance of impaired sleep after childbirth that 
is normally associated with the required care for their newborn, thus could compromise 
further the glucose tolerance increasing the risk of developing DM.  Similar results were 
found in a convenience sample of pregnant women (N=189) which identified a higher 
incidence of GD was associated with short sleep duration and snoring (Facco et al., 
2010).  
As we recognize that GD is a risk factor for DM, additional factors such as use of 
insulin during pregnancy and early diagnosis of GD assist health care providers in 
identifying the women at higher risk of DM.  As evidenced by the literature, the early 
diagnosis of GD (< 24 gestational weeks) and insulin management of GD is strongly 
associated with development of DM; therefore continuance of glucose management after 
delivery is imperative to reduce the risk.  Sleep duration has an effect on glucose, thus 
knowledge of the relationship of sleep quality and quantity and glucose intolerance can 
be used to encourage women to obtain appropriate amounts of sleep, since sleep 
disturbances are prevalent when caring for a newborn.   
In summary, there are additional factors which increase the risk of developing 
DM, such as BMI >25, sedentary lifestyles and sleep duration.  Furthermore, factors such 
as use of insulin during pregnancy, early diagnosis of GD and family history are strong 
predictors of DM, therefore providing valuable information to health care providers to 
monitor these women more closely for DM.  
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Perceived Risk of Developing DM 
Health beliefs have a major influence on lifestyle behaviors (Jones et al., 2009).  
Perceived risk is a subjective judgment of a person and is an important factor in a 
person‘s decision to adopt and sustain preventive behaviors (Pinnelli, Berlie, Slaughter, 
& Jaber, 2009; Walker, Schechter, Caban, & Basch, 2008).  A cross sectional study 
(Adriaanse et al., 2008) in a large general population found individuals, both men and 
women, believed DM was a serious condition, but did not believe they were at risk.  
Another study showed individuals who had family members with DM and had metabolic 
syndrome perceived a higher risk of DM.  Those who reported a higher perceived risk of 
developing DM also reported a greater intention to implement healthy lifestyles (Hivert, 
Warner, Shrader, Grant, & Meigs, 2009).  These findings indicate that a family history of 
DM increase the perceived risk of DM, however, the study participants were primarily 
Caucasian, middle-aged and well educated.  The perceptions of different ethnic groups 
with varied socioeconomic backgrounds warrant further exploration. 
Findings of risk perception from the general population are also evidenced among 
women with GD, indicating that women have limited knowledge about their risk of 
developing the DM (Malcolm et al., 2009).  Kim, McEwen, Piette, et al. (2007) 
conducted telephone interviews and found that 90% of 217 women with a history of GD 
understood GD was a risk factor for developing DM, but only 16%  of the GD women 
believed that they would develop the disease.  Women, who perceived themselves at risk 
for developing DM, indicated that they planned to change lifestyle behaviors to prevent 
the disease.  The women with greater perceived risk of developing DM also had 
associated factors of DM such as greater BMI, use of insulin during pregnancy, and a 
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family history of GD.  Kim, McEwen, Piette et al. (2007) believed that identifying the 
connection between risk perception and health behavior would assist health care 
providers in developing interventions focusing on risk perception first and then engage 
women to modify unhealthy lifestyle behaviors that lead to DM.  Women with higher 
perceived risk of DM are more likely to engage in a healthy diet and exercise, but in 
contrast women with low perception of risk will less likely engage in those behaviors.  
In a nine year follow-up project (Malcolm et al., 2009) of predominantly 
Caucasian (92%) GD women, almost one-third of the women believed their risk for DM 
was no different from other women in the general population.  Of these women, 60% had 
a family history of DM.  When a two hour glucose tolerance test was performed, almost 
half of the 77 women had abnormal results (Malcolm et al., 2009).  A recent study 
(Morrison, Lowe, & Collins, 2010) of women diagnosed with GD (N=1372), over  
one- third considered themselves at low risk of developing DM.  Those who perceived 
themselves at higher risk of developing DM had a BMI >25, a family history of DM, and 
used insulin during pregnancy, thus identifying that personal history does affect 
perception of DM risk.   
Self-Efficacy to Adopt Health Behaviors 
Self-efficacy is an individual‘s belief that he/she is capable of performing specific 
tasks to obtain certain goals and is a strong predictor of health behaviors (Bandura, 1994; 
Bandura, 1998).  Individuals with high self-efficacy are more likely to set goals, stay 
committed to those goals, and work harder to achieve the goals, therefore they are more 
likely to make a behavior change and adhere to those behaviors over a long period of 
time, thus leading to better health outcomes (Rosenstock et al., 1988).  In contrast, people 
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with low self-efficacy will expect poor outcomes, have low aspirations, little commitment 
to achieve goals, and give up if tasks become difficult (Anderson, Anderson, & Hurst, 
2010; Bandura, 2004).  Health promoting behaviors are influenced by a belief of being 
able to appropriately perform the activity, thus the engagement and maintenance of health 
behaviors will more likely occur in individuals with stronger self-efficacy (Bandura, 
2004; Luszczynska, Scholz, & Schwarzer, 2005). 
Self-efficacy can be enhanced by enactive attainments (success increases self-
efficacy, failure lowers self-efficacy), vicarious experiences (observations), and verbal 
persuasion (encourage to succeed, promote development of skills) (Bandura, 1982).  An 
experimental study (Podder et al., 2010) to improve self-efficacy and behaviors related to 
dairy intake was conducted in male and female college students (n=294).  Students 
randomized into the intervention group, participated in a five week study using the 
internet for a web-based nutrition education through email messages, posted information, 
and checklists of intake of dairy product behaviors.  Post-test measurement indicated an 
improvement in self-efficacy for total dairy intake and self-regulation.  In another 
experimental study, an increase in self-efficacy of physical activity was identified in 
sedentary, obese women (N=29) (Dallow & Anderson, 2003).  Women randomized into 
the intervention group participated in a 24 week physical activity program which focused 
on changing the way women thought about exercise and the behavior of exercise, while 
the control group participants were involved in a traditional exercise program.  A 
significant increase in self-efficacy to increase physical activity was found in the 
intervention group women, while those in the control group had no change in self-
efficacy.  The encouragement from counselors during the physical activity program may 
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have been a major factor in increasing the participant‘s self-confidence to engage in 
exercise.  
Self-efficacy is an important concept in adoption of health behaviors.  A study of 
college aged men and women (N=162) reported a significant relationship between self-
efficacy and health-promoting lifestyles (r=.61, p< 0.01), demonstrating that individuals 
with higher self-efficacy were more involved in healthy lifestyle behaviors (Jackson, 
Tucker, & Herman, 2007).  Neupert, Lachman & Whitbourne (2009) described that older 
adults with higher self-efficacy continued to engage in exercise behaviors nine to twelve 
months after engaging in an instructional intervention encouraging resistance training.  
Self-efficacy of oral self-care was found to be a significant predictor of adults engaging 
in performing oral care using brushing and flossing (Buglar, White, & Robinson, 2009).  
In contrast, individuals with low self-efficacy in performing self-management activities 
do not engage in health behaviors.  For example, a pilot study (Jennings-Sanders, 2009) 
measured the self-efficacy for mammography screening in African American women 
(mean age of 75) who lived in a senior high rise apartment building in an urban area.  
This study identified that the women were not confident in their ability to obtain a 
mammogram.  In these women, 80% had not had a previous mammogram, thus 
demonstrating low engagement in a health behavior when self-efficacy is low. 
There are limited studies which focus on the self-efficacy and adoption of health 
behaviors in women with GD.  Kim, McEwen, Kieffer, Herman, & Piette (2008) 
identified that women, a dominate group of well-educated White women, with GD 
(N=228) who had low self-efficacy scores also had low physical activity, unhealthy diets, 
and higher BMI.  In comparison, Koh, Miller, Marshall, Brown, & McIntyre (2010) 
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performed a cross-sectional telephone survey of women with a recent history (<3 years) 
of GD to determine physical activity and psychosocial factors associated in engagement 
of the health activity.  Women with higher social support (support from significant other 
or other family members) and self-efficacy were more likely engaged in physical activity, 
although the study determined a low prevalence of physical activity in general (Koh et 
al., 2010).   
Prevention of DM: Healthy Lifestyle Behaviors  
Prevention of DM through adoption of healthy behaviors has been well 
established in the literature (Knowler et al, 2002; Tuomilehto et al., 2001).  The 
International Diabetes Federation has developed a three step plan for prevention of DM 
through 1) identification of those at higher risk for developing type 2 diabetes, 2) use of a 
measurement of that risk and 3) interventions to prevent the disease (Alberti, Zimmet, & 
Shaw, 2007).  In relation to this study, women with GD are identified as a population at 
risk.  Postpartum blood glucose screening is recommended and healthy behaviors for 
prevention of type 2 diabetes include weight loss, engagement in physical activity (a 
minimum of 30 minutes of moderate exercise five times a week), and eating a healthy 
diet low in fat and calories (Alberti et al., 2007; Blue, 2007; Quinn, 2003).  
There are modifiable risk factors associated with the development of DM which 
include obesity, unhealthy diet, and physical inactivity.  Studies have shown that obesity, 
which is a body mass index (BMI) > 25, leads to poor insulin secretion and sensitivity, 
thus increasing the risk of DM.  A simple weight loss (through use of a healthy diet) of 
10% of body weight can improve glycemic control (Case, Willoughby, Haley-Ziltin, & 
Maybee, 2006; Costacou & Mayer-Davis, 2003).  In a study that targeted participants 
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who were obese, lacked physical activity, and had impaired glucose tolerance; simple 
interventions of weight loss and exercise reduced the risk of DM by 58% (Tuomilehto et 
al., 2001).  This study, known as the Finnish Diabetes Prevention Study Group, grouped 
men and women (N= 522) either in an intervention group (received individual counseling 
about weight reduction, healthy diet, and physical exercise) or a control group.  The 
participants in the control group were only given general information about diet and 
exercise at the beginning of the study and at annual visits, while the intervention group 
participants received seven sessions of detailed information from a nutritionist during the 
first year of the study and then a session every three months in the following years of the 
study.  In addition, these men and women received supervised and individual structured 
exercise and resistance training.  In a mean duration of 3.2 years, the intervention group 
had the most significant reduction of DM risk.  A follow-up with participants of the 
Finnish study identified sustained lifestyle changes and a reduction in incidence of 
diabetes, even after counseling had stopped (Lindstrom et al., 2006).  
The prevention strategies seem simple, but changing behaviors takes time and can 
only be achieved when the individuals are engaged in the process (Saunders & Pastors, 
2008; Yun, Kabeer, Zhu, & Brownson, 2007).  Modifiable life behaviors and prevention 
strategies are important concepts to prevent or delay the development of DM (Yun et al., 
2007).  The Diabetes Prevention Program (DPP) identified a 58% reduction of risk of 
DM when weight loss, exercise, and healthy diet were implemented (Knowler et al., 
2002).  This clinical trial used individualized training of nutrition, weight loss and 
management as well as physical activity to assist with the participant‘s health behavior 
modifications.  Participants (3,234) were randomly assigned into three groups: lifestyle 
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intervention group, metformin intervention group, and placebo group.  Diabetes was 
diagnosed with an oral glucose tolerance test (200mg/dl or higher) or fasting plasma 
glucose test (126mg/dl or higher).  Confirmation was made with a second test within six 
weeks of initial testing using the same criteria.  In a cumulative incidence of diabetes 
review, individuals assigned to the lifestyle intervention group (crude incidence 4.8/100 
person) had less incidence of DM with greater weight loss and physical activity than the 
other groups (7.8/100 person-metformin group; 11.0/100 person- placebo group).  In a 
subsequent review of the DPP (Ratner et al., 2008), the researchers focused on women 
(n=350) with a history of GD specifically and found that lifestyle modifications (healthy 
diet and exercise) decreased their DM risk by half.  Women in the placebo group with a 
history of GD had a greater incidence of DM (15.2 cases/100 persons).   
A similar study to the DPP (Knowler et al., 2002) and the Finnish Diabetes 
Prevention Study Group (Tuomilehto et al., 2001) was conducted in China with 577 
adults with impaired glucose tolerance (Li et al., 2008).  Participants were randomly 
assigned to either the control group or one of three intervention groups (diet only, 
exercise only, or a combination of diet and exercise interventions).  The combined 
intervention group had a 51% lower incidence of DM during the actual intervention 
active phase of the study, but also had a 43% lower incidence rate over the duration of 20 
years of the follow-up study of participants, therefore demonstrating the long-term effects 
of lifestyle modification on the risk of developing DM (Li et al., 2008). 
It has been suggested that once individuals are identified as at risk for diabetes, 
they should be counseled by health care providers, therefore women with GD should be 
provided with information on the long term effects of GD and DM preventative care 
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including diet, exercise and weight reduction (Ratner, 2007).  Although the DPP did 
include women with GD, studies implementing lifestyle modification in the prevention of 
DM in women with GD are limited.  A majority of the reviewed studies in women with 
GD focused on low engagement of healthy lifestyle behaviors.  A cross sectional study of 
women diagnosed with GD (N=331) identified that physical activity behavior was 
performed in only 37% of the women (Koh et al., 2010).  In another cross-sectional 
study, almost three-fourths of women with a history of GD who currently had DM did not 
meet the recommended physical activity of thirty minutes a day, five days a week, and 
over 80% of the women were overweight (Yun et al., 2007).  The findings suggest that 
modifiable risk factors have a potential to prevent DM, thus leading to a recommendation 
from the researchers that health care providers should educate and motivate women with 
GD to implement preventive lifestyle health strategies.  A survey of GD women (N=121) 
identified that although women were instructed about postpartum adoption of healthy 
lifestyle behaviors, they were not implementing the strategies.  More than one-third of the 
participants gained weight after the pregnancy (Stage, Ronneby, & Damm, 2004).  
In the management of GD, nutrition therapy is the primary intervention for 
glycemic control.  An education intervention study (Fehler, Kennedy, McCargar, Bell, & 
Ryan, 2007) of women with GD (n=19), which focused on nutrition and exercise, 
identified that the women made significant behavior changes in nutrition during 
pregnancy, but did not sustain those changes postpartum.  The researchers did not 
elaborate on the reason the women did not sustain the changes postpartum, but the 
significant increases of nutrition behavior were measured two weeks post intervention 
(group nutrition education session).  In addition, 45% of these women tested positive for 
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glucose intolerance postpartum, while 60% did not lose weight to return to pre-pregnancy 
weight at the six week and six month assessments.  Therefore, this study indicates that 
interventions should focus not only on the education of the behavior, but researchers need 
to target other factors which encourage or hinder sustaining the behavior after childbirth. 
Available data from intervention studies have identified that general strategies of 
healthy diet, exercise, and modest weight loss lowers the risk of DM.  According to the 
ADA (2010) and ACOG (2009), women with GD should be counseled to lose weight, eat 
a healthy diet and engage in moderate exercise (150 minutes) after delivery and continue 
these behaviors for a lifetime.  These recommendations are consistent with the 
information provided for the general public who are at risk for developing DM.  Studies 
such as the DPP identify that women with GD had similar reduction of DM risk as 
women with no GD diagnosis when diet and exercise interventions were followed 
(Ratner, 2007), thus demonstrating that these behaviors are appropriate for women with 
GD.  However, research is limited in addressing the best approach to engage women with 
GD to adopt those healthy lifestyle behaviors.  Furthermore, women who are caring for a 
newborn have unique needs and are more likely to have a difficult time participating in 
multiple counseling sessions, therefore modification of known lifestyle intervention 
strategies to fit the busy lifestyle of a new mother is necessary (England et al., 2009). 
Barriers in Adoption of Health Behaviors   
With prevention strategies of DM identified, health care providers need to be 
aware of barriers that impede women with GD from implementing healthy behaviors 
after delivery.  In an assessment of readiness to make postpartum health behavior 
changes, Swan, Kilmartin, & Liaw (2007), found a low prevalence of physical activity 
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and weight loss in GD women (N=53) living in rural Australia.  The participants were 
aware of the risk of developing DM and were aware of preventive strategies, but were not 
engaged in the activity, thus a need of promotion for weight loss and physical activity for 
this population was indicated.   
There is a gap between knowledge and the behavior which may be associated 
with time commitments, especially mothers of multiple children.  Numerous 
responsibilities compete with diet, exercise, sleep habits, and work schedules, thus 
making it difficult for the mother to implement healthy lifestyle strategies.  In addition, 
women do not have an immediate concern of DM, primarily because there are no 
symptoms in the early development of the disease (Swan et al., 2007).  An individual‘s 
health beliefs are also essential components for engaging in healthy lifestyle behaviors.  
Downs and Ulbrecht (2006) assessed exercise beliefs and behaviors of postpartum GD 
women (N=28) and identified that only 7% believed that physical exercise during 
postpartum would decrease their risk of developing DM.  Exercise activities were 
predominantly for weight management and not for prevention of a disease.  The women 
identified that lack of time was the major barrier that limited their engagement of 
physical exercise.  Some limitations of this study included a small sample size, 
participants were predominantly white, married women and the study participants were 
from only one clinic, thus limiting generalizability due to lack of diversity of the 
population.  Although the study had some limitations, a notable characteristic of this 
sample was that 75% of  participants had a family history of DM, but the belief of 
physical exercise in the prevention of DM was low (Downs & Ulbrecht, 2006).  Family 
history of DM is an associated factor of developing DM, thus knowledge deficit of the 
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relationship for developing DM and preventive self-care should be emphasized to 
increase knowledge and motivate women to engage in a healthy lifestyle. 
Physical activity of postpartum women is determined by time constraints, child 
care, and social support (Doran, 2008; Evenson, Aytur, & Borodulin, 2009; Graco, 
Garrard, & Jasper, 2009; Smith, Cheung, Bauman, Zehle, & Mclean, 2005).  A mixed 
method study (Doran, 2008) of GD women 6-12 month post-delivery (N=38), identified 
that postpartum is a difficult time to engage in physical activity due to recovery from 
labor and delivery and taking care of a newborn.  Lack of time, feeling tired, and lack of 
child care were major barriers.  Similar results were reported in semi-structured 
interviews with women (N=10) with a previous GD diagnosis (Graco et al., 2009).  
Common barriers to participation in physical activity was due to lack of time to engage in 
an activity, placing family needs before their own, and lack of appropriate childcare.  The 
women of this study perceived that diet was important in prevention of DM, but did not 
understand the important role of physical activity in prevention of the disease.  
Barriers for adoption of a healthy diet were noted in a random sample of GD 
women (N=226) who were surveyed by telephone to evaluate psychosocial factors 
related to diet (Zehle et al., 2008).  Half of the women reported that major barriers to 
eating a healthy diet was a busy lifestyle and lack of knowledge, with one-third of the 
participants reporting that they did not know which foods should be included in their diet 
to prevent DM.  This same group of investigators (Smith et al., 2005), also assessed 
psychosocial factors for physical activity in women with GD reporting that only one-third 
of the women engaged in regular activity.  The most common barriers to engaging in 
physical activity were lack of time and lack of assistance with child care.  In addition, the 
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women reported other barriers including feeling tired, they did not enjoy physical 
activity, and that their neighborhood was not suitable for physical activity.  These studies 
also identified a knowledge deficit of appropriate lifestyle modifications to prevent DM. 
Early Diagnosis: Postpartum Glucose Screening for DM 
Early diagnosis of DM is essential for positive health outcomes.  In general, 
evidence supports diagnostic screening practices are useful tools for early diagnosis of 
disease such as cervical and breast cancer, retinopathy, and DM (Engelgau, Narayan, & 
Herman, 2000; Nguyern, Larocque, Paquette, & Irace-Cima, 2009; Rue et al., 2009; 
Zhang et al., 2007).  Screening has reduced mortality rates in breast cancer (Rue et al., 
2009) as well as cervical cancer (Fisher & Brundage, 2009).  Early detection can decrease 
the co-morbidities that are associated with DM including cardiovascular disease, 
blindness, and amputations (Ambady & Chamukuttan, 2008; Marshall & Flyvbjerg, 
2006).  Smirnakis et al. (2005) found that only 37% of women with GD were screened 
for DM postpartum, but in comparison 94% of women obtained cervical cancer 
screening, demonstrating that other screening rates are higher and are being performed by 
health care providers.   
Although there are specific recommendations from the ADA and ACOG (ADA, 
2003;  ACOG, 2009) for follow-up testing of women with GD, there is evidence that 
many women are not screened for DM postpartum according to guidelines (Almario et 
al., 2008; Kim et al., 2006).  There is a problem with continuity of screening after the 
index pregnancy (pregnancy with diagnosis of GD) due to lack of knowledge of the risk 
of DM, as well as, affected women being primarily healthy and asymptomatic and do not 
seek routine health care appointments (Kapustin, 2008).  This population is a young, busy 
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population therefore follow-up care is not a priority.  In addition, healthcare providers are 
knowledgeable of practice recommendations for follow-up with women with GD, but 
incorporation of the recommended guidelines into practice is not well established 
(Kapustin, 2008).  With this in mind, health care providers have an essential role in 
increasing awareness and implementing screening practices that can help delay or prevent 
this disease.  Early diagnosis and early intervention can prevent DM complications  
(Case et al., 2006) therefore, women with GD need to be educated about their risk for 
developing DM and become their own advocates for postpartum glucose screening. 
Kapustin (2008) highlighted that the lack of postpartum glucose screening for DM 
in women with GD misses the opportunity to diagnose DM and manage the disease to 
prevent long term complications.  Kim et al. (2006) found that less than one quarter of the 
570 women with a history of GD were screened postpartum using either a fasting blood 
glucose screening or OGTT.  This study was primarily White married women and the 
majority (90%) of those screened visited an endocrinologist during the pregnancy. 
Similar results were reported in a cross sectional study in which researchers performed a 
retrospective chart review (Alamario et al., 2008).  Their results indicated that two-thirds 
of postpartum women with GD (N= 90) did not have postpartum glucose screening, with 
only 20% of health records having a documented physician‘s order for the postpartum 
DM screening.  A slight increase in screening (33%) was noted in women who were 
referred back to their primary care physician for postpartum blood glucose screening 
(Alamario et al., 2008).  
Russell et al. (2008) identified that only 45% of GD women (N=344) had 
postpartum glucose screening and of those women who were screened, 36% had an 
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increased glucose level.  Moreover, this high incidence rate supports the need for women 
with GD to be screened and educated on DM prevention.  In identification of postpartum 
screening rates, beliefs among the health care provider are also important.  Case et al. 
(2006) stated that DM educators, nurses, and physicians have an essential role in 
increasing awareness and implementing screening practices which can help prevent this 
disease.  In a survey (Case et al., 2006) of 399 health care professionals, almost all 
providers (98%) performed a 50g Oral Glucose Tolerance Test (OGTT) for screening of 
GD during pregnancy, but only 21% of those providers stated that they performed 
glucose screening postpartum for DM.  This finding may indicate that health care 
providers may not see the benefit of the postpartum screening or there is a knowledge 
deficit of recommended guidelines. 
Barriers to Screening  
Lack of consistency of postpartum glucose screening recommendations from 
professional societies in the past may have contributed to low screening practices and 
may have been a major barrier for women obtaining glucose screenings postpartum 
(Bennett, Bolen, Wilson, Bass, & Nicholson, 2009; Bentley-Lewis, Levkoff, Stuebe, & 
Seely, 2008; England et al., 2009).  In 2007, the Fifth International Workshop-
Conference on GD supported the ADA postpartum glucose screening guidelines, but the 
committee‘s only recommendation was administering an OGTT at 6-12 weeks post-
delivery (Metzger et al., 2007).  The ADA guidelines suggest a blood glucose test or an 
OGTT performed at 6-12 weeks postpartum with annual follow-up screening if abnormal 
results are obtained and every three years if normal (ADA, 2003).  Baker et al. (2009) 
found that a failure to screen patients was primarily associated with inconsistent 
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screening guidelines and failure of patient‘s adherence to follow-up visits to obtain blood 
glucose screening.  Agarwal, Punnose, & Dhatt (2004) compared recommendations from 
the ADA and WHO and concluded that there is confusion and lack of universal 
recommendations in the clinical practice for screening in the postpartum period.  
Bentley-Lewis et al. (2008) found there are many barriers to postpartum screening 
including lack of communication between obstetricians and primary care providers about 
blood glucose screening, unclear glucose postpartum screening recommendations, and 
missed postpartum appointments.  The patient factors included risk awareness and 
adherence to screening appointments.  Hunt & Conway (2008) identified in a large 
Mexican-American sample of 707 women that only 57% returned for the postpartum 
glucose screening.  The women who failed to return for screening had higher glucose 
levels at diagnosis of GD, were overweight before pregnancy, and were more likely to 
have had a history of GD in previous pregnancies.  These women are more likely to be at 
high risk for developing DM, but are not receiving screening for diagnosis of DM.  
These studies demonstrate that the postpartum screening rates are low and that 
standard guidelines are not being followed.  Health care provider‘s establishment of 
glucose screening during postpartum care is imperative to identify women with persistent 
glucose intolerance.  In addition, women with GD need to be knowledgeable of not only 
their risk of developing DM, but also the screening guidelines, so they can become their 
own advocates to obtain essential testing.  
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Strategies to Increase Adoption of Healthy Lifestyle Behaviors 
Knowledge 
Health promotion begins with the knowledge of health risks and information to 
assist individual in making decisions about health and health behaviors.  Bandura (2004) 
described that individuals change habits if they have the knowledge about how lifestyle 
behaviors affect their health.  If the understanding is lacking, then change will not occur 
because the individual will have limited reason to change a behavior that is unhealthy and 
one they enjoy.  The impact of information is more beneficial to address the positive 
aspects of behavior change rather than to use information that instigates fear of the 
disease.  Bandura (2004) also describes that knowledge is only part of the process to 
change behavior and that there are additional factors (such as self-efficacy) that 
influences the adoption of healthy behaviors.  Hjelm et al. (2008) discussed that health 
behaviors depended on an individual‘s knowledge about those behaviors, stressing that 
the knowledge is based on what is provided by the health care provider.  Numerous 
awareness campaigns for prevention of disease such as breast cancer, cardiovascular 
disease, and diabetes (NIH, 2011; International Diabetes Federation, 2011; Susan G. 
Komen for the Cure, 2011) have been used over the years to provide knowledge to the 
public.  The International Diabetes Federation (2011) has instituted World Diabetes Day 
to highlight education to the public and health care professionals about prevention and 
management of DM.    
Although limited studies have addressed knowledge of healthy behavior and 
women with GD, a recent study in women with GD contradicts the basic premise that 
knowledge equals behavior.  Swan and colleagues (2007) determined that although 
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women with GD had a high awareness of healthy behaviors to prevent DM, engagement 
in those activities were low, thus demonstrating incongruence between the knowledge 
and behavior.  In contrast, some studies have demonstrated an association between 
knowledge and behavior.  Smith et al. (2005) identified, in a study of women with a 
history of GD (N=226), that the participants did not know what type of physical activity 
would decrease their risk of developing DM and therefore only one-third of the 
participants reported engaging in exercise that met recommended moderate exercise 
requirements after childbirth.  In a qualitative study (Rosal, Borg, Bodenlos, Tellez, & 
Ockene, 2011) of low income Latinos (N=41) with no diagnosis of diabetes, participants 
(85% women) had limited knowledge of DM risk factors or lifestyle changes that could 
prevent or delay DM.  Although half of the participants recognized family history as a 
risk factor for DM, very few mentioned ethnicity or gestational diabetes as an associated 
risk.  Chen and Lin (2010) identified a positive relationship between pre-diabetes 
knowledge and health promoting lifestyles.  This cross sectional study (N=260) of adults 
discussed the importance of increasing awareness to assist with encouraging activities 
that were health promoting.  
Cues to Action 
Providing information about prevention strategies of DM may occur in a variety 
of ways.  Advice from health care providers, media campaigns, and intensive counseling 
sessions have all been used to increase the likelihood that an individual will adopt health 
behaviors.  Preventive counseling has shown to be effective in the adoption of health 
behaviors, such as the individualized counseling in the premiere DM prevention studies 
(Knowler et al., 2002; Tuomilehto et al., 2001) to promote healthy diet and exercise in 
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the prevention of DM.  Motivation from health care providers to engage in a health 
behavior can increase the likelihood that an individual will adhere to the behavior long 
term.  In a randomized clinical trial in overweight women (N=217), individuals who were 
involved in individual sessions in which motivational interviewing was used in 
conjunction with a weight control program, had more weight loss at six months and 18 
months than the control group (Smith, DiLillo, Bursac, Gore, & Greene, 2007). 
Motivational interviewing, a client-centered approach to engage individuals to adopt 
health behaviors, was successful in engaging participants to be involved in weight loss, 
thus leading to an achievement of weight loss. 
Internet based behavioral counseling has also been effective in adoption of health 
behaviors (Tate, Jackvony, & Wing, 2003; Tate, Jackvony, & Wing, 2006), allowing 
individuals to use health behavior interventions at their convenience and without one on 
one sessions with a health care provider.  Bandura (2004) believes that with the 
accessibility, convenience, and anonymity that the internet provides, those individuals 
who ignore traditional preventative health services will more likely use this type of 
service.  One hundred ninety-two adults were involved in a randomized trial comparing 
computer-automated counseling, email counseling, or no counseling.  Weight loss was 
significantly greater in groups that received email counseling (Tate et al., 2006).  
Similarly, a randomized controlled trial in overweight adults (N=92) reported a greater 
weight loss in one year in participants of the internet counseling group who received diet 
and exercise information and weekly emails from a counselor (Tate et al., 2003).  A 
limitation of these internet based interventions is that all information is a self-report, thus 
reporting bias may be an issue in the findings. 
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Research has also explored strategies (cues) that would enhance screening rates.  
The most effective strategies in increasing breast and cervical cancer screenings have 
been behavioral interventions that target the patients (Mandelblatt & Yabroff, 1999; 
Yabroff, Mangan, & Mandleblatt, 2003).  Although overall screening rates for DM were 
suboptimal, a cross sectional survey of 228 non-Hispanic White women identified that 
women who were given advice regarding postpartum screening and received a laboratory 
slip for the screening had a higher rate of receiving glucose screening postpartum than 
those who did not (Kim, McEwen, Kerr, et al., 2007).  The researchers also wanted to 
determine if there was an association of recall of health care provider advice with healthy 
diet and physical activity, but no significant association was found.  A limitation of this 
study was that the sample included predominately White, college educated, and 
overweight women who had been diagnosed with GD in the last five years.  The length of 
time between education and diagnosis could have led to recall bias. 
Success has also been reflected in studies focusing on reminders to patients and 
physicians about screening needs.  Telephone interventions have proven effective in 
increasing overall screening rates in a variety of preventive practices.  A randomized 
clinical trial to promote diabetic retinopathy screening found that there was a 74% 
increase in the retinopathy screening in those who were reminded by telephone compared 
to those only given printed material (Walker et al., 2008).  The short telephone 
interventions were significant in participants who had poor control of DM and had an 
influence on their perception of risk of complications from DM.  Zhang et al. (2007) 
discussed that increasing awareness, improving health care provider performances, and 
improving healthcare systems processes had a significant effect on increasing screening 
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practices for diabetic retinopathy.  In women with GD, a postal reminder that was sent to 
the women and their physicians increased postpartum OGTT screening rates to 60.5% in 
comparison to a no reminder group with a rate of 14.3% (Clark, Graham, Karovitch, & 
Keely, 2009).  The randomized controlled trial assigned 223 GD women to one of four 
groups.  One group had postal reminders sent to the physician and the patient while the 
second group reminders were only sent to the physician.  The third group reminders were 
only sent to the patient and the fourth group received no postal reminders (Clark et al., 
2009).  In Australia, a new system has been developed to register women with GD into 
the South Australian Gestational Diabetes Mellitus Recall Register (Chittleborough et al., 
2010).  An annual reminder was sent to the women reminding them of their risk of type 2 
diabetes and encouraging them to receive blood glucose screening.  Of the 429 women 
who received the first reminder letter, over 56% obtained glucose screening. 
Summary of the Relevant Literature  
In summary, in comparison to the general population, women with GD are at high 
risk of developing DM after childbirth due to several factors such as overweight/obesity 
(BMI >25), sedentary lifestyles, use of insulin during pregnancy, an early diagnosis of 
GD (<24 weeks gestation), and sleep duration.  Numerous intervention studies of the 
general public have demonstrated that adoption of healthy lifestyle behaviors (e.g. 
healthy diet, exercise, weight loss) decreases the risk of developing DM, but limited 
research has explored strategies to encourage women with a diagnosis of GD to 
implement those behaviors during the postpartum period and throughout their lifetime.  
Perception of risk of developing DM is low in women with GD.  In addition, there are 
numerous barriers such as fatigue, time constraints, and lack of social support which 
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prohibit women from engaging in healthy behaviors postpartum and/or to obtain 
postpartum glucose screening for early diagnosis of DM.  A variety of strategies 
(counseling, technology, advice from health care providers) have been used to motivate 
and encourage adoption of healthy lifestyle behaviors in general populations, yet limited 
research has been conducted to encourage adoption of healthy lifestyle behaviors in 
women with GD. 
There is strong empirical support for the development of interventions to increase 
adoption of healthy lifestyles and postpartum glucose screening practices.  In the past, 
nursing care has focused on management of GD during pregnancy to achieve positive 
pregnancy outcomes, but evidence demonstrates the importance of nursing care after 
childbirth as well.  With an increased incidence of DM in women with GD and evidence 
that the disease can be prevented or delayed through adoption of healthy lifestyle 
behaviors (e.g. weight loss, healthy diet, exercise), it is important that preventive care be 
instituted throughout her lifetime.  In women with a history of GD, screening practices 
for postpartum glucose screening are low and the incidence rate of DM is high.  
Established guidelines from the ADA and ACOG for postpartum glucose screening for 
DM in women with GD gives strong credence to the importance of women having blood 
glucose or OGTT screening performed postpartum.  No studies have identified 
educational interventions to increase GD women‘s knowledge of DM risk and 
postpartum glucose screening practice.  Several studies were reviewed for the 
modification of lifestyles to prevent or delay DM in adult men and women in the general 
population (Knowler et al., 2002; Quinn, 2003; Tuomilehto et al., 2001), however, there 
were limited studies which addressed healthy lifestyle modifications for women with a 
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history of GD (Ratner et al., 2008).  The focus of the research in women with GD has 
been the risk of developing DM, but few studies have focused on risk perception and 
health behaviors of women with GD (Jones et al., 2009).  
There are several methodological problems in studies associated with women with 
GD and the risk for developing DM.  A majority of the studies used a retrospective 
design thus; prospective longitudinal studies that review the effect of educational 
interventions during prenatal or postpartum time frames and the effect on health choices 
of women with GD are needed.  A diverse sample base is lacking, with studies 
predominantly comprised of Caucasian women.  Hispanics, African Americans, and 
Native Americans have a disproportionate risk of developing DM (CDC, 2008), but few 
studies have a representative sample of these at risk groups.  Few studies have identified 
a woman‘s risk perception of developing DM following GD and there is a gap in the 
literature on the effect of the perception of risk on glucose screening postpartum or 
adoption of health behaviors.  Furthermore, a majority of studies reviewed did not have 
theoretical foundations. 
To contribute to nursing‘s body of knowledge, future research for preventive care 
of women with GD needs to focus on prevention programs established for the needs and 
challenges of adoption of healthy lifestyles of postpartum women.  Examination of 
influences that enhance or prevent engagement of healthy behaviors will assist health 
care providers in developing effective DM prevention programs that are tailored for 
childbearing age women with GD.  Prevention of DM is plausible, but adherence to 
healthy behaviors for a lifetime is a challenge, especially for women who have 
responsibilities of motherhood that can be overwhelming (England et al., 2009).  
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Madden, Loeb, & Smith (2008) who conducted a review of literature of DM prevention 
programs pointed out that nurses have the greatest opportunity for health promotion, but 
in the prevention studies, very few nurses contributed to research, therefore nursing 
research for the prevention of DM is an essential area for nurses to contribute.  With diet 
and exercise being effective for the prevention of DM, the focus of research should now 
be on different strategies for delivery of education and counseling for women with GD. 
Interventions may occur as one on one counseling sessions or development of other 
creative strategies, such as the use of technology, may be useful for many women who 
have difficulty adhering to appointment schedules.  Another important area for research 
should be focused on compliance of postpartum glucose screening by the patient and 
health care provider and determine efficient ways to have continuity of care and linking 
of obstetrical history even when multiple health care providers are utilized (England et 
al., 2009). 
This review of the scholarly literature on women with GD and their risk for 
developing DM demonstrates a need for further research with this vulnerable population. 
Throughout this review of the literature, variables have been identified for a quantitative 
study including perceived risk for developing DM, barriers to adopting health behaviors, 
self-efficacy to adopt health behaviors, and cues to action to implement behavior.  The 
purpose of this pre-test, post-test, two group study is to determine the effectiveness of 
SUGAR  (Start Understanding Gestational Diabetes and Risk of Type 2 Diabetes), an 
educational intervention designed to enhance women‘s perceived susceptibility (risk) of 
developing DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors 
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(e.g. weight loss, healthy diet, and exercise) and adoption of healthy lifestyle behaviors 
after childbirth among women with GD.  As demonstrated throughout the literature, DM 
can be prevented or delayed through adoption of healthy lifestyle behaviors, but women 
with GD do not perceive themselves at risk for developing DM and have barriers to 
implementing health actions.  The creation of specific strategies for this at risk population 
is imperative to decrease the incidence of DM in women with GD and can be developed 
based on specific influences of adoption of health behavior.  In pursuing studies that 
focus on women with GD, effective strategies could lower the incidence rate of overt 
DM, thus avoiding associated complications in young women that lead to physical, 
psychological, and financial consequences.  
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CHAPTER III 
METHODOLOGY 
This pre-test, post-test, two group study was to determine the effectiveness of 
SUGAR (Start Understanding Gestational Diabetes and Risk of Type 2 Diabetes), an 
educational intervention designed to enhance women‘s perceived susceptibility (risk) of 
developing DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors 
(e.g. weight loss, healthy diet, and exercise), and adoption of healthy lifestyle behaviors 
after childbirth among women with GD.  The purpose of this chapter is to describe the 
methodology for the pilot study.  Detailed discussion includes research design, study 
setting, sampling, and protection of human subjects, instrumentations, study procedures, 
and data analysis. 
Research Design 
  A pre-test, post-test, two group study design was used to pilot test an educational 
intervention SUGAR (Start Understanding Gestational Diabetes and Risk of Developing 
Type 2 Diabetes) in women with GD to determine if the structured intervention would 
result in an increased perceived susceptibility (risk) of developing DM, knowledge of 
DM, and adoption of healthy lifestyle after childbirth to prevent or delay the development 
of DM.  This design has been developed to answer the following research questions for 
this study:
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1. To what degree is the likelihood of adopting healthy lifestyle behaviors explained 
by pregnant women‘s selected demographic (age, education, ethnicity, use of 
insulin during pregnancy, BMI>25 before pregnancy, sleep duration), structural 
variable (knowledge of diabetes, family history of type 2 diabetes), perceived risk, 
and self-efficacy? 
2. What effect sizes are expected for perceived susceptibility (risk) of developing 
DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors, and 
adoption of healthy lifestyle behaviors after childbirth when comparing the two 
experimental groups (control group: standard care with attention control and 
treatment group: educational intervention) at 6-8 weeks postpartum? 
3. What are the barriers to obtaining postpartum glucose screening and adopting 
healthy lifestyle behaviors after childbirth among women with a diagnosis of GD? 
4. What type of cues of action encourages postpartum glucose screening and adoption 
of healthy lifestyle behaviors among women with a diagnosis of GD? 
Study Setting 
The setting for this pilot study was three OB/GYN offices in a not-for-profit 
health system located in the southeastern United States.  The health system had over 
12,000 births in 2010 and serves a diverse population.  The prenatal care protocol for 
women with GD at the OB/GYN offices included scheduled prenatal visits, maternal-
fetal medicine consultation, participation in a diabetes education class, glucose 
monitoring, and non-stress tests beginning at 32 or 36 weeks for fetal well-being 
evaluation.  After delivery, a follow-up appointment was scheduled approximately six to 
eight weeks postpartum. 
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Sample  
In order to recruit participants for this pilot study, a meeting with the managers 
and staff of the OB/GYN offices was conducted by the student Principal Investigator (PI) 
to review the purpose of the project and requirements of participation.  The student PI 
posted flyers (Appendix A) in the OB/GYN offices and provided staff with additional 
flyers to seek potential participants.  In addition, the student PI reviewed medical records 
for the diagnosis of gestational diabetes and to identify first time diagnosis of gestational 
diabetes.   
A convenience sample of pregnant women 32-36 weeks gestation who were 
diagnosed with GD was used for this study.  Study participants were enrolled during their 
third trimester of pregnancy and assigned into the intervention (SUGAR) group or the 
attention control group after baseline data had been obtained.  Participants were 
randomized into the groups until the control group reached five participants, and then 
participants were placed in the intervention group only.  Sample criteria included first 
diagnosis of GD, 18 years of age or older, able to read, write, and speak English.  
Exclusions for this study included women with a previous diagnosis of type 1 or type 2 
diabetes, since the diagnosis is different than GD according to the ADA (2010).  Women 
with cognitive impairment or mental illness were also excluded from the study due to 
limited ability to complete questionnaires and participate in educational sessions.  
Women experiencing pregnancy complications which limited activities (e.g. placed on 
bed rest) were considered for the study if it was determined that participation in the study 
did not cause additional stress to the woman.  The determination was based on the health 
care provider‘s medical comment. 
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A sample size of 20 was selected for this pilot study since it is an adequate sample 
size for a normal shaped distribution (S. Koval, personal communication, April 8, 2011).   
Due to the nature of the pilot study, the small sample size does not have enough power to 
test for hypothesis; however we calculated the effect size for a future large-scale study.  
To ensure a final sample size of 20, the researcher over sampled by 25% resulting in a 
total of 25 mothers enrolled in the study.   
Protection of Human Subjects 
    Institutional Review Board (IRB) approval was obtained from Georgia State 
University (Appendix B & C) and committee approval by the Nursing Research 
Committee (NRC) of the health care system (Appendix D).  A partial Health Insurance 
Portability and Accountability Act (HIPPA) waiver allowed the student PI access to 
patient records to obtain additional baseline data.  Once potential participants were 
identified, the student PI met with the pregnant woman to invite her to participate in the 
study and to provide details of the research project including information explaining the 
time points of contact, the randomization design, and the approximation time 
commitment of 20 minutes needed to complete the questionnaires.  The women were 
allowed to ask questions and were given ample time to consider participation before they 
consented for this study.  
Participation was voluntary and participants could withdraw from the study at any 
time.  In this study, the participant did not have any more risks than she would have in 
normal everyday life and no immediate benefit occurred for the participant.  Informed 
consent (Appendix E) was obtained by the student PI and a copy of the informed consent 
was provided for the participants‘ own records. 
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For this study, anonymity was protected by assigning code numbers to each 
participant and only the student PI had access to a master list.  To ensure confidentiality, 
all information was locked and secured with the participants‘ name and code in a separate 
location from collected data.  All collected data will be located in a locked cabinet for a 
minimum of seven years and then will be destroyed.  Data input to the computer had 
limited access for research personnel only.  For reporting purposes, only aggregated data 
is published thus, no individual data is reported. 
Since DM is a severe health risk, the study participants in the control group also 
received educational information about GD and DM at the end of the study.   
Instrumentation 
For collection of data, four instruments were selected based on the purpose of the 
study and research questions.  The study utilized instruments including the Risk 
Perception Survey for Developing Diabetes adapted for women with GD [RPS-DD] 
(Kim, McEwen, Piette et al., 2007), Self-Rated Abilities for Health Practices [SRAHP] 
(Becker, Stuifbergen, Oh, & Hall, 1993), Health Promotion Lifestyle Profile II (HPLP II) 
(Walker & Hill-Polerecky, 1996), and General Sleep Disturbance Scale [GSDS]-short 
version (Lee, 1992).  All of the instruments are at or below the 8
th
 grade reading level.  
The approval to use these instruments was obtained from the authors of the instruments.  
In addition, a demographic form, developed by the researcher, was used to collect 
baseline and postpartum patient characteristics.  Open-ended questions pertaining to 
barriers and cues for action for adoption of healthy lifestyle behaviors and postpartum 
glucose screening were developed by the investigator. 
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Demographic Information 
Baseline and Postpartum Demographic Questionnaire.  An investigator 
developed demographic form was used to obtain baseline (pre-test) individual 
characteristics including age, ethnicity, marital status, education, income, gestational 
weeks at diagnosis of GD, pre-pregnancy weight, use of insulin or oral hypoglycemic 
medications during pregnancy, height, family history of DM, and sleep duration (see 
Appendix F).  A post-test demographic form was used (6-8 weeks postpartum) to collect 
information about type of delivery, total gestation weeks, pregnancy weight gain and 
final pregnancy weight, attendance to follow-up postpartum appointment, and newborn 
characteristics including sex, birth weight, length, and NICU admittance  (see Appendix 
G).  
Perceived Susceptibility (Risk) of DM and Knowledge of Type 2 Diabetes  
Risk Perception Survey for Developing Diabetes adapted for women with GD 
(RPS-DD).  The RPS-DD (see Appendix H) was used to examine multiple areas of 
perceived risk for developing diabetes (Kim, McEwen, Piette et al., 2007).  This tool is a 
24 item questionnaire which was modified from the Risk Perception Survey for 
Developing Diabetes (Walker, Mertz, Katlen, & Flynn, 2003) to target women with GD 
(Kim, McEwen, Piette et al., 2007; Michigan Diabetes and Research Training Center, 
2010).  This tool has four subscales (optimistic bias, diabetes risk knowledge, personal 
control, barriers, and benefits) and four single item questions.  The adapted instrument 
has an 8
th
 grade reading level and is completed in ten minutes or less.     
  The Optimistic Bias subscale for not developing diabetes has two items (Section 
1, items E & F) using a 1-4 Likert-type scale from 1(strongly agree) to 4 (strongly 
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disagree).  The scores are averaged with higher scores indicating the participant is 
optimistic they will not develop diabetes.  The Diabetes Risk Knowledge subscale has 
eleven items (Section 2 & 3, items A-K) that are a summation of correct responses, with 
higher scores indicating higher knowledge of risk factors of DM.  A Likert score from 1 
(increases or raises the risk) to 4 (don‘t know) is used.  The Personal Control subscale of 
developing diabetes with four items (Section 1, items A-D) uses a 1-4 Likert type scale 
with 1 (strongly agree) to 4 (strongly disagree).  Scores are averaged with higher scores 
indicating a greater personal control to prevent development of DM.  Three items 
(Section 4, A-C) focus on women‘s perceptions on Barriers and Benefits of preventive 
behaviors and are measured on a 1 (strongly agree) to 6 (strongly disagree) Likert scale.  
The scores are averaged with higher scores indicating greater belief that health behaviors 
have benefits, while lower scores reflect greater barriers to preventive activity (Michigan 
Diabetes and Research Training Center, 2010).   
  Four individual questions of the RPS-DD relate to perceived risk of developing 
DM and change of behavior.  The measurement of risk perception is a single item (item 
5) asking, ―What do you think your risk or chance is for getting diabetes over the next 10 
years?‖  The participant chooses Likert-type scale of 1 (almost no chance) to 4 (high 
chance).   In addition, the authors added a question (item 6) using the Likert scale of 1 
(almost no chance) to 4 (high chance) pertaining to risk perception of developing diabetes 
to address the possibility that women who plan to make life changes may have lower risk 
perception. ―If you don‘t change your lifestyle behaviors, such as diet or exercise, what is 
your risk or chance of getting diabetes over the next 10 years?‖  Two questions (items 7 
& 8) focus on change of behavior and the intent to change behavior to lower chances of 
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developing DM using a yes/no response (Michigan Diabetes and Research Training 
Center, 2010).   
The initial cross-sectional study using the RPS-DD adapted for women with GD 
(Kim, McEwen, Piette et al., 2007) surveyed 217 women with a history of GD and 
reported psychometric analysis of the subscales.  The Optimistic Bias subscale 
(Cronbach‘s alpha of 0.65), Diabetes Knowledge subscale (Cronbach‘s alpha of 0.70) and 
Personal Control (Cronbach‘s alpha of 0.72) had acceptable internal consistency for a 
new instrument (Burns & Grove, 2005).  For barriers and benefits subscale, the authors 
noted that the Cronbach‘s alpha was not calculated because the questions were not 
originally designed to measure the same construct, but were a summary of benefits and 
barriers.  The four individual items have no reliability reported.  There is also no validity 
reported for the adapted RPS-DD, but the original version of the RPS-DD did report 
content and face validity by a panel of clinical diabetes experts, risk perception experts, 
and health psychologists (Walker et al., 2003).    
Barriers and Cues to Action of Healthy Behaviors and Screening 
Five open ended questions were developed by the investigator to elicit descriptive 
data for barriers to adopt healthy lifestyle behaviors and postpartum glucose screening.  
These questions include: 1) How do you describe a healthy lifestyle? 2) Is a healthy 
lifestyle important to you? 3) Can you give me the top three reasons that prevent you 
from having a healthy lifestyle (e.g. eating healthy diet, exercising, losing weight)? 4) 
Did you receive blood glucose screening at your postpartum appointment? 5) If you did 
not receive blood glucose screening at your postpartum appointment, what was the reason 
you did not have this blood work done?   Two open ended questions were developed by 
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the investigator to elicit descriptive data for cues to action to obtain postpartum glucose 
screening and adopt healthy lifestyle behaviors.  These questions include:  1) Can you tell 
me what encourages or motivates you to adopt healthy lifestyle behaviors (e.g. lose 
weight, eat healthy diet, exercise?  and 2) What motivated you to get a glucose test 
postpartum? (see Appendix I).  
Self-Efficacy for Health Practices 
Self-Rated Abilities for Health Practices (SRAHP).  The SRAHP was used to 
measure the self-efficacy to adopt healthy lifestyle behaviors.  This tool (see Appendix J) 
is a measurement of the self-perceived ability (self-efficacy) to implement behaviors that 
are health promoting, including diet as well as exercise (Becker et al., 1993; University of 
Texas at Austin School of Nursing, 2007).  This 28 item scale includes four subscales: 
exercise (items 4, 15-18), nutrition (items 1-3 and 5-7), responsible health practices 
(items 22-28), and psychological wellbeing (items 8-14).  The subscales of the Self-Rated 
Abilities for Health Practices focus on health practices that were determined important 
from the health promotion literature for implementing health promoting behaviors.  The 
Nutrition subscale (seven items) measures one‘s belief that he/she is able to perform 
activities for healthy nutrition, such as eating a balanced diet and drinking water.  The 
exercise subscale (seven items) measures beliefs about ability to perform physical 
activity/exercise.  The Responsible Health Practices subscale (seven items) is the 
individual‘s confidence to interact with the health care provider, while the Psychological 
Well Being subscale (seven items) is related to stress management skills (University of 
Texas at Austin School of Nursing, 2007). 
59 
 
 
 
The SRAHP is a five point Likert-type scale rated from 0 (not at all) to 4 
(completely) to represent an individuals‘ confidence to perform health practices.  A total 
score was calculated from a summation of all subscales, with a range from 0-112, with 
higher scores indicating greater self-efficacy for health practices (Becker et al., 1993).  
Evaluation for reliability was determined in three separate samples including adults 
attending a health fair (N=188), undergraduate students (N=111) and adults with 
disabilities (N=117) with Cronbach‘s alpha for total score ranging from 0.91-0.94 and 
subscales ranging from 0.76 to 0.92.  Content validity was established through review of 
experts while convergent validity determined significant moderate correlations with the 
General Self-Efficacy Scale (r= 0.43, p<.01) and Health Promoting Lifestyle Profile 
(r=.69, p<.01). 
Healthy Lifestyle Behaviors 
Health Promotion Lifestyle Profile II (HPLPII).  The HPLPII (Appendix K) 
measures the frequency of self-reported healthy behaviors focusing on six main areas 
including physical activity, spiritual growth, health responsibility, interpersonal relations, 
nutrition, and stress management (Walker & Hill-Polerecky, 1996).  The 52 item 
questionnaire has six subscales which focus on different areas of lifestyle behaviors 
(Frank-Stromberg & Olsen, 2004; University of Nebraska College of Nursing, 2010).  
Nutrition (items 2, 8, 14, 20, 26, 32, 38, 44, 52) includes the selection and consumption 
of a healthy diet according to guidelines of the Food Guide Pyramid which are important 
for health and well-being while physical activity (items 4, 10, 16, 22, 28, 34, 40, 46) 
questions determine participation in regular activity.  Another area of this tool is health 
responsibility (items 3, 9, 15, 21, 27, 33, 39, 45, 51) which is a belief of one‘s 
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accountability for their own health and well-being through education, attention to own 
health, and being informed when seeking professional assistance.  A subscale which 
focuses on the development of inner resources is Spiritual Growth (items 6, 12, 18, 24, 
30, 36, 42, 48, 52 ) with achievement through transcending, connecting, and developing 
thus, giving a feeling of harmony, provision of inner peace, and finding a sense of 
purpose.  Stress management  (items 5, 11, 17, 23, 29, 35, 41, 47 ) is the identification 
and implementation to control or reduce tension while the final subscale of this tool is the 
interpersonal relations (items 1, 7, 13, 19, 25, 31, 37, 43, 49) which is communication 
and developing close relationships with others (University of Nebraska College of 
Nursing, 2010). 
The HPLPII has a four point Likert-type scale ranging from 1 (never) to 4 
(routinely) to indicate the frequency a respondent engages in a certain type of health 
behavior.  An overall score of the health promoting lifestyle is a calculation of the mean 
of responses from all items.  In addition, subscale scores are calculated using the mean 
for each set of questions of the subscale.  The authors recommend a use of means for 
scoring to have more meaningful comparisons of each of the subscales (Frank-Stromberg 
& Olsen, 2004; University of Nebraska College of Nursing, 2010; Walker & Hill-
Polerecky, 1996).   
The psychometric evaluation of the HPLPII was established through data from a 
test population of (n=712) adults ranging from 18-92 years of age.  The total scale alpha 
coefficient of internal consistency was 0.943 and the subscales Cronbach‘s alpha ranged 
from 0.793 to 0.872.  Twenty-six undergraduate students were used to evaluate test-retest 
stability at a three week interval and resulted with r=0.892.  Content validity was 
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determined through evaluation of content experts and literature review, while construct 
validity was supported through factor analysis for the six subscales and convergent 
validity with the Personal Lifestyle Questionnaire (r=.678) (University of Nebraska 
College of Nursing, 2010; Walker & Hill-Polerecky, 1996).  
Sleep Disturbance 
General Sleep Disturbance Scale (GSDS).  The GSDS is a 21 item 
questionnaire (Appendix L) with seven subscales which measures the frequency, during 
the past week, a person experiences difficulty initiating sleep (one item), mid-sleep 
awakenings (one item), early awakenings (one item), sleep quality (three items), sleep 
quantity (two items), sleepiness (seven items), and use of substances to aid sleep (six 
items) (Lee, 1992).  Due to the fact that the majority of pregnant women will not use 
sleep aids during pregnancy, the items associated with sleep aids were omitted, therefore 
only items 1-15 were used.  The instrument uses an eight point Likert-type scale with 0 
(never) to 7 (everyday) weekly scale and uses a mean score of  >3 on the total scale or 
any subscale to indicate significant sleep disturbance.  This is based on the DSM-IV 
criteria for symptoms of insomnia having a frequency of at least three times per week. 
Psychometric evaluation for this tool was demonstrated in a sample of female 
registered nurses working varied shifts of day, evening, and rotating (N=760) with the 
Cronbach‘s alpha coefficient 0.88 for the overall scale and subscale of sleep quality 
(0.79) and daytime sleepiness (0.82) were reported.  Other subscales have limited number 
of items, therefore alpha coefficients were not measured.  In a study of sleep patterns in 
new mothers and fathers (N=72 couples), the Cronbach‘s alpha was 0.77 and 0.85 
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respectively (Gay, Lee, & Lee, 2004).  Construct validity of the GSDS was also evaluated 
with the modified Stanford Sleep Questionnaire Assessment of Wakefulness (Lee, 1992).  
Intervention 
SUGAR Intervention Group 
Women with GD in the SUGAR group received standard prenatal and postpartum 
care.  During the third trimester of pregnancy, the participants had regular prenatal visits 
every two to four weeks and then weekly beginning at 36 weeks gestation.  Participants 
also had monitoring of blood glucose as appropriate, a consultation appointment with a 
diabetes educator, and use of insulin or oral hypoglycemic agents as indicated to control 
blood glucose.  In addition to the standard care, the SUGAR group received an 
educational intervention, led by the student PI.  The focus of the 30 minute session was to 
provide education to the participant about the risk of DM after childbirth, associated risk 
factors of DM (such as family history, use of insulin during pregnancy, sleep duration, 
obesity, and sedentary lifestyles), glucose intolerance risk for future pregnancies, 
recommended postpartum glucose screenings, and healthy lifestyle behaviors to prevent 
or delay DM based on ACOG and ADA recommendations for women with GD.  The 
educational session was conducted by the student PI in a private room located at the 
designated OB/GYN office in a comfortable environment.  Two educational brochures 
entitled ―What I Need to Know About Gestational Diabetes‖ (NIDDK, 2006) and ―Small 
Steps Big Rewards: Your Game Plan to Prevent Type 2 Diabetes‖ (National Diabetes 
Education Program, 2006) were provided to the participant during the session (See 
Appendix M and N).  A manual of content with full script and learning activities was 
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developed to maintain consistency in delivery of the intervention managed by the student 
PI.  
Four components were reviewed during the session: 
Component 1: Discussion of general information about GD which included the 
definition of GD, causes, diagnosis, and treatment. The PI elicited knowledge the 
participant had about GD and provided additional information and/or addressed 
misconceptions. 
Component 2: The focus of this component was the risk for DM after pregnancy.  
Emphasis of information was placed on health risk for the child-bearing woman 
and health risks of children of future pregnancies. Risk of subsequent GD 
pregnancy was also discussed. 
Component 3: This component focused on the recommended postpartum glucose 
screening guidelines instituted by the ADA and ACOG. A flow-chart was 
reviewed detailing postpartum glucose screenings 6-12 weeks postpartum 
(primarily performed at follow-up postpartum visit) and future blood glucose 
screenings for DM annually or every three years, depending on postpartum 
glucose screening results.  
Component 4: Healthy lifestyle behaviors which include nutritious diet and active 
lifestyle through exercise were reviewed.  The ADA nutrition guide was reviewed 
for understanding of healthy nutrition to prevent DM.  Recommendations of 
moderate exercise of 150 minutes per week were reviewed and examples of 
moderate exercise were provided.  The PI assisted the participant in determining 
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exercise that was beneficial and activities that were realistic for the busy lifestyle 
of a mother with a newborn. 
Attention Control Group 
Women with GD in the attention control group received standard prenatal and 
postpartum care.  During the third trimester of pregnancy, the participants had regular 
prenatal visits every two to four weeks and then weekly beginning at 36 weeks gestation, 
monitoring of blood glucose as appropriate, a consultation appointment with a diabetes 
educator, and use of insulin or oral hypoglycemic agents as indicated to control blood 
glucose.  In addition to the standard care, a 30 minute attention control session was 
conducted by the student PI at the next obstetrical appointment following enrollment into 
the study.  A comfortable private room located at the designated health system OB/GYN 
office was used for the session.  The component for this group focused on care of the 
newborn including nutrition and newborn safety.  An educational brochure entitled 
―Caring for Your Newborn‖ (Appendix O) which is based on recommendations from the 
American Academy of Pediatrics (Media Partners, 2008) was used to guide the session 
and was provided to the participant during the session.  The brochure is written on a 5th-
6
th
 grade reading level and provided additional resources for information on care of the 
newborn.  A manual of content with full script and learning activities was developed to 
maintain consistency in delivery of the attention control intervention managed by the 
student PI.  
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Booster Session 
A booster session to both groups was delivered via telephone at two to four weeks 
postpartum to reinforce information provided at the educational session and served as a 
reminder of study participation.  No additional information was provided. 
Study Procedures 
After obtaining IRB and NRC approval from all sites, the student PI began the 
study procedure (see Figure 2) with recruitment of participants in their third trimester of 
pregnancy (32-36 weeks gestation) at the designated OB/GYN offices.  For recruitment, 
the student PI posted flyers in the OB/GYN offices and provided staff with additional 
flyers to give to women diagnosed with gestational diabetes.  The student PI reviewed the 
medical record for the diagnosis of gestational diabetes and to determine first time 
diagnosis of gestational diabetes.  Once the potential participant was identified, the staff 
nurse was asked to approach the patient to determine if the participant was interested in 
meeting with the student PI.  The information card was completed and the patient was 
screened for study eligibility by the student PI.  The student PI met with the participant at 
her prenatal appointment and enrolled the participant in the study, obtained written 
informed consent, and administered (paper/pencil form) the baseline demographic 
questionnaire (pre-test).   
Study participants were enrolled during their third trimester of pregnancy  
(32-36 weeks gestation) and randomly assigned to the intervention group or the attention 
control group after baseline data was obtained.  In general, the diagnosis of GD is 24-28 
weeks gestation, thus enrollment of the participant at approximately 32-36 weeks 
gestation provided the participant time to accept the medical condition and engage in 
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standard care practices of GD before participating in the educational intervention.  In 
addition, this stage of the pregnancy allowed sufficient time for the PI to provide the 
information prior to delivery.    
Women who were assigned to the intervention group (SUGAR) received the first 
educational intervention at the next obstetrical appointment (one to two weeks) after 
enrollment, while the attention control group received information on care of the 
newborn.  Prior to the educational session, questionnaires including the Risk Perception 
Survey for Developing Diabetes adapted for women with GD [RPS-DD] (Kim, McEwen, 
Piette et al., 2007), Self-Rated Abilities for Health Practices [SRAHP] (Becker, 
Stuifbergen, Oh, & Hall, 1993), Health Promoting Lifestyle Profile II [HPLPII] (Walker 
& Hill-Polerecky, 1996), General Sleep Disturbance Scale [GSDS] (Lee, 1992), and 
Barriers and Cues to Healthy Behaviors and Screening were administered.  Sessions for 
the intervention group and the attention control group were conducted by the student PI.  
For the educational intervention, a private room at the OB/GYN office was used for a 30 
minute session using strategies to engage the adult learner in discussion and activities to 
encourage engagement in the learning process and provide pertinent information to help 
motivate the learner to implement healthy strategies for their lifelong health.  Educational 
brochures were provided to the participant during the session.  For attention control, the 
control group also had a session at the next obstetrical appointment after enrollment.  A 
private room at the OB/GYN office was used for the session to discuss care of the 
newborn including nutrition and newborn safety.  In addition, an educational brochure on 
newborn care was provided during the session.  
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Two to four weeks postpartum, the participants received a telephone call from the 
student PI to remind them of the ongoing study and to reinforce information that was 
provided during the educational session.  The contact served as a booster session and 
encouraged completion of all phases of the project and required a time commitment of 
the participant of approximately five to ten minutes. 
Follow-up assessment (post-test) for both groups occurred six to eight weeks 
postpartum at the postpartum follow-up appointment.  Post-test data collection included 
postpartum demographics and repeat measures of the RPS-DD, SRAHP, HPLPII, GSDS, 
and Barriers and Cues to Healthy Behaviors and Screening.  If the participant did not 
attend the appointment, data was collected by telephone interview.  After completion of 
the study, all participants received a $10 gift card for compensation of time associated 
with participating in the study.  In addition, women that were randomized in the attention 
control group received the same educational brochures provided to the intervention 
(SUGAR) participants focusing on the risk of DM after childbirth, associated risk factors, 
and glucose intolerance risk for future pregnancies, recommended postpartum glucose 
screenings, and healthy lifestyle behaviors to prevent or delay DM. 
68 
 
 
 
Figure 2: Research Design Pretest/Posttest 
SCREEN 
Pregnant women diagnosed with GD in index pregnancy 
 
 
 
 
ENROLL, CONSENT, AND PRETEST MEASUREMENT 
(32-36 weeks gestation) 
Total 25 participants 
Demographic Form 
 
 
 
 
 
RANDOMIZATION 
 
 
 
 
 
 
    Intervention Group                                                                                     Attention Control Group     
    1) Additional Pre-test Measurement:                                                         1) Additional Pre-test Measurement:                                                                                                       
        Perceived Susceptibility (RPS-DD)                                                            Perceived Susceptibility (RPS-DD)                                                                         
        Knowledge of DM (RPS-DD subscale)                                                      Knowledge of DM (RPS-DD subscale) 
        Barriers & Cues to Action (open ended)                                                     Barriers & Cues to Action (open ended) 
        Self-Efficacy (SRAHP)                                                                               Self Efficacy (SRAHP) 
        Healthy Lifestyle Behaviors (HPLP II)                                                       Healthy Lifestyle Behaviors (HPLP II)          
        General Sleep Disturbance Scale (GSDS)                                                   General Sleep Disturbance Scale (GSDS)                                                                               
                                                                                            
     2) Educational Intervention (GD Risk)                                                                2) Attention Control (Newborn Care) 
           Session 1: (34-38 wks)                                                                                         Session 1: (34-38 wks) 
             *next OB appointment                                                                                         *next OB appointment 
             *One on one counseling                                                                                       *One on one counseling 
           Session 2: (2-4 wks PP)                                                                                       Session 2: (2-4 wks PP) 
             *Reinforcement by telephone                                                                               *Reinforcement by telephone 
 
 
 
 
 
POSTTEST MEASUREMENT 
Postpartum 6-8 weeks 
Postpartum Demographic Form 
Perceived Susceptibility (RPS-DD) 
Knowledge of DM (RPS-DD subscale) 
Barriers & Cues to Action (open-ended questions) 
Self-Efficacy (SRAHP)  
Healthy Lifestyle Behaviors (HPLP II)   
General Sleep Disturbance Scale (GSDS)  
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       Methods of Data Analysis  
  Data was transferred from the questionnaires to the computer program Statistical 
Package for the Social Sciences (SPSS) version 18 for Windows using a double entry 
method to ensure accuracy of transcribed data.  Prior to substantive analyses, the data was 
subjected to cleaning to check for impossible or improbable values.  Internal consistency 
reliability measures for all instruments were calculated using Cronbach‘s alpha 
coefficients.  Frequency distributions were also examined for reasonable approximations 
to normality for all continuous variables.  Descriptive statistics were used to describe 
sample characteristics and major study variables.  Mean scores and standard deviations 
were obtained for each scale and subscales.  T-tests or chi-square as appropriate, were 
used to determine if there are any significant differences at baseline between the groups 
of participant characteristics which could impact the outcome variables (e.g. educational 
background).  
Analysis Plan for Specific Research Questions 
Research question 1: (To what degree is the likelihood of adopting healthy 
lifestyle behaviors explained by pregnant woman‘s selected demographic (age, education, 
ethnicity, use of insulin during pregnancy, BMI >25 before pregnancy, sleep duration), 
structural variable (knowledge of diabetes, family history of type 2 diabetes), perceived 
risk, and self-efficacy?) was analyzed using Hierarchical Multiple Linear Regression to 
determine whether demographic variables, structured variables, and self-efficacy can 
predict healthy lifestyle behaviors.  To select the appropriate independent variables for 
the final regression model, a correlation matrix was used to determine the strength of 
relationships between the predictor variables and the outcome variable (healthy lifestyle 
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behaviors).  Distribution results determined use of parametric (Pearson‘s Product 
Moment Correlation coefficient) or non-parametric (Spearman‘s Rho) correlation.  The 
strength of the relationship will be described as weak (r<0.3), moderate (r=0.3 to 0.5), 
and strong (r>0.5) and direction is either positive or negative values of r (Field, 2009).  
Independent variables with a correlation coefficient equal to or greater than 0.3 were 
included in the hierarchical regression model.  Independent variables that were highly 
correlated were not used because the predictors will account for similar outcome 
variance, thus making it difficult to distinguish importance of individual predictors 
(Field, 2009).  Next, the variables were entered in two steps based on the Health Belief 
Model (Rosenstock, 1974) adopted in this pilot study.  Demographic variables (age, 
education, ethnicity, use of insulin during pregnancy, BMI >25, or sleep duration), and 
structural variables (knowledge of diabetes or family history of type 2 diabetes) were 
entered as the first step and then entered self-efficacy as the second step.  A significant 
change in R Square (use of F distribution with p<.05) (Munro, 2005) would indicate that 
the independent variable (demographic variables, structured variables, self-efficacy) was 
a predictor of healthy lifestyle behaviors.  Due to the small sample size, the total 
independent variables entered into the model were limited to three.  A post-hoc power 
analysis was conducted to examine the observed power based on the regression models. 
Research question 2: (What effect sizes are expected for perceived susceptibility 
(risk) of developing DM, knowledge of DM, self-efficacy to adopt healthy lifestyle 
behaviors and adoption of healthy lifestyle behaviors after childbirth when comparing the 
two experimental groups [control group: standard care with attention control and 
treatment group: educational intervention] at 6-8 weeks postpartum?) was tested to 
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determine the effect size by calculating the mean difference and standard deviation of the 
intervention group and control group (Cohen d).  A small effect size was defined as about 
0.2, a medium one was about 0.5, and a large one was about 0.8 (Cohen, 1988). 
Research question 3: (What are the barriers to obtaining postpartum glucose 
screening and adopting healthy lifestyle behaviors after childbirth among women with a 
diagnosis of GD?) was analyzed as descriptive data with identification of common 
themes and placed in grouping data of like categories.  Similar categories among 
participants are reported.  
Research question 4: (What type of cues of action encourages postpartum glucose 
screening and adoption of healthy lifestyle behaviors?) was analyzed as descriptive data 
with identification of common themes and placed in grouping data of like categories.  
Similar categories among participants are reported.
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CHAPTER IV 
RESULTS 
The findings of this pre-test, post-test, two group quasi- experimental pilot study 
is presented in this chapter.  Data were double entered and prior to statistical analysis, 
outliers, missing data, and normal distribution were evaluated.  Ordinal data were dummy 
coded.  Interval/ratio level variables were assessed for normality by analyzing skewness.  
All variables were normally distributed.  SPSS (Version 18) software was used for 
statistical analysis and a significance level of p <.05 was set for analysis.  Description of 
sample characteristics, reliability of instruments, and data regarding research questions 
are reported.  
Sample Characteristics 
Between September 2011 and July 2012, women diagnosed with gestational 
diabetes (GD) were screened (N=59) for eligibility for this study.  Twenty-six women 
were eligible for the study and were invited to participate.  One potential participant 
declined to participate in this study and two women withdrew from the study.  The 
women who withdrew from the study did so after baseline demographic data was 
collected and prior to the second session.  The first participant was withdrawn due to a 
preterm delivery, and the second participant declined to participant further and withdrew 
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stating that she was not feeling well during her pregnancy.  A total of twenty-three 
women completed the entire protocol. 
At the beginning of the study, participants were randomly assigned to either the 
intervention (SUGAR) group or the control group.  During the enrollment phase of 
participants, the decision was made to randomly assign only five women to the control 
group and the other participants in the intervention group to provide a better opportunity 
to pilot test the intervention.  Table 1 summarizes the characteristics of the pregnant 
women (N=25) who completed the baseline data collection.  Table 2 summarizes the 
characteristics of the postpartum women who completed the protocol (N=23).  To 
determine if there were any differences between the control and intervention group, 
appropriate Chi-Square statistics or independent t-tests were used for analysis.  This was 
a homogeneous group except for a significant difference between groups noted in 
gestational weeks at delivery (p=.005) category; however, a majority were term infants.  
Participants ranged in age from 21-37 years with a mean age of 29.7 (SD=3.9).  
Less than half of the participants were Caucasian (40%), while 60% of the participants 
were from minority populations including African American (32%), Hispanic (8%) and 
Asian (12%).  A majority of the participants (60%) had a family income of >$35,000, 
married (76%), and had previous pregnancies (72%).  The majority of the women had at 
least some college education (76%) and had a family history of DM (56%).   
Pre-pregnancy weight for participants ranged from 126-327 pounds with an average BMI 
of 33.13(SD= 7.65).  Only 8% of the participants used insulin during the pregnancy, 
while 28% used oral medications (100% used Glyburide) during the pregnancy to control 
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blood sugar.  The majority of women (64%) controlled glucose levels through diet 
management. 
Table 1 
Sample Characteristics and Inter-group Characteristics Comparison 
Characteristic 
Total Sample 
N=25 
SUGAR 
Group 
n=20 
Control 
Group 
n=5 
  
 M (SD) or N 
(%) 
M (SD) or 
 n (%) 
M (SD) or 
n (%) 
x
2
or t p 
value 
Age (years) 
 
29.68(3.88) 30.25(3.54) 27.40(4.78) -1.51 .15 
Gravida 
     1-3 
     4-6 
     8- 9 
 
20(80%)               
 3(12%)                 
 2(8%) 
 
17(85%) 
2(10%) 
  1(5%) 
 
3(60%) 
1(20%) 
1(20%) 
 
1.77 .41 
Para 
     0 
     1-2 
     3-4     
 
12(48%)               
10(40%)                   
  3(12%)                   
 
9(45%) 
9(45%) 
2(10%) 
 
3(60%) 
1(20%) 
1(20%) 
 
1.15 .56 
BMI 33.13(7.65) 34.23(7.71) 30.74(8.82) -0.77 .45 
 
Weeks Diagnosis of GD 
      >24 weeks 
      < 24 weeks 
              
19(76%)                      
  6(24%) 
             
14(70%)                 
  6(30%) 
 
0
5(100%) 
 
2.43 .12 
Health Care Provider         
     OB/GYN 
     Midwife       
 
              
12(48%)                  
13(52%)              
 
9(45%) 
11(55%) 
              
3(60%)           
2(40%)  
 
0.36 .55 
 
(continued)  
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Sample Characteristics and Inter-group Characteristics Comparison Table (continued) 
Characteristic 
Total 
Sample 
N=25 
SUGAR 
Group 
n=20 
Control 
Group  
n=5 
  
Ethnicity 
      Caucasian 
      Black/African American         
Hispanic/Latino 
Asian      
Other           
     Asian/Hispanic 
     Caucasian/Hispanic           
                
10(40%)                    
8(32%)                 
  2(8%)                 
  3(12%) 
                 
  1(4%)                 
  1(4%)               
   
 
9(45%) 
6(30%) 
1(5%) 
3(15%) 
 
0
1(5%) 
 
1(20%) 
2(40%) 
1(20%) 
0 
 
1(20%) 
0 
1.04 .31 
Marital Status 
     Married 
     Divorced 
     Separated 
     Single 
                  
19(76%)                     
  0                     
  0                    
  6(24%)           
                     
16(80%)                                              
0                      
0 
4(20%) 
                  
3(60%)
0 
0                  
2(40%) 
 
0.88 .35 
# Family Members live in   
   Home 
 
3.20(1.12)  3.10(.968)  3.60(1.67) 0.89 .38 
Education 
     Some high school/HS   
         Grad 
     Some College/>College     
   Grad 
 
               
  6(24%)                    
 
19(76%)                   
 
                    
6(30%)                    
 
14(70%)                   
 
                 
0                                 
 
5(100%)                                     
1.97 .16 
Family Income 
     < $34,999 
      $35,000-$74,999 
      $75,000 and over 
         
10(40%)                   
  9(36%)                   
  6(24%)                   
                    
8(40%)                                 
7(35%)                 
5(25%)                  
 
2(40%)
2(40%) 
1(20%) 
 
0.07 .97 
Family Member History of 
DM 
     Yes 
      No 
                  
 
14(56%)                  
11(44%) 
              
 
12(60%)                  
  8(40%) 
                 
 
2(40%)             
3(60%) 
 
0.65 .42 
 
(continued) 
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Sample Characteristics and Inter-group Characteristics Comparison Table (continued) 
Characteristic 
Total 
Sample 
N=25 
SUGAR 
Group 
n=20 
Control 
Group  
n=5 
  
Insulin Use During Preg. 
     Yes 
      No 
 
               
  2(8%)                
23(92%) 
                  
2(10%)                 
18(90%) 
 
 
0                
5(100%) 
0.54 .46 
Glyburide Use During Preg. 
     Yes 
      No 
 
                    
  7(28%)                
18(72%) 
                    
5(25%)                 
15(75%) 
                   
2(40%)                   
3(60%) 
0.45 .50 
Sleep Duration (hours) 7.48(1.53) 7.45(1.54) 
 
7.60(1.67) 0.19 .85 
*p<.05 
 
A majority of the women (70%) delivered at term with 52% of the participants 
delivering vaginally and 48% delivering by cesarean section.  The women gained an 
average of 22.8 (SD=12.79) pounds during their pregnancy.  Newborns had an average 
birth weight of 7.16 (SD=1.28) pounds.  However, one newborn in the SUGAR group 
required admission to the Neonatal Intensive Care Unit (NICU) due to complications 
related to sepsis and low blood glucose. 
Information was obtained to determine sleep issues for the pregnant and 
postpartum woman.  Women reported to feel refreshed they needed, on average, 7.64 
(SD=1.93) hours of sleep.  They were asked the average nocturnal total sleep time (in the 
past week) during their pre-test and post-test data collection time period.  During pre-test 
women, on average, slept 7.48 (SD=1.53) hours, but only slept 5.22 (SD=1.38) hours 
during post-test.  During the postpartum period, women were awakened by the newborn 
an average of 2.96 (SD=1.40) times per night and they slept significantly less than what 
they needed (paired t [22] = 4.88, p<.001). 
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Table 2 
Postpartum Sample Characteristics with Comparison of Groups 
Characteristic 
 
Total 
Sample 
N=23 
SUGAR 
Group 
 n=18 
Control 
Group 
n=5 
  
 M (SD) or              
N (%) 
M (SD) or         
n (%) 
M (SD) or     
n (%) 
x
2 
or t p 
value 
Weeks Delivered 
      <37 
       >38 
 
38.17(1.11)                      
  7(30%)                           
16(70%) 
38.5(.536)                         
  3(17%)                     
15(83%) 
37(1.23)                        
4(80%)                        
 1(20%) 
-3.16 .01* 
Type of Delivery 
      Vaginal 
      C-Section 
 
                          
12 (52%)                         
11(48%) 
                      
9(50%)                       
9(50%) 
                   
3(60%)                      
2(40%) 
0.71 .70 
Pregnancy Weight Gain 
(lbs.) 
 
22.83(12.79) 21.78(13.22) 26.6(11.61) 0.74 .47 
Sleep Duration 
 
5.22(1.38) 5.17(1.51) 5.40(.89) 0.33 .75 
Awakened by Newborn  
 
2.96(1.40) 2.94(1.55) 3.0(.71) 0.08 .94 
Baby Gender 
       Boy 
       Girl 
 
                           
10(43%)                           
13(57%) 
 
9(50%) 
9(50%) 
                   
1(20%)                      
4(80%) 
2.07 .36 
Average Weight (lbs.) 
of Newborn 
 
7.16(1.28) 7.42(1.28) 6.21(.81) -1.98 .06 
Average Length (in.) of 
Newborn 
 
18.84(.99) 19(.95) 18.25(1.00) -1.55 .14 
Baby to NICU 
        Yes 
        No 
 
                                 
  1(5%)                           
22(95%) 
                           
  1(6%)                    
17 (94%) 
 
0 (0%) 
5(100%)                                     
                                          
0.29 .59 
*p < .05 
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Description of Research Instruments 
Instruments used for this study were based on the Health Belief Model and 
included perceived risk, knowledge of diabetes, self-efficacy of healthy lifestyle 
behaviors, sleep disturbance, and healthy lifestyle behaviors.  The internal consistency of 
the instruments (Table 3) used in this study was assessed and all had an acceptable 
Cronbach‘s alpha coefficient (> .70). 
Table 3 
Reliability of Instruments 
Instrument # of items Cronbach‘s 
Alpha 
Risk Perception Survey for Developing Diabetes adapted 
women with Gestational Diabetes (RPS-DD)* 
     Diabetes Risk Knowledge 
     Risk Perception  
     Risk Perception with no Lifestyle Change    
     Personal Control* 
     Optimistic Bias* 
     Benefits and Barriers* 
     Recent Lifestyle Change 
     Plans for Future Lifestyle Change 
24 
 
11 
1 
1 
4 
2 
3 
1 
1 
0.58 
 
0.78 
n/a 
n/a 
0.55 
0.57 
0.57 
n/a 
n/a 
Self-Rated Abilities for Health Practices (SRAHP) 
     Nutrition 
     Psychological Well-Being 
     Exercise 
     Responsible Health Practices 
28 
7 
7 
7 
7 
0.94 
0.77 
0.84 
0.93 
0.84 
Health Promotion Lifestyle Profile II (HPLP II) 
     Health Responsibility 
     Physical Activity 
     Nutrition 
     Spiritual Growth 
     Interpersonal Relations 
     Stress Management 
52 
9 
8 
9 
9 
9 
8 
0.96 
0.87 
0.88 
0.82 
0.88 
0.87 
0.88 
General Sleep Disturbance Scale (GSDS) 
     Sleep Quantity 
     Sleep Quality    
     Daytime Function 
     Maintenance Insomnia*   
15 
2 
8 
5 
2 
0.93 
0.78 
0.93 
0.92 
0.67 
*deleted for final data analysis 
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The Risk Perception Survey for Developing Diabetes adapted for women with 
GD (RPS-DD) (Kim, McEwen, Piette et al., 2007; Michigan Diabetes and Research 
Training Center, 2010) was used to measure risk perception and knowledge of diabetes.  
The Cronbach‘s alpha for the 24-item total scale for the RPS-DD was not acceptable and 
therefore the total scale was not used for analysis.  In addition, the subscales of Personal 
Control, Optimistic Bias, and Benefits and Barriers were excluded from final analysis 
because of the Cronbach‘s alpha less than 0.70.  For this study, a single item from the 
RPS-DD was used to determine risk perception.  At baseline, the women perceived a 
slight to moderate chance of developing diabetes (M= 2.71, SD= .71), measured by the 
single item risk perception subscale of the RPS-DD.  
The Diabetes Risk Knowledge subscale of the RPS-DD (see Table 4) is a 
summation of correct responses (0-11), with higher scores indicating higher knowledge 
of risk factors of DM (Kim, McEwen, Piette et al., 2007; Michigan Diabetes and 
Research Training Center, 2010).  At baseline, women had an average knowledge of 
diabetes risk of 6.3 (SD= 1.87).  A majority of the women (78%) recognized that a 
diagnosis of gestational diabetes and a family history of diabetes (91%) increased their 
risk of diabetes; conversely, the women had lower knowledge of ethnicity and age risk 
factors.  In addition, the women understood that diet, exercise, and weight control 
prevented diabetes. 
Self-Rated Abilities for Health Practices (SRAHP) was used to measure self-
efficacy to adopt healthy lifestyle behaviors.  SRAHP is a measurement of the self-
perceived ability (self-efficacy) to implement behaviors that are health promoting, 
including diet and exercise (Becker et al., 1993; University of Texas at Austin School of 
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Nursing, 2007).  The SRAHP is a 28 item scale using a five point Likert-type scale rated 
from 0 (not at all) to 4 (completely) to represent their confidence to perform health 
practices.  A total score was calculated from a summation of all subscales, with a range 
from 0-112, with higher scores indicating greater self-efficacy for health practices 
(Becker et al., 1993).  Subscales include nutrition, exercise, psychological well-being, 
and responsible health practices.  Higher scores indicate higher total self-efficacy and 
self-efficacy subscale.  Since no cut off point was available, we reported the median score 
to have a better interpretation of the finding of this population.  At baseline, the control 
group indicated a higher overall self-efficacy (mdn = 105), than the SUGAR group 
(mdn= 95), although not significant in this small sample (t [21] = 1.3, p=.18). 
Health Promotion Lifestyle Profile II (HPLPII) measured the frequency of self-
reported healthy behaviors focusing on six main areas of healthy lifestyle behaviors 
(Frank-Stromberg & Olsen, 2004; University of Nebraska College of Nursing, 2010).  
The subscales focused on physical activity, spiritual growth, health responsibility, 
interpersonal relation, nutrition, and stress management (Walker & Hill-Polerecky, 
1996).  The 52 item questionnaire has a four point Likert–type scale ranging from  
1 (never) to 4 (routinely) to indicate the frequency a respondent engages in a certain type 
of health behavior.  At baseline, women had a mean score of 2.8 (SD= .50), indicating 
that the women engaged in healthy lifestyle behavior ―sometimes.‖ 
The 15 item General Sleep Disturbance Scale (GSDS) questionnaire was used to 
determine sleep disturbance in the past week for the study participants; including sleep 
initiation, maintenance insomnia, sleep quantity, sleep quality, and daytime function 
(Lee, 1992).  At baseline, study participants self-reported a mean score of 3.64 (SD= 
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1.58) which indicated a clinical significant sleep problem for they experienced 
approximately four days of sleep disturbances in the past week. 
      Inter-group comparison by using independent t- test indicated no significant 
differences among the variables at baseline in this small sample (see Table 4). 
Table 4 
Pre-test Inter-group Comparison of Theoretical Variable 
  Total  
N=23 
SUGAR 
n=18 
Control 
n=5 
 
Study Variable 
Possible 
Range 
(cut-off 
point) 
 
   M (SD) 
 
 
M (SD) 
 
M (SD) 
 
t 
Risk Perception 
 
1-4 2.7(.71) 2.8(.65) 2.2(.84) -1.66 
Knowledge of Diabetes 
 
0-11 6.3(1.87) 6.5(2.01) 5.6(1.14) -0.95 
Self-Efficacy 
   Nutrition     
   Psychological  
      Well-Being 
   Exercise 
   Responsible Health    
     Practices 
     
0-112 
0-28 
0-28 
 
0-28 
0-28 
92.96(14.66) 
24.70(3.17) 
22.96(4.04) 
 
20.65(6.85) 
24.65(3.28) 
 
90.78 (14.87) 
24.22(3.37) 
22.44(4.10) 
 
20.06(6.82) 
24.06(3.47) 
100.8(12.0) 
26.40(1.51) 
24.80(3.56) 
 
22.80(7.29) 
26.80(.84) 
1.38 
1.39 
1.16 
 
0.79 
1.72 
Healthy Lifestyle 
Behaviors 
    Nutrition 
    Physical Activity 
    Health Responsibility 
    Spiritual Growth 
    Interpersonal    
      Relations 
    Stress Management 
 
1-4 
 
2.80(.50) 
 
2.97(.55) 
2.01(.76) 
2.85(.63) 
3.20(.55) 
3.26(.52) 
 
2.57(.67) 
2.80(.54) 
 
2.97(.57) 
2.01(.83) 
2.80(.69) 
3.17(.57) 
3.19(.53) 
 
2.55(.64) 
2.90(.35) 
 
2.98(.55) 
2.00(.48) 
3.02(.32) 
3.38(.46) 
3.51(.43) 
 
2.65(.84) 
0.58 
 
0.03 
-0.04 
0.70 
0.76 
1.26 
 
0.29 
Sleep Disturbance 
    Sleep Quantity 
    Sleep Quality 
    Daytime Function 
0-7 
(>3) 
 
3.64(1.58) 
5.10(1.39) 
3.55(1.91) 
3.05(1.29) 
3.80(1.50) 
5.31(1.38) 
3.85(1.72) 
3.18(1.27) 
3.00(1.86) 
4.60(1.43) 
2.48(2.41) 
2.60(1.44) 
-1.02 
-1.00 
-1.45 
-0.88 
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Postpartum Glucose Screening 
The study participants were asked if they received postpartum glucose screening.  
Less than half of the total participants (39%) obtained postpartum glucose screening; and 
the screening was similar between the two groups.  Descriptive data was obtained for 
barriers to screening for those who did not receive screening and the motivation for those 
who did receive screening and results are reported later in this chapter.  
Findings Related to Research Questions 
Research questions and results are presented in this section.  As indicated in  
Table 4, no significant differences are noted at baseline between groups indicating a 
homogenous sample. 
Results of Research Question 1 
Research Question 1: To what degree is the likelihood of adopting healthy 
lifestyle behaviors explained by pregnant woman‘s selected demographics (age, 
education, ethnicity, use of insulin during pregnancy, BMI>25 before pregnancy, sleep 
duration), structural variable (knowledge of diabetes, family history of type 2 diabetes), 
perceived risk, and self-efficacy?  To examine research question 1, a hierarchical multiple 
linear regression was used.  Correlation among the independent variables and dependent 
variable were assessed first to determine which predictors to be entered into the 
regression model (Table 5). 
 
 
 
 
Table 5 
Relationships Among Selected Pilot Study Variables  
 Age Education Ethnicity Insulin 
Use 
BMI 
>25 
Sleep 
Duration 
GSDS Diabetes 
Knowledge 
Family Hx 
of DM 
Perceived 
Risk 
SRAHP 
Age            
Education -.23           
Ethnicity .17 .31          
Insulin Use .06 .17 -.06         
BMI>25 -.03 -.50* -.09 -.02        
Sleep Duration  
 
.14 -.13 .04 -.09 -.07       
GSDS -.06 -.20 -.33 -.22 -.09 -.10      
DM 
Knowledge 
 
.24 .48* .15 .12 -.06 .13 -.10     
Family Hx of 
DM 
 
-.01 .07 -.07 .26 .44* -.15 .01 .33    
Perceived Risk 
 
.02 -.15 -.44* -.07 .32 -.02 .26 .29 .24   
SRAHP .08 -.15 .19 .07 .32 -.02 -.55** -.08 -.12 -.13  
HPLPII .08 -.17 .14 .09 .09 .22 -.58** .17 -.31 -.25 .74** 
*p < .05, **p<.01. BMI = Body Mass Index; SRAHP= Self Rated Abilities for Health Practices; HPLPII= Health Promotion Lifestyle Profile II 
 
8
3
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Due to the smaller sample size, the total independent variables entered into the 
model were limited to three independent variables including sleep disturbance (r= -.58, 
p<.001), family history of DM (r= -.31, p=.15), and self-efficacy (r=.74, p<.001).  Based 
on the Health Belief Model adopted in this pilot study, sleep disturbance and family 
history of type 2 diabetes were entered first, which accounted for 43% of variance 
adopting healthy lifestyle (R
2
 = .43, R
2  
adj. = .37, F(2,20 )= 7.51, p<.001).  However, 
sleep disturbance was the single significant predictor.  Self-efficacy was entered as the 
second step, which added an extra 22% of the variance to adopting healthy lifestyle  
(R
2
 = .65, R
2 
adj. = .59, F (3, 19) =11.72, p< .001); however, self-efficacy was the only 
significant predictor (Table 6).  A negative correlation was found between GSDS and 
SRAHP (r=-.55, p<.01) indicating that an individual who reported higher severity of 
sleep disturbance also perceived lower self-efficacy and sleep disturbance accounted for 
30.3% of low self-efficacy.  
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Table 6 
 
Summary of Hierarchical Regression Analysis for Variables Predicting Adoption of 
Healthy Lifestyle Behaviors (N=23) 
 
 
 
 
Step 1 
________ 
  
 
Step 2 
________ 
  
 
 
 
Variable B SE β t B SE β 
 
t 
 
GSDS -.18 .05 -.58 -3.4* -.08 .05 -.27 -1.63 
 
Family History 
of DM 
 
-.30 .17 -.30 -1.80 -.24 .14 -.24 -1.73 
Self-Efficacy     .02 .01 .56 3.42* 
 
R
2
 Change  .43    .22   
 
R
2
  .43    .65   
 
Adjusted R
2
  .37    .59   
 
F  7.51*    11.59*   
 
*p < .05. GSDS = General Sleep Disturbance Scale Total Scale, Family History of 
DM = Demographic Questionnaire, and Self-Efficacy = Self Rated Abilities for Health 
Practice Total Scale 
 
Results for Research Question 2 
  Research Question 2: What effect sizes are expected for perceived susceptibility 
(risk) of developing DM, knowledge of DM, self-efficacy to adopt healthy lifestyle 
behaviors and adoption of healthy lifestyle behaviors after childbirth when comparing the 
two experimental groups (control group: standard care with attention control and 
treatment group: educational intervention) at 6-8 weeks postpartum?  To examine 
research question 2, effect size was calculated by using the mean difference and standard 
deviation of study variables from pre-test to post-test in the SUGAR and control groups.  
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Values of 0.2, 0.5, and 0.8 were defined as small, medium, and large effect size (Cohen, 
1988).  Estimated effect size ranged from small to large; with knowledge of diabetes 
having the largest effect and some of the direction was unexpected (Table 7). 
Table 7 
Variables at Pre-test and Post-test for SUGAR Group and Control Group  
 SUGAR Group (n=18) 
__________ 
Control Group (n=5) 
__________ 
 
 
Study Variable 
(Possible Range) 
 
Pre-Test 
M (SD) 
Post-Test 
M (SD) 
Pre-Test 
M (SD) 
Post-Test 
 M (SD) 
Cohen’s 
d 
Risk Perception 
(1-4) 
 
2.8(.65) 2.9(.80) 2.2(.84) 2.4(.55) 0.04 
Knowledge of 
Diabetes 
(0-11) 
 
6.5(2.01) 7.6(1.79) 5.6(1.14) 5.2(2.59) 1.04* 
Self-Efficacy 
(0-112) 
     
90.78(14.87) 91.94(19.0) 100.8(12.0) 103(9.27) -0.07 
Healthy Lifestyle 
Behaviors 
(1-4) 
2.8(.54) 2.9(.53) 2.9(.35) 3.1(.22) -0.31 
* p< .05. Cohen‘s d was calculated using the mean difference between pre-test and post-
test and standard deviation. 
Results for Research Question 3 
Research Question 3: What are the barriers to obtaining postpartum glucose 
screening and adopting healthy lifestyle behaviors after childbirth among women with a 
diagnosis of GD?  To examine research question 3, descriptive data was obtained using 
two open ended questions to determine barriers for postpartum glucose screening and 
adoption of healthy lifestyle behaviors: ―Can you give me the top three reasons that 
prevent you from having a healthy lifestyle (e.g. eating healthy diet, exercising, losing 
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weight)?‖ and ―If you did not receive blood glucose screening at your postpartum 
appointment, what was the reason you did not have this blood work done?‖  
During the semi-structured interview, participants described a healthy lifestyle as 
including a healthy diet and exercise, but also reported there were numerous barriers (see 
Table 8) that prevented them from engaging in those behaviors postpartum.  The top five 
barriers for adopting healthy lifestyle behaviors after childbirth included time, caring for 
baby/family, recovery, finances, and lack of sleep.  The most common barrier that 
prevented the women from engaging in healthy lifestyle behaviors during pregnancy and 
after delivery was time.  Time was a consistent barrier identified by the study 
participants, with work schedules and caring for their families as the most common time 
constraints.  Women stated they, ―need quick things‖ and they had a ―lack of time to cook 
the right foods.‖  Women also indicated that busy schedules affected cooking and 
engaging in exercise.  For instance, after the delivery of the newborn, many women 
stated that caring for the newborn provided little or no time to exercise and made it 
difficult to grocery shop to purchase healthy food.  Next, women indicated that recovery 
after the delivery was a barrier, especially for the women who had cesarean sections.  The 
women stated that the recovery from surgery interfered primarily with their engagement 
in exercise activities.  Finances were also noted as a common barrier to adopt healthy 
lifestyle behaviors.  Some women stated that, ―eating healthy cost more money‖ and that 
they could not afford a gym membership.   In addition, some women stated that laziness, 
lack of will power, and procrastination were also factors. 
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Table 8 
Barriers to Adopting Healthy Lifestyle Behaviors Postpartum (N=23) 
Barrier 
 
# of Women 
 
Lack of Time 15 
Recovery after Childbirth 5 
Baby/Family 4 
Expense of Food and Gym 4 
Lack of Sleep 3 
Convenience of Fast Food 2 
Food Preferences 2 
Lack of motivation/will power 2 
Lack of Energy 2 
Lazy 2 
Work/Job 2 
Difficult to get to grocery store 1 
Procrastination 1 
Lack of knowledge 1 
 
The most common barrier to postpartum glucose screening was that the health 
care provider did not order the test.  One participant stated, ―the health care provider told 
her to randomly check blood sugar with her home monitor and make an appointment with 
her primary care physician to check glucose.‖  Similarly, another participant stated that 
the health care provider, ―told her to keep checking her glucose at home once a week.‖  
Two participants who did not receive testing did not attend her scheduled postpartum 
appointment. 
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Results for Research Question 4 
Research Question 4: What type of cues of action encourages postpartum glucose 
screening and adoption of healthy lifestyle behaviors among women with a diagnosis of 
GD?  To obtain descriptive data for research questions 4, two open ended questions were 
used in a semi-structured interview to determine motivation or encouragement for 
postpartum glucose screening and adoption of healthy lifestyle behaviors:  ―What 
motivated you to get a glucose test postpartum?‖ and ―Can you tell me what encourages 
or motivates you to adopt healthy lifestyle behaviors (e.g. lose weight, eat healthy diet, 
exercise)?‖   
The participants reported that the motivation for postpartum glucose testing was 
due to health care provider recommendation and scheduling of test.  The nine participants 
that obtained glucose screening stated that the health care provider scheduled the test 
either on the scheduled postpartum appointment or a different appointment time.  One 
participant stated, ―the midwife initiated (the test), but I knew to do the test and planned 
to ask about doing the test.‖ 
Common motivators for adopting healthy lifestyle behaviors included living 
longer, being there for baby/family, and prevention of health issues (see Table 9).  
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Table 9 
Motivation for Adoption of Healthy Lifestyle Behaviors Postpartum (N=23) 
Motivator 
 
# of Women 
 
Being there for Baby/Family  7 
Live longer 6 
Prevention of Health Issues 5 
Health 3 
To have More Energy 2 
Be a Healthy example to children 2 
Lose weight 2 
Fit into clothes 2 
Better quality of life 1 
Feel good about myself 1 
Keep up with Kids 1 
Fear of being obese 1 
Health of future pregnancies 1 
Newborn complications after delivery 1 
 
The women described that living longer for their families was the most common 
motivator for adopting healthy lifestyle behaviors.  A participant stated that she wanted, 
―be around for her baby,‖ while another stated her priority was to, ―live a long life with 
family.‖  Some women (7) stated that the encouragement for adopting healthy lifestyle 
behaviors was the baby and/or family.  A woman wanted to be a good example to her 
children, while another participant wanted to be healthy to take care of her children and 
family.  Another common theme for the women‘s motivation to adopt healthy lifestyle 
behaviors was to prevent health issues.  Many women voiced concerns of family history 
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of health issues and indicated a desire to prevent disease which had occurred in her 
family.  One participant stated that her grandfather‘s diabetes motivated her to be healthy 
because her ―grandfather has diabetes and his leg was amputated.‖  Another participant 
had a father with diabetes that led to renal failure and death, while another participant 
stated that her mother has diabetes and, ―I know that I am ‗thin line‘ to get diabetes too.‖  
In addition, after delivery of the newborn, some women were focused on losing weight 
and wanting to, ―fit into clothes.‖  
Summary 
This chapter presented the results of the pilot educational intervention SUGAR.  
Twenty-three women completed all phases of the study, with two women withdrawing 
after collection of baseline demographic data due to preterm delivery and not feeling well 
with the pregnancy.  Four research questions were evaluated.  Self-efficacy was the only 
independent variable that was a significant predictor of healthy lifestyle behavior; 
however sleep disturbance was correlated to low self-efficacy.  Estimated effect size was 
calculated using the mean difference and standard deviations, with knowledge of diabetes 
having the largest effect of all study variables and small effects with unexpected 
directions for self-efficacy and healthy lifestyle behaviors.  Women identified barriers 
that prohibit them to engage in healthy lifestyle behaviors after childbirth including time, 
caring for baby/family, postpartum recovery, finances, and lack of sleep.  In addition, the 
women reported common motivators for adopting healthy lifestyle behaviors which 
included living longer, being there for baby/family, and prevention of health issues.  The 
postpartum glucose screening rate was low.  Women who did not receive postpartum 
glucose screening reported the most common barrier to postpartum glucose screening 
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was that the health care provider did not order the test.  Women who received the 
recommended postpartum glucose screening stated that the reason they obtained the 
screening was due to the health care provider‘s recommendation and scheduling of test.
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
The purpose of this pre-test, post-test, two group study was pilot testing an 
educational intervention ―SUGAR‖ (Start Understanding Gestational Diabetes and Risk 
of Developing Type 2 Diabetes) in women with GD to determine if the structured 
educational intervention would result in an increase perceived susceptibility of 
developing DM, knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors, and 
adoption of healthy lifestyle after childbirth among women with GD.  This chapter 
presents a discussion of study findings and subsequent conclusions.  The discussions will 
focus on study findings with respect to principal findings of research questions and 
additional findings.  Furthermore, this chapter will address the strengths and limitations 
of this study and implications for future study and clinical practices. 
Principal Findings 
Predictors of Adopting Healthy Lifestyle Behaviors for Pregnant Women  
In this study, self-efficacy was the only significant predictor (R
2
 = 0.65, R
2 
adj. = 
0.59, F (3, 19) =11.59, p< .001) for adopting healthy lifestyle behaviors for pregnant 
women with GD, which is consistent with previous studies in the general populations 
(Jackson et al., 2007; Nuepert et al., 2009; Podder et al., 2004).  There is limited research 
exploring the relationship of self-efficacy and healthy behaviors specifically in women 
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with GD; however, Koh and colleagues (2010) described that GD women with higher 
self-efficacy were more likely engaged in physical activity.  Moreover, Kim et al. (2008) 
identified that women who had low self-efficacy had low physical activity, unhealthy 
diets, and higher BMI.  The significant predictor finding in this pilot study concurs with 
earlier studies and demonstrates that when a woman has the confidence that she can 
perform a behavior, she is more likely to engage in the healthy lifestyle behavior.  
Although factors affecting self-efficacy were not examined, in the current study women 
who had more sleep disturbance also perceived a lower self-efficacy.  Since the review of 
current literature has not yielded studies that have explored the relationship between sleep 
disturbance and self-efficacy among pregnant women, future research would be 
beneficial to investigate if improved sleep could increase self-efficacy for the pregnant 
woman. 
Factors that the HBM model (Janz & Becker, 1984; Rosenstock, 1974; 
Rosenstock et al., 1988) purported as influences to adopt healthy lifestyle behaviors such 
as perceived risk and knowledge of DM were not associated with the adoption of healthy 
lifestyle behaviors in this study.  Despite the fact that the women in this study believed 
they had a slight-moderate risk of developing diabetes, perceived risk had a non-
significant and inverse relationship with adoption of healthy lifestyle behaviors.  This 
finding is inconsistent with other prior studies (Janz & Becker, 1984; Rosenstock, 
Strecher, & Becker, 1988), but is consistent with Morrison et al. (2010) study of GD 
women indicating no association between risk perception and lifestyle behaviors.  
Morrison and colleagues (2010) suggested that perceived risk may be an insufficient 
motivator for adoption of health behaviors for prevention of disease.  The finding of this 
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pilot study suggest that risk perception may not consistently change behaviors and that 
other factors such as self-efficacy, sleep disturbance, and family DM history may have 
more of an influence on adoption of  healthy lifestyle behaviors.  In addition, this study 
had a small sample size, therefore further examination of perceived risk and the 
relationship of adoption of healthy lifestyle behaviors in a larger sample size warrants 
further investigation. 
The HBM implies higher knowledge influences the adoption of healthy lifestyle 
behaviors.  In this study, diabetes knowledge was positively correlated with healthy 
lifestyle behaviors, though it was not statistically significant.  The finding is consistent 
with a previous study with GD women (Swan et al, 2007); however, the non-significant 
finding from the current study may be a result of the small sample size and suggests 
further research with a larger sample size to confirm the association between knowledge 
and healthy lifestyle behavior is needed.   
The Effectiveness of the SUGAR Intervention 
      The effect sizes of the intervention on perceived risk of developing DM, 
knowledge of DM, self-efficacy to adopt healthy lifestyle behaviors, and adoption of 
healthy lifestyle behaviors after childbirth, ranged from small to large (d= -.07 to 1.04); 
with knowledge of diabetes having the largest effect (d=1.04). 
The effect size for perceived risk was small.  At baseline, the total sample of 
women in this study indicated they perceived a slight to moderate risk of developing DM.  
At post-test, the SUGAR group women still reported a similar perception with only 25% 
of this group indicating a belief that they had a high risk of developing DM.  The 
SUGAR‘s group‘s belief, however did increase from 10% pre-test.  No one in the control 
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group perceived a high risk of developing DM and the majority (60%) of them perceived 
a slight risk of developing DM.  The findings are consistent with other studies which 
found that women with a history of GD did not perceive themselves at greater risk for 
developing DM (Kim, McEwen, Piette, et al., 2007; Malcolm et al., 2009; Morrison et 
al., 2010).  There was no difference between groups post-test, indicating that the 
intervention did not increase risk perception.  This unexpected finding may be a result of 
all participants‘ exposure to GD information from health care providers throughout the 
pregnancy.  Educational material used for the SUGAR group provided knowledge based 
information, but may have been inadequate to influence a participant‘s perceived risk.  
Therefore, identification of strategies to increase risk perception needs to be explored 
before replication of the current study. 
      At baseline, women‘s knowledge of diabetes was comparable between the 
SUGAR and control groups.  A majority of the women recognized that a diagnosis of GD 
and a family history of diabetes increased their risk of diabetes and that diet, exercise, 
and weight control prevented diabetes; conversely, the largest knowledge gap for the 
women was information that ethnicity and increase in age are risk factors for developing 
DM.  The effect size for the DM knowledge was large.  This finding suggests that the 
educational intervention given to the SUGAR group was beneficial in increasing the 
diabetes knowledge.  Furthermore, it is important to note that post-test data was obtained 
approximately three months after the initial educational session, with a small booster 
session occurring 2-4 weeks postpartum which served as a quick reference to the 
education and reminder of study participation.  This demonstrates that the participants 
were able to retain session information over an extended period of time.  Although 
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knowledge increased in the SUGAR group, there was not a significant relationship 
between knowledge and healthy lifestyle behaviors, thus indicating a translation gap 
between knowing information and the actual engagement in the health behavior; however 
the small sample size may explain the non-significant relationship in this sample.  
       Self-efficacy is an individual‘s belief that he/she is capable of performing specific 
tasks to obtain certain goals and is a strong predictor of health behaviors (Bandura, 1994; 
Bandura, 1998).  The participants in this study reported a high self- efficacy in both pre-
test and post-test indicating they were confident that they could perform health behaviors, 
which might have been related to education and support received from the diabetes 
educators and health care providers during prenatal care.  However; the effect size was 
small, suggesting that the educational material used in this study was not adequate to 
increase self-efficacy.  Other researchers reported that multiple individual sessions using 
strategies such as goal setting, persuasive messaging, and motivation schemes have been 
effective in increasing self-efficacy (Gaston, Cramp, & Prapavessis, 2012; Moore et al., 
2011; Prestin & Nabi, 2012;  Smith et al., 2010), therefore exploration of  alternative type 
of strategies to increase self- efficacy in women with GD is essential in future studies.  
An alternative explanation for the small effect size may be due to the study participants 
already having a high self -efficacy scores at pre-test, thus it was difficult to improve 
after the intervention.   
Studies in the general population have supported that a healthy diet, exercise, and 
modest weight loss lowers the risk of DM (Knowler et al., 2002; Li et al., 2008; 
Lindstrom et al., 2006; Moore et al., 2011; Tuomilehto et al., 2001).  The effect size for 
adopting health behaviors was moderate, however, it was an unexpected opposite 
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direction since the control group had a higher adoption of healthy lifestyle behavior than 
the SUGAR group.  This finding should be interpreted cautiously, however, due to the 
small sample size.  In addition, one must take into consideration the possibility of 
numerous influences during the postpartum period such as lack of time, recovery after 
childbirth, and caring for a newborn which may interfere with engagement in healthy 
lifestyle behaviors.  All of these potential factors need to be considered in future research.  
In addition, a more accurate assessment of behavior change such as weight loss, BMI, 
and diary of physical activity may be evaluated after the woman has adjusted to the new 
role of mother of a newborn.  There is limited literature of healthy lifestyle behaviors in 
women with GD, but an education intervention study (Fehler et al., 2007) of GD women 
which focused on nutrition and exercise, identified that the women made significant 
behavior changes in nutrition during pregnancy but did not sustain those changes 
postpartum.  
Barriers to Obtain Postpartum Glucose Screening and Adoption of Healthy 
Lifestyle Behaviors 
Early diagnosis of DM is essential for positive health outcomes; therefore, the 
ADA and ACOG have provided guidelines to perform glucose screening 6-12 weeks 
postpartum in women diagnosed with GD (ADA, 2003; ACOG, 2009).  In this study, the 
most common barrier to postpartum glucose screening was that the testing was not 
scheduled by the health care provider.  Only 39% of the women in this study received 
recommended glucose screening, which is slightly higher than other studies reported 
(Alamario et al., 2008; Case et al., 2006; Kim et al., 2006).  The findings of this study 
were consistent with another study of GD women which reported that a high percentage 
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of health care providers initiated the prenatal glucose screening, but they were 
significantly lower in initiation of the postpartum glucose screening (Case et al., 2006).  
Women in the SUGAR group were taught the recommendations for postpartum glucose 
screening, but there was no difference between the control group and the SUGAR group 
in the number who were screened.  This finding suggests that although information was 
provided to the participants on screening recommendations, the women relied on the 
health care provider‘ recommendations and did not request that screening be obtained.  In 
addition, there were no differences in screening rates between the type of health care 
provider (midwife or OB/GYN); which suggests further investigation related to all health 
care providers‘ knowledge of glucose screening guidelines and rationale for not 
following recommendations.  
Finally, one must consider the lack of adherence to follow-up appointments.  In 
this study, three participants did not attend the separate screening appointments made by 
the health care provider though no further rationale was given.  Similar results of lack of 
adherence to follow-up appointments have been identified as a factor for low postpartum 
glucose screening (Baker et al., 2009; Bentley-Lewis et al., 2008).  Again, this finding 
suggests further exploration into health care provider‘s procedures related to follow-up 
appointments and postpartum glucose screening.  
Women in this study identified certain barriers prevented their engagement in 
health behaviors during the postpartum period.  Consistent with prior studies (Doran, 
2008; Graco et al., 2009; Razee et al., 2010; Swan et al., 2007; Zehle et al., 2008), 
women in this pilot study reported the most common barriers were lack of time, caring 
for baby/family, recovery, finances, and lack of sleep.  Similarly, Razee et al. (2010) 
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reported that although the women tried to maintain a healthy lifestyle, lack of time, 
energy, and family responsibilities interfered with healthy lifestyle after childbirth.  In 
addition, engagement of physical activity was the lowest form of healthy behavior for 
women in this study at the pre-test and post-test period.  This finding is similar to those of 
another study (Doran, 2008) which  reported that women have a difficult time engaging 
in physical activity, especially after childbirth due to postpartum recovery and care of the 
newborn.  Understanding barriers that prevent behaviors can assist health care providers 
in offering support and resources which encourage healthy behaviors that meets the 
unique needs of the new mother caring for a newborn.  
Cues to Initiate Postpartum Glucose Screening and Adoption of Healthy Lifestyle 
Behaviors 
In the current study, those who received postpartum glucose screening reported 
that their health care provider arranged the testing either at the six week postpartum 
appointment or a separate appointment thus demonstrating the important role of the 
health care providers to ensure the postpartum blood sugar check- up.  Similarly,  
Kim et al. (2007) found that women who were counseled by the physician about 
postpartum screening were more likely to receive the test.  Furthermore, Almario et al. 
(2008) reported that low screening rates were related to failure of health care providers to 
order the screening. 
      The participants in this study stated living longer, being there for her baby/family, 
and prevention of health issues motivated them to adopt healthy lifestyle behaviors.  
These pilot study findings are consistent with the conclusions from previous studies 
(Hansen, Landstad, Hellzen, & Svebak, 2010; Razee et al., 2010).  One study found 
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common motivators for healthy lifestyle among women with a history of GD included 
prevention of type 2 diabetes, health, a beautiful body, and being a role model for their 
children (Razee et al., 2010).  Another study of participants diagnosed with impaired 
glucose reported that health concerns and support from family and friends were important 
motivators for healthy lifestyle behaviors (Hansen et al., 2010).  In this pilot study, a 
majority of the postpartum women (91%) stated they were planning to make lifestyle 
changes to lower the chance of developing diabetes, leading us to consider the 
relationship of intent and engagement of health behaviors in future studies. 
Additional Findings 
Personal Characteristics 
Previous DM prevention studies have focused on the general population (Knowler 
et al., 2002; Li et al., 2008; Tumilehto et al., 2001); however the focus of GD women in 
this study provides useful information for DM preventative care for this specific at-risk 
population.  Consistent with prior studies, this study found the women diagnosed with 
GD were obese (Lee et al., 2007; Lobner et al, 2006; Krishnaveni et al., 2007; Ratner et 
al., 2008) and had a family history of diabetes (Krishnaveni et al., 2007).  Research has 
identified that obesity and family history of diabetes are risk factors for the development 
of DM (Alberti et al., 2007; Case et al., 2006; Knowler et al., 2002); therefore, the 
women of this study had numerous factors that placed them at greater risk for developing 
DM.  In addition, in this current study, women with a family history of diabetes also had 
a higher BMI, warranting continued research to investigate whether family genetics or 
unhealthy behavior patterns lead to overweight/obesity and DM. 
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Ethnicity was also found to have an association with perceived risk of developing 
DM, with white women‘s perception of risk higher than non-white women (t[21]=2.23, 
p=.04).  It is important to note that in this study, women of minority populations who are 
at greater risk of developing DM also have a lower risk perception of developing DM.  
This finding suggests that DM preventative education may need to focus on minority 
groups.   
A final note related to the personal characteristics of this study involved the 
education level of the participants.  All of the study participants were involved in a 
clinical GD education session after diagnosis.  The more educated (some college or 
higher educated level) individual demonstrated higher knowledge of diabetes, indicating 
that comprehension of information may be associated with educational level.   
Benefits from Clinical DM Education Class 
An important component of prenatal care of the woman with GD is to control 
glucose levels through diet and exercise with the addition of medications as warranted.  
Once a diagnosis of GD was established, the women attended a one-time diabetes 
education class to learn about diet, exercise, and glucose monitoring.  In this study, the 
participants were asked to describe the GD information they received from the clinical 
health care provider.  The women described information that they received from the 
diabetes education class such as diet and glucose monitoring, thus demonstrating the 
importance of the individual sessions given by the diabetes educators.  The women 
retained knowledge from this educator specifically; therefore exploring the benefits of the 
diabetes educators for additional teaching prenatal and postpartum would support use of 
this specialized education to influence healthy behaviors in women with GD.  This does 
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not imply that the health care providers failed to give patients information, but does 
highlight that a specific DM education was beneficial to the participant.   
      Findings from this study identified that a majority of the women controlled 
glucose levels through diet and exercise with only 8% of the women requiring insulin 
during the pregnancy and 28% were prescribed Glyburide to control glucose levels.  
Research has identified that fetuses exposed to high levels of glucose in utero are at risk 
of macrosomia (Metzger et al., 2008; Reece, 2010; Voldner et al., 2010).  A majority 
(87%) of the newborns in this study weighed less than 4,000 grams which may suggest 
that the participants had good glucose control during the pregnancy, which might be part 
of the benefits from the clinical educational program. 
Sleep Deprivation  
The participants in this study experienced a clinical significant sleep disturbance 
during both pregnancy and postpartum periods indicated by a GSDS score of >3 which is 
comparable to the DSM-IV criteria for insomnia three or more times a week for sleep 
disturbance.  During pregnancy women self- reported an average of seven hours of 
nocturnal sleep, however they reported only five hours during the 6-8 weeks postpartum.  
The sleep deprivation during the postpartum period may have resulted from caring for 
their newborn as they reported an average of three awakenings by the newborn per sleep 
period.  In addition, an inverse relationship was noted between healthy lifestyle behaviors 
and sleep disturbances suggesting that women with sleep disturbance had lower healthy 
lifestyle behaviors.  Sleep deprivation may interfere with the woman‘s engagement in 
healthy lifestyle behaviors during the postpartum period and may need to be more 
accurately assessed after sleep patterns of the newborn are more established.  
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Furthermore, self-efficacy had a negative relationship with sleep disturbance, indicating 
that the women with more sleep disturbance had lower self-efficacy.   
Strong evidences show that poor sleep quality in postpartum women with term or 
pre-term infants is associated with fatigue and health outcomes (Goyal, Gay, & Lee, 
2009;  Hunter, Rychnovsky, & Yount, 2009; Insana, Stacom, Hawley, & Montgomery-
Downs, 2011;  Lee & Hsu, 2012; Lee & Kimble, 2009; Rychnovsky & Hunter, 2009; 
Tsai & Thomas, 2012).  Furthermore, research in the general population has reported that 
poor sleep impacts insulin resistance and increases risk of type 2 diabetes (Ayas et al., 
2003; Chaput et al., 2009; Gangwisch et al., 2007) and that sleep duration is a risk factor 
for GD (Qiu et al., 2010; Facco et al., 2010).  Future research is needed to evaluate how 
sleep disturbances impact glucose control in pregnant women and postpartum women 
with GD.  
Strengths of the Study 
Participants of previous studies related to women with GD were primarily 
Caucasian women.  Therefore, a strength of this pilot study was the diverse sample 
including African Americans, Asians, and Hispanics who represent ethnic groups who 
are at higher risk of developing DM.  The low attrition rate is also a strength of this study.  
This may be a result of : 1) the session timing in conjunction with obstetrical 
appointments to prevent extra travel for the study participants and 2) the phone call 
booster session at 2-4 weeks postpartum to remind the woman of the participation in the 
study and meeting at the postpartum appointment.                  
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Limitations of the Study and Recommendations for Future Research 
Since few studies have been conducted in women with GD, the pilot study 
findings add to the limited literature and gives insight into areas of future research needed 
for this population.  Although, useful information has been obtained from this study, 
there are some limitations that should be considered.  This pilot study had a small sample 
size making it difficult to ascertain significant changes between the groups.  A replicated 
study with a larger sample and equal number of participants in each group will give 
greater statistical power to prevent Type II error. 
This study was guided by the HBM; however, findings from this study only have 
limited support for the model.  Despite the use of targeted preventative care content in 
this intervention pilot study, the estimated effect size of healthy lifestyle behaviors was 
opposite of the predicted direction indicating that the control group had a higher adoption 
of healthy lifestyle behaviors than the SUGAR group.  Therefore, the intervention did not 
increase health behaviors in the SUGAR group.  Meeting the recommendations for 
healthy behavior may be more difficult to obtain for these participants during the 
postpartum period therefore, a longitudinal study extending  to six months or one year 
after delivery may be beneficial to ascertain effective postpartum follow- up strategies 
have on promoting healthy lifestyle behaviors.  This time frame would allow for an 
adjustment period to the new role of mother, the numerous family responsibilities, and 
the additional time to overcome barriers (such as time, recovery from delivery etc.) which 
prevent engaging in healthy lifestyle behaviors when caring for a newborn.   
Self-efficacy decreased during postpartum for the SUGAR group, which indicates 
the educational intervention was more knowledge focused and had no effect on self-
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efficacy.  The informational booklets (―What I Need to Know about Gestational 
Diabetes‖ [NIDDK, 2006] and ―Small Steps Big Rewards: Your Game Plan to Prevent 
Type 2 Diabetes‖ [National Diabetes Education Program, 2006]) used for the educational 
intervention provided information on diet, exercise, and prevention of DM and offered 
key points to change health behaviors by presenting suggestions of eating healthy, losing 
weight, and incorporating exercise into daily activity.  However, no specific information 
was provided that addressed self-efficacy to adopt healthy behaviors.  Given that self-
efficacy was a significant predictor of healthy lifestyle behaviors, future studies should 
explore strategies such as setting achievable goals and use of motivational interviewing to 
increase self-efficacy in women with GD.  These strategies to increase self- efficacy in 
women with GD should then be added to the developed intervention when this pilot study 
is replicated.  In addition, women with sleep deprivation had lower self-efficacy.  This 
pilot study revealed a significant clinical sleep disturbance in postpartum women 
therefore intervention research is needed to promote sleep in women caring for a 
newborn.   
Finally, postpartum glucose screening rates remained low in this sample, therefore 
research should focus on compliance of postpartum glucose screening by the patient and 
health care provider and determine efficient ways to ensure blood testing even when 
multiple health care providers are utilized. 
Implications for Clinical Practice 
The growing epidemic of DM in women underscores the need to educate and 
assist patients to adopt and sustain healthy lifestyle behaviors that prevent the disease 
(Feig et al., 2008; Knowler et al., 2002; Lee et al., 2007; Lee et al., 2008; Ratner et al., 
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2008).  The results of this pilot study have implications for health care providers and 
diabetes educators.  The participants stated that a healthy lifestyle was important and they 
understood the components of a healthy lifestyle (diet, exercise, and weight loss), 
however there is a gap between knowledge and actual implementation of the healthy 
lifestyle behaviors.  Counseling of nurses and other health care providers of important 
influences (such as self-efficacy) and the effects of sleep disturbance on the health 
behaviors is warranted.  Nurses at different stages of care including prenatal care, 
hospital postpartum care, and after childbirth can incorporate this type of information in 
various health education given to these women.  Collaboration between all caregivers in 
the OB/GYN offices and hospital settings would assist in consistent interventions and 
education provided to the patients.  In addition, providing  women with GD a preventive 
checklist guide that includes information on  diet, exercise, and screening guidelines may 
be useful to help patients self-advocate during postpartum follow-up appointments. 
The diabetes education class was an important tool for the women in obtaining 
information for glucose control through diet and exercise during the pregnancy.   
Exploration of extended diabetes education into the postpartum period could also be 
beneficial in sustaining healthy behaviors adopted during pregnancy.  The continued 
education and support could focus on reducing barriers, increasing self-efficacy, and 
promoting sleep that is tailored for the unique needs of women of childbearing age.  
Diabetes prevention requires major lifestyle changes that are not easily sustained, 
therefore interventions over an extended period of time would provide needed support to 
implement and attain the behaviors.   
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A few suggestions are warranted to assist the health care providers in assisting 
these women in their adoption of healthy behaviors.  For example, to improve adherence 
to ACOG and ADA recommendations on postpartum glucose screening, strategies to 
enhance education to health care providers is necessary.  In addition, the development 
and incorporation of screening reminders attached to electronic medical records to assist 
health care providers in scheduling the recommended glucose screening and send 
email/text reminders to women diagnosed with GD may increase postpartum screening 
rates. 
Conclusion 
Although the effect of the SUGAR intervention with a small sample was not 
expected to have statistically significant changes, this pilot study adds to the limited 
research of DM preventative care of women with GD and provides preliminary findings 
to develop meaningful education and support of women diagnosed with GD.  Findings 
from this small pilot study revealed that the educational intervention significantly 
increased DM knowledge for women in the SUGAR group; however, not for perceived 
risk, self-efficacy or healthy lifestyle behaviors.  Overall women had high self-efficacy 
during pregnancy and the postpartum period and self-efficacy was the single significant 
predictor of healthy lifestyle behaviors.  Estimated effect size ranged from small to large, 
with knowledge of diabetes having the largest effect of all study variables.  Moreover, 
women had a clinical significant sleep disturbance during pregnancy and postpartum.  
Low postpartum screening rates in this sample were due to no screening recommendation 
from the health care provider.  In addition, women identified barriers and motivators 
which influenced the adoption of healthy lifestyle behaviors and postpartum glucose 
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screening.  To increase healthy lifestyle behavior in women with GD, interventions are 
warranted that focus on self-efficacy, enhance sleep promotion, and decrease barriers 
which interfere with healthy lifestyle behaviors.  To ensure a better preventive care of 
GD women, education focusing on DM risk in GD women, increasing self-efficacy to 
adopt healthy behaviors, the influence of sleep disturbance on DM risk, self-efficacy and 
adoption of health behaviors, common barriers to healthy lifestyle behaviors and 
postpartum glucose screening recommendations should be provided to both patients and 
health care providers.
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  Atlanta, Georgia  30302-3999  30 Courtland St, Suite 217 
 Phone: 404/413-3500 
 Fax:  404/413-3504 
June 19, 2012 
Principal Investigator: Lee, Shih-Yu (Sylvia) 
Student Principal Investigator:  Amason, Janeen 
Protocol Department: B.F. Lewis School of Nursing 
Protocol Title: The Effect of an Educational Intervention in Women with Gestational 
Diabetes: A Pilot Study 
Funding Agency:  
Submission Type: Continuing Review #1 for H11536 
Review Type: Expedited Review, Category 7 
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Approval Date: June 28, 2012 
Expiration Date: June 27, 2013 
The Georgia State University Institutional Review Board (IRB) reviewed and approved 
the above referenced study in accordance with 45 CFR 46.111.  The IRB has reviewed 
and approved the research protocol and any informed consent forms, recruitment 
materials, and other research materials that are marked as approved in the application.  
The approval period is listed above. 
 
Federal regulations require researchers to follow specific procedures in a timely manner.  
For the protection of all concerned, the IRB calls your attention to the following 
obligations that you have as Principal Investigator of this study. 
 
1. For any changes to the study (except to protect the safety of participants), an 
Amendment Application must be submitted to the IRB.  The Amendment 
Application must be reviewed and approved before any changes can take 
place 
 
2. Any unanticipated/adverse events or problems occurring as a result of 
participation in this study must be reported immediately to the IRB using the 
Unanticipated/Adverse Event Form. 
 
3. Principal investigators are responsible for ensuring that informed consent is 
properly documented in accordance with 45 CFR 46.116.   
 
a. The Informed Consent Form (ICF) used must be the one reviewed and 
approved by the IRB with the approval dates stamped on each page. 
 
4. For any research that is conducted beyond the approval period, a Renewal 
Application must be submitted at least 30 days prior to the expiration date.  
The Renewal Application must be approved by the IRB before the expiration 
date else automatic termination of this study will occur.  If the study expires, 
all research activities associated with the study must cease and a new 
application must be approved before any work can continue. 
 
5. When the study is completed, a Study Closure Report must be submitted to 
the IRB.   
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All of the above referenced forms are available online at https://irbwise.gsu.edu.  Please 
do not hesitate to contact the Office of Research Integrity (404-413-3500) if you have any 
questions or concerns. 
 
Sincerely, 
 
 
Susan K. Laury, IRB Chair 
Federal Wide Assurance Number:  00000129 
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Appendix D 
Nursing Research Committee Approval 
 
 
From:  Nancy Ballard 
To: Janeen Amason, MSN, RN 
Date:  5-31-2011 
Subject:  NRC Approval for Study  
 
Dear Ms Amason 
Study Number: 11-09 
Study Title: The Effect of an Educational Intervention in Women with Gestational 
Diabetes: A Pilot Study 
Your research proposal has been approved by the WellStar Nursing Research Committee, 
and you may begin your study as described effective immediately. Any changes to the 
study must be reported promptly to the Nursing Research Committee for approval.  
A 6 month Progress Report (form is available on the Center for Nursing Excellence 
Website) is due in November of 2011 unless the study is closed before that date. At the 
completion of the study, please contact me to schedule a date to report the results of your 
study to the Nursing Research Committee. 
Please contact me if you have any questions or need additional information.  
Sincerely, 
Nancy Ballard 
Nancy Ballard, MSN, RN,  
Chair, Nursing Research Committee 
WellStar Health System 
Center For Nursing Excellence 
Atlanta, GA 30339 
Phone  770 956-6441 
FAX    770 937-4044 
Nancy.ballard@wellstar.org  
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Appendix E 
Georgia State University 
Byrdine F. Lewis School of Nursing 
Informed Consent and HIPPA Authorization 
 
Title:  The Effect of an Educational Intervention in Women with Gestational Diabetes 
 
Principal Investigator:   Shih-Yu (Sylvia) Lee RNC, PhD (PI) 
                                        Janeen Amason MSN, RN (Student PI) 
 
I. Purpose:   
 
The purpose of the study is to examine which educational material is most helpful for 
women with gestational diabetes. You are invited to this study because you have 
gestational diabetes. About 40 women will help with this study. You will have an equal 
chance to receive one of the educational materials: something about you or caring for 
your newborn. A ―flip of a coin‖ will be used to decide it. 
 
II. Procedures:  
If you sign the informed consent, the following will happen: 
1. Your medical records will be reviewed by the research team member. 
2. You will be interviewed today for some information about you (10 minutes) 
3. During your next routine office visit you will: 
a. Answer  5 questionnaires (30-45 minutes) 
b. Attend an educational session (30 minutes) 
4. A research team member will call you 2-4 weeks after you deliver your baby 
to: 
a. Collect information about the birth of your baby (5 minutes) 
b. Review the education information (5 minutes) 
5. During your routine postpartum checkup, you will answer 5 questionnaires 
(30-45 minutes) 
6. Once you have finished the study, you will receive a $10 gift card. 
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III. Risks:  
In this study, you will not have any more risks than you would in a normal day of 
life. However, you may feel distress when answering questions. If this happens, 
you may refuse to answer the question, or you can stop the participation 
completely. 
 
IV. Benefits:  
There will be no direct benefit as a result of your participation. The findings from this 
study will help to provided better care for women with gestational diabetes. 
 
V. Voluntary Participation and Withdrawal:  
 
Participation in research is voluntary. You do not have to be in this study.  If you 
decide to be in the study and change your mind, you have the right to drop out at any 
time.  You may skip questions or stop participating at any time.  Whatever you decide, 
you will not lose any benefits to which you are otherwise entitled.  
 
VI. Confidentiality and Protected Health Information (PHI):  
 
 PHI is a term used to protect your health information. Any health information 
given to us will be used for the purpose of this study. We will keep your records 
private to the extent allowed by law.  
 Only the PI and student PI will have access to the information you provide.  
 Information may be shared with those who make sure the study is done correctly; 
such as the Institutional Review Board at Georgia State University, the Office for 
Human Research Protection and the WellStar Nursing Research Committee.  
 We will use a code number rather than your name on collected data.  
 To ensure confidentiality, all information will be locked and secured with your 
name and code kept in a separate location from collected data. 
 The information you provide will be stored in a locked cabinet in the student PI‘s 
office. Only the student PI will have access to it. 
 Information stored on a computer will have limited access for research personnel 
only.  
 The findings will be summarized and reported in group form. You will not be 
identified personally. 
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VII.    Contact Persons:  
           For questions about this study:  
             Shih-Yu (Sylvia) Lee at 404-413-1176 or nusyl@langate.gsu.edu  
              Janeen Amason at 678-797-2162 or jamason1@student.gsu.edu  
           For questions about your rights as a participant:  
             Susan Vogtner in the Office of Research Integrity at 404-413-3513 or    
             svogtner1@gsu.edu. 
 
VIII. Copy of Consent Form to Subject:  
We will give you a copy of this consent form to keep. 
 
If you are willing to volunteer for this research, please sign below.  
  
____________________________________________                ______________ 
Participant                                                 Date  
 
_____________________________________________   _______________ 
Principal Investigator or Researcher Obtaining Consent             Date  
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Appendix F 
Demographic Form (Pre-Test) 
1. Age:_______ 
2. Ethnic group: 
________White (Caucasian) 
________Black/African American 
________Hispanic/Latino 
________Asian 
________Other, please specify____________ 
3. Marital Status: 
________Married 
________Divorced 
________Separated 
________Single 
4. How many family members live in your home?______________ 
 
5. Education: (please mark highest degree earned) 
________Some high school 
________High school graduate 
________Some College 
________College Graduate (Undergraduate) 
________Graduate Degree 
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6. Family Income: 
_______Under $15, 000 
_______$15,000-$24,999 
_______$25,000-$34,999 
_______$35,000-$49,999 
_______$50,000-$74,999 
_______$75,000-$99,999 
_______$100,000 and over 
7. Do you have a family member who has been diagnosed with Type 2 Diabetes? 
_________yes 
_________no 
If yes, who?___________________________ 
      8.  What type of information has your health care provider given you about  
               Gestational Diabetes status? ______________________ 
      9. What type of impact do you believe Gestational Diabetes has on your  
              health?_______________ 
       10.  Are you using insulin to manage your blood sugar? 
                     _______________yes 
                    ________________no 
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    11.  Are you using oral medications (pills) (e.g. Metformin) to manage your blood      
              sugar? 
                   ________________yes 
                   ________________no 
       12.   On average in the past week, how many total hours do you sleep each night? 
                 _______________ 
       13.   Before pregnancy, on average how many total hours did you sleep each  
                night?______________ 
      14.   How many hours of sleep do you need to feel refreshed? ________________ 
Additional Demographic Data  
 
1.     Gravida ________ 
 
2.     Para__________ 
 
 
3.     Due Date___________ 
 
4.      Height_______ 
5.      Pre-pregnancy weight    ______ 
6.    Weeks gestation diagnosis of GD _________ 
 
7.     Health care provider for this pregnancy: 
         _______________OB/GYN 
 
         _______________Midwife (CNM) 
       
         _______________Nurse Practitioner 
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Appendix G 
Postpartum Demographic Form 
1. Delivery 
a. How many weeks gestation at delivery?________________ 
 
b. Did you deliver vaginally or by c-section?______________ 
 
 
2. Weight gain during pregnancy 
 
a. How many pounds did you gain during the pregnancy?________________ 
 
b. What was your final weight at the end of your pregnancy?______________ 
 
3. Newborn Characteristics 
 
a. Baby 
 
____________boy 
 
____________girl 
 
b. What was the birth weight and length of your baby?_____________ 
 
c. Did your baby go to the NICU? 
 
____________yes 
 
____________no 
 
4. On average, how many total hours do you sleep each night? _________ 
 
5. How many times are you awaken during the night by your newborn? __________ 
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Appendix H 
RPS-DD Adapted for Women with Gestational Diabetes 
 
The next set of questions ask about what you think of your risk or chance for getting 
diabetes.  
1. What statement best reflects your 
opinion for each?  
Strongly 
Agree  Agree  Disagree 
Strongly 
Disagree 
A. I feel that I have little control over 
risks to my health.  
1 2 3 4 
B. If I am going to get diabetes, there is 
not much I can do about it.  
1 2 3 4 
C. I think that my personal efforts will 
help control my risks of getting 
diabetes.  
1 2 3 4 
D. People who make a good effort to 
control the risks of getting diabetes 
are much less likely to get diabetes.  
1 2 3 4 
E. Compared to other women of my 
same age, I am less likely than they 
are to get diabetes.  
1 2 3 4 
F. Compared to other women of my 
same age, I am less likely than they 
are to get a serious disease.  
1 2 3 4 
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2. We would like you to think about 
people in the general public and 
NOT about your own personal risk 
of getting diabetes. Which 
statement most closely reflects 
your view of how each item 
affects their risk for diabetes? 
Check the box for each statement 
that best describes your opinion.  
Increases 
or raises 
the risk  
Has 
NO 
effect 
on risk  
Decreases 
or lowers 
the risk  
Don’t 
know  
A. Being Asian American  1 2 3 4 
B. Being Caucasian (White)  1 2 3 4 
C. Eating a healthy diet  1 2 3 4 
D. Being Black or African-American  1 2 3 4 
E. Being Hispanic  1 2 3 4 
F. Having had diabetes during 
pregnancy  
1 2 3 4 
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3. We would like you to think about 
people in the general public and NOT 
about your own personal risk of getting 
diabetes. Which statement most closely 
reflects your view of how each item 
affects their risk for diabetes? Check the 
box for each statement that best 
describes your opinion. 
Increases 
or raises 
the risk 
Has 
NO 
effect 
on 
risk 
Decreases 
or lowers 
the risk 
Don’t 
know 
G. Having a blood relative with 
diabetes  1 2 3 4 
H. Being 65 years of age or older  1 2 3 4 
I. Exercising regularly  1 2 3 4 
J. Being American Indian  1 2 3 4 
K. Controlling weight gain  1 2 3 4 
 
4. For each item below, let us 
know the response that BEST 
DESCRIBES YOUR OPINION 
about possible ways to prevent 
diabetes. Strongly Agree 
Neither 
Agree or 
Disagree Disagree 
Strongly 
Disagree 
A. Doing regular exercise 
and following a diet take 
a lot of effort. 
1 2 3 4 6 
B. Regular exercise and diet 
may prevent diabetes 
from developing. 
1 2 3 4 6 
C. Benefits of following a 
diet and exercise program 
outweigh the effort to do 
it. 
1 2 3 4 6 
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5. What do you think your risk or chance is for getting diabetes over the next 10 years?  
1    Almost no chance  
2    Slight chance  
3    Moderate chance  
4    High chance  
 
 
6. If you don‘t change your lifestyle behaviors, such as diet or exercise, what is your risk 
or chance of getting diabetes over the next 10 years?  
1    Almost no chance  
2    Slight chance  
3    Moderate chance  
4    High chance  
 
7. Have you recently made changes in any lifestyle behaviors that you believe will 
lower your chances of getting diabetes?  
  0     No  
  1     Yes  
 
 
8. Are you planning to make changes in any lifestyle behaviors in the near future that 
you believe will lower your chances of getting diabetes?  
  0     No  
  1     Yes   
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Appendix I 
 
Barrier and Cues to Action Questions for Adoption of Healthy Lifestyle  
Behaviors and Postpartum Glucose Screening 
 
 
 
1. How do you describe a healthy lifestyle? 
 
2. Is a healthy lifestyle important to you? 
 
3. Can you give me the top three reasons that prevent you from having a 
healthy lifestyle (eating healthy diet, exercising, losing weight)?  
 
 
4. Can you tell me what encourages or motivates you adopt healthy lifestyle 
behaviors (e.g. lose weight, eat healthy diet, exercise?  
 
Postpartum questions only: 
5. Did you receive blood glucose screening at your postpartum appointment? 
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6. If you did not receive blood glucose screening at your postpartum 
appointment, what was the reason you did not have this blood work done? 
 
 
 
7. What motivated you to get a glucose test postpartum?‖ 
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Appendix J 
Self Rated Abilities for Health Practices Scale (SRAHP) 
(University of Texas at Austin School of Nursing, 2007) 
Adapted Version for Women with Gestational Diabetes 
Read each statement and use the following scale to indicate how confident you are to do 
each of the health practices, not how often you actually do it.  
0 = Not at all 
1 = A little 
2 = Somewhat 
3 = Mostly 
4 = Completely 
I am confident that I can: 
1. Find healthy foods that are within my budget 0 1 2 3 4  
2. Eat a balanced diet 0 1 2 3 4  
3. Figure out how much I should weight to be healthy 0 1 2 3 4  
4. Brush my teeth regularly 0 1 2 3 4  
5. Tell which foods are high in fiber content 0 1 2 3 4  
6. Figure out from labels what foods are good for me 0 1 2 3 4  
7. Drink as much water as I need to drink every day 0 1 2 3 4  
8. Figure out things I can do to help me relax 0 1 2 3 4  
9. Keep myself from feeling lonely 0 1 2 3 4  
10. Do things that make me feel good about myself 0 1 2 3 4  
11. Avoid being bored 0 1 2 3 4  
12. Talk to friend and family about the things that are bothering me 0 1 2 3 4  
13. Figure out how I respond to stress 0 1 2 3 4  
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14. Change things in my life to reduce my stress 0 1 2 3 4  
15. Do exercises that are good for me 0 1 2 3 4  
16. Fit exercise into my regular routine 0 1 2 3 4  
17. Find ways to exercise that I enjoy 0 1 2 3 4  
18. Find accessible places for me to exercise in the community 0 1 2 3 4  
19. Know when to quit exercising 0 1 2 3 4  
20. Do stretching exercises 0 1 2 3 4  
21. Keep from getting hurt when I exercise 0 1 2 3 4  
22. Figure out where to get information on how to take care of my health 0 1 2 3 4  
23. Watch for negative changes in my body‘s condition  0 1 2 3 4  
24. Recognize what symptoms should be reported to a doctor or nurse 0 1 2 3 4  
25. Use medication correctly. 0 1 2 3 4  
26. 
Find a doctor or nurse who gives me good advice about how to stay 
healthy 
0 1 2 3 4  
27. Know my rights and stand up for myself effectively 0 1 2 3 4  
28. Get help from others when I need it 0 1 2 3 4  
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Appendix K 
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Appendix L 
 
GENERAL SLEEP DISTURBANCE SCALE 
 
How often in the past week did you:                   NO       EVERY 
             DAYS        DAY 
 
  1. have difficulty getting to sleep ............................................... 0 1 2 3 4 5 6 7 
 
  2. wake up during your sleep period ........................................... 0 1 2 3 4 5 6 7 
 
  3. wake up too early at the end of a sleep period ........................ 0 1 2 3 4 5 6 7 
 
  4. feel rested upon awakening at the 
end of a sleep period ............................................................... 0 1 2 3 4 5 6 7 
 
  5. sleep poorly ............................................................................ 0 1 2 3 4 5 6 7 
 
  6. feel sleepy during the day ....................................................... 0 1 2 3 4 5 6 7 
 
  7. struggle to stay awake during the day ..................................... 0 1 2 3 4 5 6 7 
 
  8. feel irritable during the day..................................................... 0 1 2 3 4 5 6 7 
 
  9. feel tired or fatigued during the day........................................ 0 1 2 3 4 5 6 7 
 
10. feel satisfied with the quality of your sleep ...........  ............... 0 1 2 3 4 5 6 7 
 
11. feel alert and energetic during the day .................................... 0 1 2 3 4 5 6 7 
 
12. get too much sleep .................................................................. 0 1 2 3 4 5 6 7 
 
13. get too little sleep .................................................................... 0 1 2 3 4 5 6 7 
 
14. take a nap at a scheduled time ................................................ 0 1 2 3 4 5 6 7 
 
15. fall asleep at an unscheduled time .......................................... 0 1 2 3 4 5 6 7 
 
16. drink an alcoholic beverage to help  
you get to sleep ....................................................................... 0 1 2 3 4 5 6 7 
 
17. use tobacco to help you get to sleep ....................................... 0 1 2 3 4 5 6 7 
 
18. use herbal product to help you get to sleep ............................. 0 1 2 3 4 5 6 7 
 
19. use an over-the-counter sleeping pill 
to help you get to sleep ........................................................... 0 1 2 3 4 5 6 7 
 
20. use a prescription sleeping pill to help 
you get to sleep ....................................................................... 0 1 2 3 4 5 6 7 
 
21. use aspirin or other pain medication to help  
you get to sleep ....................................................................... 0 1 2 3 4 5 6 7 
 
K. Lee (GSDS, Sleep, 1992) 
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Appendix M 
What I Need to Know About Gestational Diabetes 
(NIDDK, 2006) 
 
What is gestational diabetes? 
 
Gestational diabetes is diabetes that is found for the first time when a woman is 
pregnant. 
Gestational (jes-TAY-shun-ul) diabetes is diabetes that is found for the first time 
when a woman is pregnant. Out of every 100 pregnant women in the United 
States, three to eight get gestational diabetes. Diabetes means that your blood 
glucose (also called blood sugar) is too high. Your body uses glucose for energy. 
But too much glucose in your blood can be harmful. When you are pregnant, too 
much glucose is not good for your baby. 
This booklet is for women with gestational diabetes. If you have type 1 or type 2 
diabetes and are considering pregnancy, call the National Diabetes Information 
Clearinghouse at 1–800–860–8747 for more information and consult your health 
care team before you get pregnant. 
What causes gestational diabetes? 
Changing hormones and weight gain are part of a healthy pregnancy. But both 
changes make it hard for your body to keep up with its need for a hormone 
called insulin. When that happens, your body doesn't get the energy it needs 
from the food you eat. 
What is my risk of gestational diabetes? 
To learn your risk for gestational diabetes, check each item that applies to you. 
Talk with your doctor about your risk at your first prenatal visit. 
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o I have a parent, brother, or sister with diabetes. 
o I am African American, American Indian, Asian American, 
Hispanic/Latino, or Pacific Islander. 
o I am 25 years old or older. 
o I am overweight. 
o I have had gestational diabetes before, or I have given birth to at least 
one baby weighing more than 9 pounds. 
o I have been told that I have "pre-diabetes," a condition in which blood 
glucose levels are higher than normal, but not yet high enough for a 
diagnosis of diabetes. Other names for it are "impaired glucose 
tolerance" and "impaired fasting glucose." 
If you checked any of these risk factors, ask your health care team about testing 
for gestational diabetes. 
 You are at high risk if you are very overweight, have had gestational 
diabetes before, have a strong family history of diabetes, or have glucose 
in your urine. 
 You are at average risk if you checked one or more of the risk factors. 
 You are at low risk if you did not check any of the risk factors. 
When will I be checked for gestational diabetes? 
Your doctor will decide when you need to be checked for diabetes depending on 
your risk factors. 
 If you are at high risk, your blood glucose level may be checked at your 
first prenatal visit. If your test results are normal, you will be checked 
again sometime between weeks 24 and 28 of your pregnancy. 
 If you have an average risk for gestational diabetes, you will be tested 
sometime between weeks 24 and 28 of pregnancy. 
 If you are at low risk, your doctor may decide that you do not need to be 
checked. 
How is gestational diabetes diagnosed? 
Your health care team will check your blood glucose level. Depending on your 
risk and your test results, you may have one or more of the following tests. 
Fasting blood glucose or random blood glucose test 
Your doctor may check your blood glucose level using a test called a fasting 
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blood glucose test. Before this test, your doctor will ask you to fast, which 
means having nothing to eat or drink except water for at least 8 hours. Or your 
doctor may check your blood glucose at any time during the day. This is called a 
random blood glucose test. 
These tests can find gestational diabetes in some women, but other tests are 
needed to be sure diabetes is not missed. 
 
Your health care provider will check your blood glucose level to see if you have 
gestational diabetes. 
Screening glucose challenge test 
For this test, you will drink a sugary beverage and have your blood glucose level 
checked an hour later. This test can be done at any time of the day. If the results 
are above normal, you may need further tests. 
Oral glucose tolerance test 
If you have this test, your health care provider will give you special instructions 
to follow. For at least 3 days before the test, you should eat normally. Then you 
will fast for at least 8 hours before the test. 
The health care team will check your blood glucose level before the test. Then 
you will drink a sugary beverage. The staff will check your blood glucose levels 
1 hour, 2 hours, and 3 hours later. If your levels are above normal at least twice 
during the test, you have gestational diabetes. 
Above-normal results for the oral glucose tolerance test* 
Fasting 95 or higher 
At 1 hour 180 or higher 
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At 2 hours 155 or higher 
At 3 hours 140 or higher 
Note: Some labs use other numbers for this test. 
*These numbers are for a test using a drink with 100 grams of glucose.  
How will gestational diabetes affect my baby? 
Untreated or uncontrolled gestational diabetes can mean problems for your 
baby, such as 
 being born very large and with extra fat; this can make delivery difficult 
and more dangerous for your baby 
 low blood glucose right after birth  
 breathing problems 
If you have gestational diabetes, your health care team may recommend some 
extra tests to check on your baby, such as 
 an ultrasound exam, to see how your baby is growing 
 "kick counts" to check your baby's activity (the time between the baby's 
movements) or special "stress" tests 
Working closely with your health care team will help you give birth to a healthy 
baby. 
Both you and your baby are at increased risk for type 2 diabetes for the rest of 
your lives.  
How will gestational diabetes affect me? 
Often, women with gestational diabetes have no symptoms. However, 
gestational diabetes may 
 increase your risk of high blood pressure during pregnancy 
 increase your risk of a large baby and the need for cesarean section at 
delivery 
The good news is your gestational diabetes will probably go away after your 
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baby is born. However, you will be more likely to get type 2 diabetes later in 
your life. (See the information on how to lower your chances of getting type 2 
diabetes.) You may also get gestational diabetes again if you get pregnant again. 
Some women wonder whether breastfeeding is OK after they have had 
gestational diabetes. Breastfeeding is recommended for most babies, including 
those whose mothers had gestational diabetes. 
Gestational diabetes is serious, even if you have no symptoms. Taking care of 
yourself helps keep your baby healthy. 
How is gestational diabetes treated? 
Treating gestational diabetes means taking steps to keep your blood glucose 
levels in a target range. You will learn how to control your blood glucose using 
 
Using a meal plan will help keep your blood glucose in your target range. 
 a meal plan 
 physical activity 
 insulin (if needed) 
Meal Plan 
You will talk with a dietitian or a diabetes educator who will design a meal plan 
to help you choose foods that are healthy for you and your baby. Using a meal 
plan will help keep your blood glucose in your target range. The plan will 
provide guidelines on which foods to eat, how much to eat, and when to eat. 
Choices, amounts, and timing are all important in keeping your blood glucose 
levels in your target range. 
You may be advised to 
167 
 
 
 
 limit sweets 
 eat three small meals and one to three snacks every day 
 be careful about when and how much carbohydrate-rich food you eat; 
your meal plan will tell you when to eat carbohydrates and how much to 
eat at each meal and snack 
 include fiber in your meals in the form of fruits, vegetables, and whole-
grain crackers, cereals, and bread 
For more about meal planning, call the National Diabetes Information 
Clearinghouse for a copy of What I need to know about Eating and Diabetes. 
 
Physical activity can help you reach your blood glucose targets. 
Physical Activity 
Physical activity, such as walking and swimming, can help you reach your blood 
glucose targets. Talk with your health care team about the type of activity that is 
best for you. If you are already active, tell your health care team what you do. 
Insulin 
Some women with gestational diabetes need insulin, in addition to a meal plan 
and physical activity, to reach their blood glucose targets. If necessary, your 
health care team will show you how to give yourself insulin. Insulin is not 
harmful for your baby. It cannot move from your bloodstream to the baby's. 
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How will I know whether my blood glucose levels are on target? 
Your health care team may ask you to use a small device called a blood glucose 
meter to check your levels on your own. You will learn 
 
Each time you check your blood glucose, write down the results. 
 how to use the meter 
 how to prick your finger to obtain a drop of blood 
 what your target range is 
 when to check your blood glucose 
You may be asked to check your blood glucose 
 when you wake up 
 just before meals 
 1 or 2 hours after breakfast 
 1 or 2 hours after lunch 
 1 or 2 hours after dinner 
The following chart shows blood glucose targets for most women with 
gestational diabetes. Talk with your health care team about whether these targets 
are right for you. 
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Blood glucose targets for most women with gestational 
diabetes 
On awakening not above 95 
1 hour after a meal not above 140 
2 hours after a meal not above 120 
Each time you check your blood glucose, write down the results in a record 
book. Take the book with you when you visit your health care team. If your 
results are often out of range, your health care team will suggest ways you can 
reach your targets. 
Will I need to do other tests on my own? 
Your health care team may teach you how to test for ketones (KEE-tones) in 
your morning urine or in your blood. High levels of ketones are a sign that your 
body is using your body fat for energy instead of the food you eat. Using fat for 
energy is not recommended during pregnancy. Ketones may be harmful for your 
baby. 
If your ketone levels are high, your health care providers may suggest that you 
change the type or amount of food you eat. Or you may need to change your 
meal times or snack times. 
After I have my baby, how can I find out whether my diabetes is gone? 
You will probably have a blood glucose test 6 to 12 weeks after your baby is 
born to see whether you still have diabetes. For most women, gestational 
diabetes goes away after pregnancy. You are, however, at risk of having 
gestational diabetes during future pregnancies or getting type 2 diabetes later. 
How can I prevent or delay getting type 2 diabetes later in life? 
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After you have your baby, you can do a lot to prevent or delay type 2 diabetes.  
You can do a lot to prevent or delay type 2 diabetes. 
 Reach and maintain a reasonable weight. Even if you stay above your 
ideal weight, losing 5 to 7 percent of your body weight is enough to 
make a big difference. For example, if you weigh 200 pounds, losing 10 
to 14 pounds can greatly reduce your chance of getting diabetes. 
 Be physically active for 30 minutes most days. Walk, swim, exercise, or 
go dancing. 
 Follow a healthy eating plan. Eat more grains, fruits, and vegetables. Cut 
down on fat and calories. A dietitian can help you design a meal plan. 
Remind your health care team to check your blood glucose levels regularly. 
Women who have had gestational diabetes should continue to be tested for 
diabetes or pre-diabetes every 1 to 2 years. Diagnosing diabetes or pre-diabetes 
early can help prevent complications such as heart disease later. 
Your child‘s risk for type 2 diabetes may be lower if you breastfeed your baby 
and if your child maintains a healthy weight. 
Where can I get more information? 
Diabetes Teachers (nurses, dietitians, and other health professionals) 
To find a diabetes teacher near you, call the American Association of Diabetes 
Educators toll-free at 1–800–TEAMUP4 (1–800–832–6874). Or go to 
www.diabeteseducator.org and click on "Find a Diabetes Educator." 
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Dietitians 
To find a dietitian near you, call the American Dietetic Association's National 
Center for Nutrition and Dietetics at 1–800–877–1600. Or go to 
www.eatright.org and click on "Find a Nutrition Professional." 
Health Information 
To learn more about pregnancy, contact the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development (NICHD), part of the 
National Institutes of Health. Call NICHD toll-free at 1–800–370–2943. Or go 
to www.nichd.nih.gov. 
For more information about diabetes, contact the National Diabetes Information 
Clearinghouse (NDIC) for free copies of these publications or read them online: 
Managing Diabetes 
What I need to know about Diabetes Medicines 
What I need to know about Eating and Diabetes 
What I need to know about Physical Activity and Diabetes 
Your Guide to Diabetes: Type 1 and Type 2 
Preventing Type 2 Diabetes 
Am I at Risk for Type 2 Diabetes? 
Small Steps. Big Rewards. Your GAME PLAN for Preventing Type 2 Diabetes 
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Appendix N 
 
Small Steps. Big Rewards. Your GAME PLAN to Prevent Type 2 Diabetes:  
Information for Patients 
Download This Publication (NDEP-60) 
 
This three-booklet package helps people assess their risk for developing diabetes and 
implement a program to prevent or delay the onset of the disease and it includes an 
activity tracker and a fat and calorie counter. 
Publication date: 07/01/2006  
Introduction 
 
You don’t have to knock yourself out to prevent diabetes. The key is: small steps that 
lead to big rewards. 
Diabetes prevention is proven, possible, and powerful. Studies show that people at 
high risk for diabetes can prevent or delay the onset of the disease by losing 5 to 7 
percent of their weight, if they are overweight—that's 10 to 14 pounds for a 200-pound 
person. Two keys to success: 
 Get at least 30 minutes of moderate-intensity physical activity five days a week. 
 Eat a variety of foods that are low in fat and reduce the number of calories you eat 
per day.* 
In other words, you don't have to knock yourself out to prevent diabetes. 
Have you wondered or possibly been told that you are at risk for developing diabetes or 
that you have pre-diabetes? To find out more about what things put you at risk, go to and 
read the ―Are You At-Risk Check List‖ section. If you haven't already done so, be sure to 
talk with your health care team about your risk and whether you should be tested. 
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*See Small Steps for Eating Healthy Foods starting on page 18 for examples of foods that 
are lower in fat and calories. 
Small steps lead to big rewards. 
 
When you take steps to prevent diabetes, you will also lower your risk for possible 
complications. That’s a big reward for you and your family and friends. 
When you take steps to prevent diabetes, you will also lower your risk for possible 
complications of diabetes such as heart disease, stroke, kidney disease, blindness, nerve 
damage, and other health problems. That‘s a big reward for you and your family and 
friends. 
This Small Steps. Big Rewards. GAME PLAN kit is based on the Diabetes Prevention 
Program (DPP). This research study proved that type 2 diabetes could be prevented or 
delayed in persons with increased risk by losing a small amount of weight and getting 30 
minutes of moderate-intensity physical activity, such as brisk walking, five days a week. 
We used the findings from the study to prepare this kit and to make it as easy as possible 
for you to take steps now to prevent diabetes. 
Congratulations on taking your first small step! 
Here‘s what‘s in your GAME PLAN kit: 
Type 2 diabetes can be prevented ... by losing a small amount of weight and getting 30 
minutes of activity, such as brisk walking, five days a week. 
 
Those who kept a daily log of food intake were more likely to lose the recommended 
amount of weight than those who did not. 
GAME PLAN Booklet—This booklet will help you take steps to prevent diabetes. Learn 
how to start your own GAME PLAN by setting goals, and tracking your progress. Learn 
more about pre-diabetes and your risk for getting diabetes. 
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Get healthy eating and physical activity tips to keep you focused and reach your goals. 
Learn more from the list of groups and websites that can help you lose weight and be 
more physically active. 
GAME PLAN Food and Activity Tracker—This booklet will help you keep track of the 
foods you eat and how much physical activity you get. The DPP study showed that those 
who kept a daily log of their food intake and physical activity were more likely to lose 
the recommended amount of weight than those who did not. You can make more copies 
as you need them. Feel free to photocopy the Food and Activity Tracker pages at the back 
of this booklet. 
GAME PLAN Fat and Calorie Counter—Use this booklet to look up the calories and fat 
grams in the foods you eat and drink and record the amounts in your Food and Activity 
Tracker. 
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Overview of the small steps Big Rewards. GAME PLAN 
 
One Small Step: Know your risk.  
Work with your health care team to find out if you have pre-diabetes, a condition that 
puts you at risk for type 2 diabetes. Learn more about your risk for diabetes. 
Big Reward: Knowing you can prevent or delay diabetes can give you peace of mind. 
Ask yourself these questions and write down your answers. 
 Why do you want to prevent diabetes? 
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 Who do you want to do it for? 
Review your answers every week to help you stay with your GAME PLAN. 
One Small Step: Start your GAME PLAN. 
Use this booklet to create your own GAME PLAN to prevent diabetes. Work with your 
health care team, family, and friends. All of you can form a winning team to prevent 
diabetes. Here's how to get started.  
Plan to set a weight loss goal:  
The key to preventing diabetes is to lose weight by eating healthy foods that are lower in 
fat and calories and being physically active. Set a goal that you can achieve. A good goal 
is to lose at least 5 to 10 percent (10 to 20 pounds if you weigh 200 pounds) of your 
current weight. A 5 to 7 percent weight loss was shown to have a big impact on lowering 
the risk of diabetes in the DPP study. 
Here's how to figure out your weight loss goal. Multiply your weight by the percent you 
want to lose. For example, if John weighs 240 pounds and wants to lose 7 percent of his 
weight, he would multiply 240 by .07. 
240 pounds 
x .07 (7 percent) 
16.8 pounds 
240 pounds 
- 17 pounds 
223 pounds 
 
Find out if you are at risk for diabetes. Talk to your health care provider.  
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Losing 5 to 7 percent of your weight is one big step to reduce your risk of diabetes. 
John's goal is to lose about 17 pounds and bring his weight down to 223 pounds. 
Choose your weight loss goal 
Now, start thinking about how much better you will feel when you reach your goal. Keep 
in mind that losing even a small amount of weight can help you prevent diabetes. Weigh 
yourself at least once a week and write down your progress. Research shows that people 
who keep track of their weight reach their goals more often than those who don't. 
 
Make Healthy food choice to help reach your weight loss goal. 
Eat healthy foods:  
Make healthy food choices to help reach your weight loss goal. There are many weight 
loss plans from which to choose. But the DPP showed that you can prevent or delay the 
onset of diabetes by losing weight through a low-fat, reduced calorie eating plan, and by 
increasing physical activity. Use the tips to eat healthy to help you reach your goals.  
Figure out how many calories and fat grams you should have per day. Use this chart to 
figure out your goals for losing one to two pounds per week. 
Recommended Calories and Fat Grams Daily 
**It is not advised to eat less than 1,200 calories a day 
Current Weight  Calories and Fat Grams per day  
120 –170 pounds 1,200 calories a day 
33 grams fat a day 
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Current Weight  Calories and Fat Grams per day  
175 – 215 pounds 1,500 calories a day 
42 grams fat a day 
120 – 245 pounds 1,800 calories a day 
50 grams fat a day 
250 – 300 pounds 2000 calories a day 
55 grams fat a day 
Source: DPP Lifestyle Manual of Operations 
 
Try dancing, swimming, biking, walking, or any activity that keeps you moving for 30 
minutes most days.  
It is important to find out early if you have diabetes or if you are at risk for developing 
it. 
Use the Fat and Calorie Counter to help you keep track of the number of fat grams and 
calories you take in each day. 
Move more: 
When you move more every day, you will burn more calories. This will help you reach 
your weight loss goal. Try to get at least 30 minutes of moderate-intensity physical 
activity five days a week. If you have not been active, start off slowly, building up to 
your goal. Try brisk walking, dancing, swimming, biking, jogging, or any physical 
activity that helps get your heart rate up. You don't have to get all your physical activity 
at one time. Try getting some physical activity throughout the day in 10 minute sessions. 
Use the tips on getting more physically active to get moving toward your goals. 
Big Reward: Losing weight by eating healthy and getting more physical activity not only 
can help you prevent diabetes, but it also lowers your risk for heart disease, certain types 
of cancer, arthritis, and many other health problems. Also, you will feel better, and have 
more energy to do the things you enjoy. 
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Take your next small step now! Add one or two healthy changes every week. 
One Small Step: Track your GAME PLAN progress. 
Write down your goals in the GAME PLAN Food and Activity Tracker. Make copies of 
the tracker and keep them with you. Write down everything you eat and drink. Then, 
when you have time, use the GAME PLAN Fat and Calorie Counter booklet to add up 
your calories and fat grams for the day. 
Big Reward: Keeping track of what you eat and drink and how many minutes of 
physical activity you get each day is one of the best ways to stay focused and reach your 
goals. As you lose weight, you will feel better about yourself and about reaching your 
goal. 
One Small Step: Start your own team to prevent diabetes. 
You don't have to prevent diabetes alone. Invite other people to get involved. Try 
teaming up with a friend or family member. Start a local walking group with your 
neighbors or at work or at your church. Trade healthy recipes and weight loss tips with 
your co-workers. Tell other people about the small steps you are taking to prevent 
diabetes and make sure you help each other stick to your GAME PLANs. 
Big Reward: When you involve other people in your GAME PLAN, you will be more 
likely to stay at it and you will be helping others to prevent diabetes and other health 
problems. 
Take your next small step now! 
Add one or two healthy changes every week. If you fall off the wagon, don't get down on 
yourself. Review your GAME PLAN and get back on track. It's not easy to make lifelong 
changes in what you eat and in your level of physical activity, but you can use the tips 
and ideas in this booklet to help you stick to your goals and succeed. And remember: 
Preventing diabetes is good for you and for your family and friends. Keep at it! 
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Am I at risk for type 2 diabetes and pre-diabetes? 
 
What is diabetes? 
At least 54 million Americans have pre-diabetes and are more likely to go on to develop 
diabetes within 10 years. 
Almost 21 million Americans have diabetes, a serious disease in which blood glucose 
(blood sugar) levels are above normal. Most people with diabetes have type 2, which 
used to be called adult-onset diabetes. At one time, type 2 diabetes was more common in 
people over age 45. But now more young people, even children, have the disease because 
many are overweight or obese. 
Diabetes can lead to problems such as heart disease, stroke, vision loss, kidney disease, 
and nerve damage. About one-third of people with type 2 diabetes do not even know they 
have it. Many people do not find out they have diabetes until they are faced with 
problems such as blurry vision or heart trouble. That's why you need to know if you are 
at risk for diabetes. 
 
What is pre-diabetes? 
At least 54 million Americans over age 20 have pre-diabetes. Before people develop type 
2 diabetes, they usually have "pre-diabetes"—that means their blood glucose levels are 
higher than normal, but not yet high enough to be called diabetes. People with pre-
diabetes are more likely to develop diabetes within 10 years and they are more likely to 
have a heart attack or stroke. 
Are You At-Risk Check List 
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Find out if you are at risk for diabetes and pre-diabetes. 
 
Almost 21 million Americans have diabetes—one-third don't even know it. You 
need to know if you are at risk for diabetes. 
 
There are many factors that increase your risk for diabetes. 
There are many factors that increase your risk for diabetes. To find out about your risk, 
check each item that applies to you. 
 I am 45 years of age or older. 
 The At-Risk Weight Chart shows my current weight puts me at risk. 
 I have a parent, brother, or sister with diabetes. 
 My family background is African American, Hispanic/Latino, American Indian, 
Asian American, or Pacific Islander. 
 I have had diabetes while I was pregnant (this is called gestational diabetes) or I 
gave birth to a baby weighing 9 pounds or more. 
 I have been told that my glucose levels are higher than normal. 
 My blood pressure is 140/90 or higher, or I have been told that I have high blood 
pressure. 
 My cholesterol (lipid) levels are not normal. My HDL cholesterol (―good‖ 
cholesterol) is less than 35 or my triglyceride level is higher than 250. 
 I am fairly inactive. I am physically active less than three times a week. 
 I have been told that I have polycystic ovary syndrome (PCOS). 
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 The skin around my neck or in my armpits appears dirty no matter how much I 
scrub it. The skin appears dark, thick and velvety. This is called acanthosis 
nigricans. 
 I have been told that I have blood vessel problems affecting my heart, brain, or 
legs. 
 
 
AT-RISK WEIGHT CHARTS 
Find your height in the correct chart. If your weight is equal to or greater than the weight 
listed, you are at increased risk for type 2 diabetes. 
IF YOU ARE 
ASIAN AMERICAN 
  
AT RISK BMI ≥ 23  
HEIGHT WEIGHT 
4'10" 110 
4'11" 114 
5'0" 118 
5'1" 122 
5'2" 126 
5'3" 130 
5'4" 134 
5'5" 138 
5'6" 142 
5'7" 146 
5'8" 151 
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IF YOU ARE 
ASIAN AMERICAN 
  
AT RISK BMI ≥ 23  
HEIGHT WEIGHT 
5'9" 155 
5'10" 160 
5'11" 165 
6'0" 169 
6'1" 174 
6'2" 179 
6'3" 184 
6'4" 189 
IF YOU ARE 
PACIFIC ISLANDER 
  
AT RISK BMI ≥ 26  
HEIGHT WEIGHT 
4'10" 124 
4'11" 128 
5'0" 133 
5'1" 137 
5'2" 142 
5'3" 146 
5'4" 151 
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IF YOU ARE 
PACIFIC ISLANDER 
  
AT RISK BMI ≥ 26  
HEIGHT WEIGHT 
5'5" 156 
5'6" 161 
5'7" 166 
5'8" 171 
5'9" 176 
5'10" 181 
5'11" 186 
6'0" 191 
6'1" 197 
6'2" 202 
6'3" 208 
6'4" 213 
IF YOU ARE NOT 
ASIAN AMERICAN OR 
PACIFIC ISLANDER 
AT RISK BMI ≥ 25  
HEIGHT WEIGHT 
4'10" 119 
4'11" 124 
5'0" 128 
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IF YOU ARE NOT 
ASIAN AMERICAN OR 
PACIFIC ISLANDER 
AT RISK BMI ≥ 25  
HEIGHT WEIGHT 
5'1" 132 
5'2" 136 
5'3" 141 
5'4" 145 
5'5" 150 
5'6" 155 
5'7" 159 
5'8" 164 
5'9" 169 
5'10" 174 
5'11" 179 
6'0" 184 
6'1" 189 
6'2" 194 
6'3" 200 
6'4" 205 
Source: Adapted from Clinical Guidelines on the Identification, Evaluation, and 
Treatment of Overweight and Obesity in Adults: The Evidence Report 
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What is the next step? 
Be sure to talk to your health care team about your risk for diabetes and whether you 
should be tested. 
If you have checked any of the items on pages 13 or 14, be sure to talk to your health care 
team about your risk for diabetes and whether you should be tested. 
 If you are age 45 or older, testing for pre-diabetes and diabetes should be 
considered, especially if you have an at-risk weight according to the charts on page 
15. 
 If you are age 45 or older without any risk factors, ask about your risk for pre-
diabetes or diabetes and if you should get tested. 
 If you are 20 to 44 years old, have an at-risk weight, and have checked any other 
items on pages 13 or 14, ask about your risk for pre-diabetes or diabetes and if you 
should get tested. 
 Repeat testing should be done every 3 years 
Know Your Blood Glucose Numbers 
  Fasting Blood 
Glucose Test 
2-Hour Oral Glucose 
Tolerance Test 
Normal Below 100  Below 140  
Pre-diabetes 100-125 140-199 
Diabetes 126 or above  200 or above  
 
It is important to find out early if you have pre-diabetes or type 2 diabetes, because 
early treatment can prevent the serious problems caused by high blood glucose. 
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Ask your health care team about these tests and ask for your blood glucose numbers. It is 
important to find out early if you have pre-diabetes or type 2 diabetes, because early 
treatment can prevent the serious problems caused by high blood glucose. 
 
Medicare Benefits for People At Risk for Diabetes 
For people with Medicare who are at risk for diabetes, Medicare covers a screening blood 
glucose test to check for diabetes. If you are obese or have a history of high blood 
glucose, high blood pressure, high cholesterol, or other risk factors, you may qualify for 
this test. Based on the test results, you may be able to get up to two screening tests per 
year. Medicare covers the full cost of this screening test. For more information, visit the 
Medicare page for people with diabetes. 
Type 2 diabetes is a serious disease but it can be prevented or delayed. Take steps 
now to lower your risk for diabetes. 
 
 
Small steps for eating healthy foods  
 
When it comes to eating healthy to lose weight, the three most important steps are: 
1. Take in fewer calories than you burn during the day. 
2. Eat less fat (especially saturated fats and trans fats—see page 20) than you 
currently eat. 
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3. Eat smaller portions of high fat and high calorie foods than you currently eat.  
 
 
Portion sizes are often smaller than we think. Use this chart as a guide for portion sizes: 
  Portion Size Same size as 
 
1/2 cup of cooked rice or pasta  
An ice cream scoop 
 
1 1/2 ounces of low fat cheese  Four dice  
 
3 ounces of lean meat or fish  
A deck of cards or  
a cassette tape 
 
2 tablespoons low-fat peanut butter  A ping pong ball  
Use the Fat and Calorie Counter to look up the number of grams of fat and the number of 
calories in the foods you eat. 
The key to losing weight and preventing diabetes is to make lifelong changes—not 
quick fixes—that work for you. 
Remember: The key to losing weight and preventing diabetes is to make lifelong 
changes—not quick fixes—that work for you. While some diets may be popular now, 
there is no proof about their long-term success or if they can prevent diabetes. But the 
DPP showed that you can prevent or delay the onset of diabetes by losing weight through 
a low-fat, reduced calorie eating plan, and by increasing physical activity. 
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Saturated fat is found mostly in foods that come from animals like fatty cuts of beef, 
lamb, pork, poultry with skin, whole and 2% milk, butter, cheese, and lard. It can also be 
found in palm and coconut oil. 
Trans fat is found in some of the same foods as saturated fat, such as vegetable 
shortening and hard or stick margarine. It can also be found in processed foods that are 
made with partially hydrogenated vegetable oils, for example, cookies, baked goods, 
fried foods and salad dressings. 
Eat a Variety of Healthy Foods From Each Food Group 
 
Focus on fruits. Eat a variety of fruits—whether fresh, frozen, canned, or dried—rather 
than fruit juice for most of your fruit choices. For a 2,000-calorie diet, you will need 2 
cups of fruit each day (for example, 1 small banana, 1 large orange, and 1/4 cup of dried 
apricots or peaches). 
  
 
Vary your veggies. Eat more dark green veggies, such as broccoli, kale, and other dark 
leafy greens; orange veggies, such as carrots, sweet potatoes, pumpkin, and winter 
squash; and beans and peas, such as pinto beans, kidney beans, black beans, garbanzo 
beans, split peas, and lentils. 
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Get your calcium-rich foods. Get 3 cups of low fat or fat-free milk—or an equivalent 
amount of low-fat yogurt and/or low-fat cheese (11/2 ounces of cheese equals 1 cup of 
milk)—every day. For kids aged 2 to 8, it's 2 cups of milk. If you don't or can't consume 
milk, choose lactose-free milk products and/or calcium-fortified foods and beverages. 
  
Make half your grains whole. Eat at least 3 ounces of whole-grain cereals, breads, 
crackers, rice, or pasta every day. One ounce is about 1 slice of bread, 1 cup of breakfast 
cereal, or 1/2 cup of cooked rice or pasta. Look to see that grains such as wheat, rice, 
oats, or corn are referred to as "whole" in the list of ingredients. 
  
 
Go lean with protein. Choose lean meats and poultry. Bake it, broil it, or grill it. And 
vary your protein choices— with more fish, beans, peas, nuts, and seeds. 
  
Know the limits on fats, salt, and sugars. Read the Nutrition Facts label on foods. Look 
for foods low in saturated fats and trans fats. Choose and prepare foods and beverages 
with little salt (sodium) and/or added sugars (caloric sweeteners). 
2005 USDA DIETARY GUIDELINES FOR AMERICANS 
 
Drink lots of water. 
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Take these small steps to eat healthy: 
A healthy eating plan is one that: 
 Highlights eating fruits, vegetables, whole grains, and fat-free or low-fat milk, and 
milk products. 
 Includes lean meats, poultry, fish, beans, eggs, and nuts. 
 Is low in saturated fats, trans fats, cholesterol, salt (sodium), and added sugars.  
Keep these healthy eating tips in mind: 
 Try not to exceed the amount of calories and fat grams that you need on a daily 
basis. 
 Try to eat meals and snacks at regular times every day. 
 Make less food look like more by serving your meals on a smaller plate. 
 Take your time when you eat. It takes about 20 minutes for your stomach to tell 
your brain that you are full. 
 Try to limit your alcoholic beverage intake. If you drink alcohol, chose light beer 
and avoid mixed drinks. 
 
Chew sugar-free gum between meals to help cut down on snacking.  
At home: 
 Choose foods that are not fried. Instead of fried chicken, try it grilled or baked. 
Instead of greasy french fries or potato chips, slice potatoes, mix them with a little 
bit of oil, herbs, and pepper, and bake them in the oven. 
 Lighten your recipes by using reduced-fat (light) or fat-free versions of items such 
as sour cream, cream cheese, mayonnaise, cheese and salad dressing. 
 Use herbs and seasonings to add flavor to low-fat dishes. Instead of salt, give foods 
a little kick by adding hot sauce or red pepper flakes. 
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 Wrap up and refrigerate leftover foods right after cooking so you're less tempted to 
go back for seconds. 
 Make time to cook healthy main dishes, casseroles, or soups. Freeze portions so 
you have healthy meals ready for days when you are too busy or too tired to cook. 
 For dessert, eat a piece of fruit. Also, try fat-free or low-fat frozen yogurt or sherbet 
instead of ice cream. Instead of cakes or brownies, have one scoop of vanilla fat-
free frozen yogurt with a tablespoon of fat-free chocolate sauce on top. 
In-between meals: 
 Replace snacks high in fat with crunchy fruits, vegetables, or a tablespoon or two 
of unsalted nuts. 
 Drink lots of water. Choose water or sugar-free soda instead of a regular 20-ounce 
soda or juice drink. By doing this, you can cut about 250 calories. 
 Chew sugar-free gum between meals to help cut down on snacking. Reach for a 
piece of gum or a hard candy instead of a snack high in fat or calories. 
 
Read and compare food labels when shopping. 
When shopping: 
 Make a list of what you need ahead of time and try to stick to it. 
 Avoid going shopping when you are hungry. Often, you will end up with things 
you really don't want or need. 
 Read and compare food labels when shopping. Choose foods with fewer calories 
and that are lower in saturated fats, trans fats, cholesterol and sodium. Check the 
serving size and the number of servings in the package on the label. 
 Buy a variety of fruits, vegetables, and whole grain foods. Try a new fruit or 
vegetable each week, such as kiwi fruit or butternut squash. 
 Choose reduced-fat or light versions of mayonnaise, cheese, and salad dressing. 
Use fat-free or 1 percent low-fat milk instead of whole milk. 
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 You know best what high-calorie foods tempt you the most, such as cookies, cake, 
ice cream and snacks. Make it easy on yourself: Don‘t have them in your home, 
your office, or anywhere else. 
 
Bring your lunch to work so you can take charge of what you eat.  
At work or on the run: 
 Bring your lunch to work so you can take charge of what you eat. Make a sandwich 
with whole grain bread and turkey or lean beef. Use mustard or a little bit of "light" 
mayonnaise. Pack carrots and celery sticks instead of chips. Choose low-fat/fat-free 
milk, water, or other drinks without added sugar. 
 Pack a healthy snack in case you get hungry. Try an apple, a banana, a cup of fat-
free yogurt, or reduced-fat or light string cheese sticks. 
 Try to pack your lunch the night before so it‘s ready to go when you are. 
 Take a different route to work to avoid passing by tempting high-calorie foods at 
nearby restaurants, bakeries, or stores. 
 
Take time to look over the menu and make a healthy choice. 
When eating out: 
 Take time to look over the menu and make a healthy choice. 
 Don't be afraid to ask for items not on the menu or to have a meal prepared with 
less or no added fat. 
 Ask about portion sizes and the fat and calorie content of menu items. 
 Choose steamed, grilled, or broiled dishes instead of those that are fried or sautéed. 
 Be the first to order so you are not influenced by what others are ordering. 
194 
 
 
 
 Always order the smallest size meal instead of the larger, super-sized versions at 
fast-food restaurants. 
 You can eat half of what you order and take the rest home for a second meal. 
 Order salad dressing, gravy, sauces, or spreads "on the side." 
 Order a salad for starters and share a main dish with a friend. 
 When you crave high-calorie foods, desserts, or snacks, don't be too hard on 
yourself. It's okay to have a small portion once in a while or to share a dessert with 
a friend. Just keep your weight loss goal in mind. 
 Stay away from "all-you-can-eat restaurants or buffets" where it's hard to control 
portion sizes and how much you eat. 
 
Once you get going, you'll find lots of other ways to make small changes.  
These healthy eating tips are examples of the small steps you can take to jumpstart your 
GAME PLAN. Try a few new steps each week. Once you get going, you'll find lots of 
other ways to make small changes. 
For more ideas and help, check your local library or bookstore for healthy cookbooks and 
weight loss books. These web sites have lots of ideas as well. 
United States Department of Agriculture (USDA) 
Dietary Guidelines for Americans 
Food and Drug Administration's (FDA) Nutrition Facts Label 
My Pyramid: Steps to a Healthier You 
National Heart, Lung, and Blood Institute 
Weight-Control Information Network 
American Diabetes Association 
American Dietetic Association 
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You don't have to play a sport or go to a gym to be more active, unless that's what you 
like to do. 
Small steps for getting more physical activity  
The Diabetes Prevention Program (DPP) showed that you could prevent or delay the 
onset of diabetes by losing weight through small changes in eating and physical activity. 
To help lose weight, most of the people in the study who made lifestyle changes chose 
walking briskly for 30 minutes, 5 days a week. 
There are lots of things you can do at home and at work to get more physical activity 
throughout the day. You don't have to play a sport or go to a gym to be more active, 
unless that's what you like to do. You can walk or try swimming, water aerobics, biking, 
dancing, or any activity that keeps you moving toward the goal of 30 minutes of 
moderate-intensity physical activity five days a week. Before you start a physical activity 
program, be sure to talk with your health care provider. 
Use these tips to get started, keep you moving, and make your physical activity time 
more fun. 
Dress to move. 
 
Dress to move. Wear supportive shoes with thick, flexible soles that will cushion your 
feet and absorb shock. 
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Wear supportive shoes with thick, flexible soles that will cushion your feet and absorb 
shock. Your clothes should allow you to move, and keep you dry and comfortable. Look 
for synthetic fabrics that absorb sweat and remove it from your skin. 
Start off slowly. 
Start off by taking a 5-minute walk (or doing another physical activity that you like) on 
most days of the week. Slowly, add more time until you reach at least 30 minutes of 
moderate-intensity physical activity five days a week. 
Build physical activity into your day. 
Start or end your day by taking your dog—or a friend's dog—for a brisk walk. When 
shopping, park a little further away from the store's entrance. If it's safe, get off the bus a 
stop or two before your work place and walk the rest of the way. While watching TV, 
walk or dance around the room, march in place, or do some sit-ups and leg lifts. Double 
bonus: cut out a TV show and get moving instead! 
 
Start off by taking a 5-minnute walk (or doing another physical activity that you like) 
on most days of the week.  
Move more at work. 
Try to get a "movement break" during the day. Take a walk during lunchtime. Deliver a 
message in person to a coworker instead of sending an email. Walk around your office 
while talking on the telephone. Take the stairs instead of the elevator to your office. 
Count your steps. 
You may be surprised to learn how much walking you already do every day. Try using a 
pedometer to keep track of every step in your Game Plan Food and Activity Tracker. A 
pedometer is a gadget that counts the number of steps you take. The number of steps in 
one mile depends on the length of your stride, but one mile equals roughly 2,000 steps. 
Each week, try to increase the number of steps you take by 1,000 (about 250 steps per 
day), aiming for a goal of 10,000 steps per day. If you decide to count steps as a part of 
your GAME PLAN, use this information to help you meet your 30 minutes of physical 
activity per day. Also, be sure to read the instructions for your pedometer. 
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When you involve others in your activities, you are more likely to stick to your 
program.  
Stretch it out. 
Avoid stiff or sore muscles or joints by stretching after doing physical activity. Try not to 
bounce when you stretch. Perform slow movements and stretch only as far as you feel 
comfortable. 
Make it social. 
Try to schedule walking "dates" with friends or family members throughout the week. 
For family fun, play soccer, basketball, or tag with your children. Take a class at a local 
gym or recreation center. Organize a walking group with your neighbors or at work. 
When you involve others in your activities, you are more likely to stick to your program. 
 
Getting more physical activity doesn't have to be boring. 
Have fun. 
Getting more physical activity doesn't have to be boring. Turn up the music and boogey 
while cleaning the house. Go dancing with friends and family members. Play sports with 
your kids. Try swimming, biking, hiking, jogging, or any activity that you enjoy and gets 
you moving. Vary your physical activities so you won't get bored. 
Keep at it. 
Pay attention to small successes. The longer you keep at it, the better you'll feel. Making 
changes is never easy, but getting more physical activity is one small step toward a big 
reward—a healthier life. 
Making changes is never easy, but getting more physical activity is one small step toward 
a big reward—a healthier life. 
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Additional Resources 
American Association of Diabetes Educators 
1-800-TEAM-UP4 or www.diabeteseducator.org 
American Diabetes Association 
1-800-DIABETES or www.diabetes.org 
American Dietetic Association 
1-800-877-1600 or www.eatright.org 
Centers for Disease Control and Prevention 
1-877-232-3422 or www.cdc.gov/diabetes 
United States Department of Agriculture (USDA) 
www.nutrition.gov 
Healthier US Initiative 
www.healthfinder.gov 
National Institute of Diabetes and Digestive and Kidney Diseases 
National Diabetes Information Clearinghouse 
1-800-860-8747 or www.niddk.nih.gov 
Weight-Control Information Network 
win.niddk.nih.gov/ 
National Heart, Lung, and Blood Institute 
301-592-8573 or www.nhlbi.nih.gov 
For on-line fat and calorie counters, visit these web sites: 
National Heart, Lung, and Blood Institute 
hp2010.nhlbihin.net/menuplanner/menu.cgi 
United States Department of Agriculture 
Nutrient Data Laboratory 
www.nal.usda.gov/fnic/foodcomp/search/ 
Revised October 2006 
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Appendix O 
Brochure Attention Control Group (copyright material) 
 
 
 
 
 
 
 
 
